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3 Operational definitions 
1. Aggregated data: consolidated data relating to multiple patients, and therefore 
unable to be traced back to a specific patient.1 
2. Antenatal care coverage: proportion of women with a live birth in a given time 
period that received antenatal care four or more times.2 
3. Clinical algorithm: a set of detailed, step-by-step instructions, which tell the user 
not only which task to perform but, in addition, the sequence in which they are to 
be performed.3 
4. Clinical guideline: statements that include recommendations, intended to 
optimize patient care, and are informed by a systematic review of evidence and an 
assessment of the benefits and harms of alternative care options.4 
5. Digital health intervention: a discrete functionality of the digital technology to 
achieve health sector objectives.5 
6. Effective coverage: proportion of the population who need a service that receive 
it with sufficient quality for that service to be effective.6 The term effective 
coverage is used in this dissertation to indicate quality-corrected coverage.7,8  
7. eRegistries: electronic health information systems using communication 
technologies for the systematic longitudinal collection, storage, retrieval, analysis, 
and dissemination of uniform information on health determinants and outcomes of 
individual persons, to serve healthcare services, health surveillance, health 
education, knowledge and research.9 
8. Health management information systems: a data collection system specifically 
designed to support planning, management, and decision making in health 
facilities and organizations.10 
9. Health system performance indicators: indicators to measure one or more 
aspects of health system performance including, but not limited to, population 
health, health outcomes from treatment, clinical quality and the appropriateness of 
care, responsiveness, equity and productivity.11 
10. MCH eRegistry: name of the electronic health registry currently being 
implemented for maternal and child health services in Palestine.12 
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11. Patient registry: an organized system that uses observational study methods to 
collect uniform data (clinical and other) to evaluate the specified outcomes for a 
population defined by a particular disease, condition, or exposure, and that serves 
one or more predetermined scientific, clinical, or policy purposes.13 The term 
‘registry’ is used to refer to both the act of recording or registering and to the 
record itself.14 
12. Quality of care: the extent to which health care services provided to individuals 
and patient populations improve desired health outcomes. In order to achieve this, 
health care must be safe, effective, timely, efficient, equitable, and people-
centered.15 
13. Quality of care for women and newborns: the degree to which maternal and 
newborn health services (for individuals and populations) increase the likelihood 
of timely, appropriate care for the purpose of achieving desired outcomes that are 
both consistent with current professional knowledge and take into account the 
preferences and aspirations of individual women and their families.15  
14. Routine health information system: a system that provides information at 
regular intervals of a year or less through mechanisms designed to meet 
predictable information needs. This includes paper-based or electronic health 
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15. SDG: Sustainable Development Goal  
16. SFH: Symphysis fundus height 
17. SPA: Service Provision Assessments  
18. UNICEF: United Nations International Children's Emergency Fund  
19. UNRWA: United Nations Relief and Works Agency for Palestine Refugees in the 
Near East 










Background: A routine health information system (RHIS) serves as an important 
source of data for monitoring health of clients and health system performance. All 
countries use RHIS data for some form of priority setting; the extent of use varies 
across settings depending on the nature and availability of data. In the West Bank, 
Palestine, the paper-based routine health information system consisting of manually 
aggregated data is currently undergoing a transformation to an electronic health 
registry (eRegistry) consisting of individual-level data collected at the point-of-care 
for antenatal care services in primary healthcare.  
Aim: The overall aim of the present study was to examine the consequences of the 
transformation from the existing RHIS based on manual aggregation, to an RHIS 
based on clinical records data for calculations of routine indicators and health system 
performance indicators. Various aspects of anticipated data-related changes were 
examined in the three papers constituting this PhD dissertation. In paper I, we 
calculated the routinely reported indicators from individual-level clinical data from 
antenatal paper records, and compared the values to the existing aggregate RHIS 
reports. In paper II, we calculated the coverage of at least one screening, coverage of 
appropriate number of screenings, and effective coverage of timely and appropriate 
screening of antenatal care interventions in public primary healthcare clinics, and 
explored selected infrastructure-related and maternal sociodemographic factors 
potentially associated with effective coverage. In paper III, we assessed the 
implications of using different available data sources in the health data ecosystem for 
modeling the scale up of antenatal care interventions in the Lives Saved Tool. 
Materials and methods: Four data sources were used. First, manually aggregated 
RHIS reports submitted by care providers for primary healthcare clinics were 
retrieved (2015). Second, a cross-sectional study was conducted, where data were 
extracted from paper-based clinical records of women attending antenatal care (2015) 
from a random sample of public primary healthcare clinics. Third, secondary data 
were exported from the eRegistry electronic clinical records (2017). Fourth, data 
were obtained from the Palestinian multiple indicator cluster survey (2014). Using the 
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paper-based clinical records data, routinely reported indicators were calculated and 
compared to the aggregate RHIS reports (paper I). Data from paper-based clinical 
records were also used to generate coverage of clinical antenatal care interventions 
(paper II). All four sources of data were used to calculate distinct sets of values of 
input indicators in the Lives Saved Tool, and the mortality and morbidity averted 
through the scale-up of antenatal care interventions was modeled (paper III).  
Results: Paper I: The values of the routinely reported indicators were significantly 
different when computed with clinical records data, compared to aggregate RHIS 
reports. The magnitude of the difference varied across indicators. There was 
divergence in the coverage of anemia screening between the clinical records data and 
aggregate RHIS reports.  
Paper II: Effective coverage of antenatal care interventions was considerably lower 
than the coverage of at least one screening and coverage of the appropriate number of 
screenings for antenatal care interventions. Timely attendance at antenatal care in the 
clinics was low. Effective coverage of antenatal care interventions was higher in 
clinics with laboratory and ultrasound. 
Paper III: All indicators required for input in the Lives Saved Tool could be 
calculated directly from the clinical records. The various sources of data yielded 
notably different results for the number of deaths averted. With clinical records data, 
the number of maternal deaths, stillbirths, and anemia cases that could be averted 
with the scale-up of health interventions were higher compared to the RHIS aggregate 
reports and the multiple indicator cluster survey. Each of the data sources also yielded 
varying compositions of antenatal care interventions averting deaths. 
Conclusions: The transition from an RHIS based on manual aggregations to an RHIS 
based on individual-level clinical records data will lead to significant changes in the 
values of routinely-reported indicators, and the understanding of health system 
performance of antenatal care. Health systems managers should be aware of the 
underlying mechanisms of data-related changes.  
Paper I: Reliable and complete routine indicators can be generated when clinical 
records data are directly used for automated computations. In such a system, 
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transcription errors involved in diagnosis and referral, and manual counting and 
application of indicator definitions are minimized, and the existing complex reporting 
structure can be circumvented.  
Paper II: The metric used to quantify antenatal care service provision has 
consequences for the understanding of health system performance. Effective coverage 
of antenatal care interventions in public clinics can be increased by improving the 
provision of care according to recommended guidelines, including timely ANC 
attendance.  
Paper III: The demonstrated variability in the Lives Saved Tool model output from 
using the various data sources highlights the importance of understanding the 
characteristics of data available in a health information system by program managers 
















6 Summary in Arabic 
  :المقدمة
 صحة ومتابعة النظام أداء لمراقبة الالزمة للمعلومات مهم مصدر الصحية الروتيني المعلومات نظام يعتبر
لصحية ا المعلومات نظام تحويل الغربية الضفة في وتحديدا فلسطين في حاليايتم . مستمر بشكل مستخدميه
 جميعت على يعتمد إلكتروني نظام إلىتجميع المعلومات يدويا  يتم فيهوالذي  الحمل رعاية عيادات في الورقية
 .الحمل برعاية المتعلقة الصحية الرعاية تلقي لحظة وذلك,  فردي مستوى علىالمعلومات مباشرة 
  :الدراسة هدف
 تمديع إلكتروني سجل نظام إلى الورقية المعلومات نظام من التحويل تبعات هوفحص الدراسة لهذه العام الهدف
وتلك  ينيةالروت المؤشرات لحساببشكل مباشر  تستخدم التي حوامل)ال( فرادلأل السريرية المعلومات تجميع على
 سابح -الأو:التغيرات المرتبطة بالمعلومات من عدة نواح هذه فحص تم. الصحيةنظام المعلومات  أداءب المتعلقة
  نم مناسب عدد أو قلاأل ىلع واحدة للحوامل سواء زيارة تقصيزيارات الحساب  -ثانيا, الروتينية مؤشراتال
 الئمم طبيقوت المناسب موعدال حضور الحامل في  ىلع بناء التقصي لزيارات الفعالة التغطية أو,زياراتال
 من  لمتاحةا للبيانات مختلفة  مصادر استخدام  أثار تتضمن: ثالثا , الحمل برعاية المتعلقة الصحية تدخالتلل
 الحياة انقاذ برنامج في الوالدة قبل ما الحامل للسيدة للرعاية اجل من التداخالت وتحسين تصميم تعكيس  اجل
.(Lives Saved Tool)  
  :البحث طريقةدوات و أ
 المعلومات ستخراجإل دراسة مقطعية إجراء تم :الأو :الدراسة هذه في للمعلومات مصادر ربعأ إستخدام تم 
 عن 2015 الحكومية لعام والطفل االم صحة رعاية عيادة في للحوامل المسجالت الورقية الملفات في الموجودة
 .2015 عامل الصحية الرعاية مقدمي قبل من يدويا المعدةالتقاريرالتجميعية : اثاني. عشوائية عينةإختيار طريق
 :ارابع .2017 لعام لكترونياإلصحة االم والطفل  سجل من خاصة بالحوامل ثانوية معلومات إستخراج تم: اثالث
 .2014 نفلسطي دولة في المؤشرات متعددال مسحال
 قاريرالت مع ومقارنتها الحوامل بملفات الخاصة السريرية المعلومات إستخدامبالروتينية  مؤشراتال حساب تم
 بالتدخالت الخاصة للتغطية مؤشرات نشاءإلأيضا  المعلومات هذه إستخدام تم وقد. يدويا المعدة التجميعية
 للمؤشرات محددة قيم لحساب للمعلومات المصادراالربعة هذه إستخدام تم .الحمل برعاية المتعلقة الصحية
 تطويرنموذج خالل من مكن تجنبها ي من المولحساب الوفيات والمراضة الت الحياة إنقاذ أداةفي   المدخلة






 للحامل ريةالسري المعلومات من حسابها عند إحصائيا تختلف يدويا المعدة التجميعية التقارير في المؤشرات قيمة-
 لوماتالمع بين الدم فقرتقصي  تغطية معدل في انحراف هناك كان.التجميعية االحصائية التقارير مع مقارنة
 .االم صحةب المتعلقة الظروف كل في منخفضا كان الخطر ألسباب التحويل معدل, التجميعي والتقرير السريرية
 معدلب مقارنة ملحوظ بشكل قليلة الحمل برعاية المتعلقة الصحية بالتدخالت الخاصة الفعالة التغطية قيمة-
 الحامل حضوركما أن  , التقصي زيارات من مناسب عددل أوالتغطية االقل ىلع واحدة تقصي زيارةل تغطيةال
 الخاصة التقصي لزيارات الفعالة التغطية معدل .منخفضا كان التقصي لزيارات المحدد الموعد في للعيادة
 الموجات فوق وفحص مختبر فيها يتوافر التي العيادات في أعلى كان الحامل لرعاية الصحية بالتدخالت
 .للزيارات الفعالة التغطية مع ةحصائيإ عالقة يأ الديموغرافية ائصصالخ تظهر لم ينما. الصوتية
 اتالسياد وعدد المتوفاه، األجنة عدد و للحوامل، الوفيات كعدد العيادات، من المجمعة السجالت البيانات حسب-
 وديالعنق المسح مؤشرات و الروتينية الصحية المعلومات دم، أعلى من أعدادهن في نظام فقر من يعانين الالتي
)multiple indicator cluster survey. ( الموجودة الصحية التدخالت مع منه والحد تجنبه يمكن ذلك كل  
 في  اختالف أظهر للبيانات مصدر وكل .)Lives Saved Tool( الحياة انقاذ برنامج بإستخدام اقتداء وذلك
 .الوفيات لتجنب الصحية للرعاية التداخالت
  :االستنتاج
 سيؤدي ملللحوا السريرية المعلومات عن الصادرة التقارير إلى يدويا المعدة التجميعية التقارير من التحول نقطة
 .الحمل برعاية المتعلقة الصحي النظام أداء فهم وفي المؤشرات قيمة في إحصائيا مختلفة تغييرات إلى
, ريريةالس المعلومات من تلقائي وبشكل مباشرة حسابها عند افضل بشكل ومكتملة معتمدة مؤشرات إنشاء يمكن
 منها يعيةالتجم التقارير عمل اثناء حدوثها مكنالم من التي الكتابية االخطاء تقليل طريق عن اسياس بشكل وذلك
 .ذاته بحد المؤشر تعريف عند أو للمؤشرات اليدوي الحساب ثناءأ أيضا و والتحويل التشخيص
 ايةبرع المتعلق الصحي النظام أداء فهم في الصحية الرعاية خدمات المستخدم لقياس مقياسلل تبعات هناك
 عياداتال في الحمل برعاية المتعلقة الصحية بالتدخالت الخاصة الفعالة التغطية تحسين يمكن حيث. الحمل
 اتاستراتيجيو البرامج مخططوا .حكوميا المعتمد البروتوكول حسب المقدمة الرعاية تطوير خالل من الحكومية
 رارالق صنع عملية في الصحية المعلومات نظم في الموجودة المعلومات ميزات يفهموا نأ بد ال الصحي للنظام
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9.1 Health information systems  
A health system consists of several components and actors that provide a set of 
functions towards the delivery of health services to the population in order to improve 
people’s health.17 Several frameworks that characterize health systems have been put 
forth. According to the World Health Organization’s (WHO) framework, a health 
system consists of six key components, also referred to as “building blocks”, 
including 1) service delivery; 2) health workforce; 3) health information systems; 4) 
access to essential medicine; 5) financing; 6) leadership and governance.17 A well-
functioning health system composed of these building blocks intends to improve 
health, responsiveness and efficiency of services, while providing financial risk 
protection.17 Some scholars have taken a critical view of the WHO “building blocks 
framework”, citing its failure to account for the complexity and dynamicity of a 
health system.18,19 Roberts et al (2008) proposed an alternative framework that 
accounts for the complex nature of health systems.19 They defined “control knobs” of 
a health system consisting of financing, payment, organization, regulation and 
behavior.  
While different frameworks for understanding a health system have divergent 
conceptual underpinnings, they all highlight the importance of routine data for health 
systems planning. Health information systems constitute a key building block in the 
WHO’s framework,17 and their cross-cutting role in the health system is 
acknowledged.20 
Strengthening health information systems is an important aspect of establishing and 
maintaining strong health systems, and monitoring healthcare.16,20 The availability of 
good quality and timely data is central to decision-making in public health. Data from 
health information systems are crucial for optimal planning and priority setting 
processes; the extent of use varies across settings and stakeholder types, and depends 
to a large extent on data quality and availability.  
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Several global initiatives have been established with the primary purpose of 
strengthening health information systems, such as MEASURE Evaluation21 and the 
Health Metrics Network.22 In 2010, the WHO director general called for collaborative 
efforts towards strengthening health information systems to enable countries to 
monitor progress in achieving better health.23   
Data generated by a health information system needs to be scrutinized and improved 
for a health information system to fulfil its intended role of supporting, planning and 
monitoring a health system. A country health information system may encompass 
several sub-systems with distinct sources of data from population-based surveys, 
censuses, civil registrations and vital statistics, and from health-facilities. USAID’s 
Demographic and health surveys (DHS)24 and United Nations International Children's 
Emergency Fund’s (UNICEF) Multiple Indicator Cluster Surveys (MICS)25 are two 
examples of population-based household surveys. Health facility data can be derived 
from reports of the routine health information system (RHIS). Standardized tools 
such as the Service Provision Assessment (SPA)26 and Service Availability and 
Readiness Assessment (SARA)27 are also used to periodically gather data from a 
representative sample of health facilities to assess service provision in low- and 
middle-income countries (LMIC).  
9.2 Routine health information systems  
A RHIS constitutes an important part of any health information system. In many 
LMIC, RHIS data may be the only source of information immediately available to 
policy-makers.   
Traditionally in LMIC, RHIS data are composed of a rather small and simplified set 
of indicators of aggregated data.20 Conventionally, data availability in an RHIS has 
been shaped by the information needs of health systems managers for planning health 
services, and international donors for programmatic monitoring.  
Primary data collections to support the information needs of a RHIS happen at places 
where care is provided, in health facilities and communities, with care providers 
undertaking the bulk of the data collections.20,28 However in traditional RHIS, care 
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providers’ and clients’ information needs tend to receive little attention. At the same 
time, care providers often lack incentive and motivation to report good quality data, 
and have little appreciation of the information needs of health systems managers, 
much to the detriment of data quality.28 Beyond the point of primary data collection, 
data in traditional RHIS are typically only available in aggregated form. The data 
aggregation happens first at the level of the health facilities, and then at district- and 
sub-national levels.  
Many frameworks have been put forth for the development and evaluation of 
information systems.29-31 The Performance of Routine Information Systems 
Management (PRISM) is a widely-used conceptual framework for data generation 
and data use in a RHIS.32 In presenting this framework, Aqil et al (2009) discuss a 
“paradigm shift” in assessing country-level RHIS, moving beyond purely technical 
considerations of information systems to incorporate behavioral and organizational 
factors that affect a RHIS. According to the PRISM framework, a RHIS consists of 
several components – inputs, processes, outputs, outcomes and impact. Inputs consist 
of three factors: 1) technical factors of RHIS design and infrastructure; 2) 
organizational factors of RHIS governance; and 3) behavioral factors including 
competence and skills of personnel in data management.32 The PRISM framework 
postulates that RHIS inputs impact processes, which in turn affect data quality and 
information use (output), ultimately influencing health system performance and 
health of populations (outcome).  
The PRISM framework and accompanying tools33 have been used in many LMIC 
such as Uganda, Pakistan, China, and Mexico,32 to assess and improve various 
aspects of the RHIS. In general, these assessments produced fairly coherent, valid and 
actionable results.32 Global initiatives such as MEASURE Evaluation and the Health 
Metrics Network have adopted the PRISM framework and tools for evaluations of 
RHIS,33 further pointing to the framework’s applicability in LMIC. Together with 
other data use frameworks, the PRISM framework forms the basis of a logic model 




Processes of data collection, transmission, processing, and analysis are central to any 
RHIS.20,32 The PRISM performance diagnostic tool32,33 and the WHO data quality 
review toolkit35 are instruments that can be used to support RHIS data quality 
assessments. The WHO data quality review toolkit suggests four dimensions for 
quality assessments of health facility data – completeness of data and timeliness of 
reporting, internal consistency, external consistency, and external comparisons of 
RHIS and population-based data.  
Studies of RHIS data quality have assessed some or all of these dimensions of data 
quality. A literature search, conducted in 2018, revealed several issues that 
compromise data quality, with results primarily from sub-Saharan Africa. Regarding 
RHIS processes, identified problems included: inaccuracies in data transfer from one 
documentation source to another36,37, selective over- or under-reporting38-40 and errors 
in diagnosis and classification of conditions.41-43 Technical factors affecting data 
quality were also identified by these studies, including the fact that excessive data 
were collected with no apparent use for calculating indicators in Tanzania,38 Benin,44 
and South Africa.45 A multi-country study assessing routine immunization data 
showed that data quality was negatively affected by complexity of reporting 
structures.46 A separate data collection issue was the lack of consistent recording of 
numerators and denominators for calculations of indicators.46 For example, when 
reporting health conditions or outcomes, it was the number of outcomes that were 
reported and not the number of clients with the outcome.38 Behavioral factors 
affecting data quality identified by these studies included insufficient skills and 
training of care providers in RHIS tasks,44,47,48 poor understanding of indicator 
calculations and definitions by care providers49,50, and increased errors due to 
substantial burden of data collection in multiple records, registers and reports.36 
Insufficient feedback about the reported data was an important finding in many of 
these studies50-52 possibly leading to low motivation of healthcare staff.   
Digital health interventions, including electronic health information systems, have the 
potential to strengthen health information systems, and improve the quality, 
availability and accessibility of RHIS data.53 The Global Action Plan has highlighted 
21 
 
“data and digital health” as one of the accelerators for the health-related Sustainable 
Development Goal (SDG 3: Ensure healthy lives and promote well-being for all at all 
ages).  
More and more countries are adopting electronic RHIS. In settings with electronic 
health information systems, studies have shown improvements in timeliness of 
data,39,54 and completeness of the RHIS reports.54 But other issues such as over- or 
under-reporting of indicators39,55 and data discordance between clinic registers and 
submitted electronic monthly reports37,45 continue to prevail. In many 
implementations of electronic RHIS in LMIC, the overall structure of data-related 
processes of existing traditional RHIS is largely preserved – that is, data are first 
documented in clinical records, then transferred to clinic registers and finally 
submitted as electronic monthly reports.  
The full potential of an electronic RHIS may not be achieved without paying due 
attention to workflow in health facilities during implementation. For example, a 
review of electronic health information systems in South Africa found that the 
number of indicators reported in the RHIS was still high with many of them 
perceived to be of no use, and that event counts were inaccurately entered into the 
electronic RHIS for indicator calculations.45 Lind et al (2005) have highlighted a 
schism between those that design information systems and those that use the 
information derived from this data, such as district- and national decision-makers,30,32 
that could further hinder effective data use.  
9.3 Maternal and child health information systems 
Health information systems data and indicators are extensively collected and reported 
for maternal and child health in LMIC, both in the context of country-level 
monitoring and for international comparisons to assess global progress.20,56,57  
An effective health information system should provide routine data on health status 
and health determinants, as well as health system performance.10,20,58 Yet, data for 
comprehensive monitoring of health system performance are typically inadequate in 
many LMIC.8 Kruk et al, in the Lancet Global Health Commission on high quality 
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health systems in the SDG era,8 reported that fewer than half of the available 
indicators at country-level were measures of processes of care provision. The 
Commission calls for the collection and reporting of indicators that depict health 
system performance, and a RHIS that is geared towards capturing healthcare 
processes and outcomes.  
Equity of healthcare was emphasized in the Countdown to 201556 and is an important 
aspect of the SDGs for global monitoring of maternal and child health.59 Assessment 
of inequalities and inequities is an integral part of measurement of maternal and child 
health. Barros et al used survey data from 54 countries, and found that many settings 
with high overall coverage of maternal and child health services could still have 
significant health inequalities and inequities.60 Much like with the availability of 
routine data for health system performance monitoring, inadequacies of health 
information systems in supporting monitoring of health equity have been pointed 
out.61   
9.3.1 Maternal health indicators  
Indicators for monitoring maternal health have been classified as those measuring 
inputs and processes, outputs, outcomes and impact62 or grouped under the domains 
of mortality and health status, access to services, availability and utilization of 
services, service coverage, and quality of healthcare, as well as measures of 
governance and finance, and health workforce.62,63 
Three main sources of data from health information systems in LMIC are commonly 
used to derive maternal health indicators: 1) population-based surveys such as DHS 
and MICS, which are the mainstay of country-level data in many LMIC; 2) health 
facility data from SPA or SARA; and 3) RHIS. 
9.3.1.1 Monitoring maternal illness   
The maternal mortality ratio was the indicator used to monitor impact of Millennium 
Development Goal 5 (MDG 5: improve maternal health). As more and more LMIC 
are achieving targets for maternal mortality reduction, there is an ever-increasing 
emphasis on addressing maternal morbidity.64 Measuring maternal morbidity is an 
23 
 
important first step towards quantifying the burden of disease and addressing 
maternal health during the course of pregnancy and childbirth, and the overall quality 
of life of women afterwards.65 Studies have pointed out the dearth of information on 
maternal morbidity estimates, with the available prevalence data probably only 
indicating the tip of the iceberg.65,66 Traditional RHIS have limited data on maternal 
illnesses. A systematic review evaluating the availability of morbidity data in RHIS 
in South Africa noted that none of the identified studies were quantitative 
assessments and concluded that obtaining morbidity data using RHIS remains under-
explored.67  
Household surveys are less than ideal, if not unsuitable, for measuring most maternal 
morbidity indicators on a routine basis since they are intermittent, consist of client-
reported data and suffer from recall bias leading to errors in classification of severity 
of disease. On the other hand, in settings with reasonable levels of healthcare 
provision and use, health facility data from antenatal care (ANC) and delivery should 
serve as an ideal source of data of maternal morbidity estimates.  
The Maternal Morbidity Working Group, a technical working group established by 
the WHO, stresses the importance of creating and improving routine data collection 
systems that are geared towards monitoring maternal morbidity.66 Purposeful 
strengthening of a RHIS can improve the quality and availability of routine data on 
maternal illnesses and usher monitoring of maternal illness into mainstream health 
data ecosystems.68 Authors have argued for the use of RHIS data for outcome 
measurement of interventions of health systems, instead of establishing parallel 
program-based data collections.68  
9.3.1.2 Monitoring antenatal care 
ANC is a ubiquitous public health measure that consists of both preventive and 
curative strategies, with the overall aim of increasing the likelihood of better 
pregnancy outcomes for the mother and her baby.69,70 In the continuum of care across 
reproductive, maternal, newborn and child health, ANC constitutes a key link. 
The proportion of pregnant women having at least four visits with a trained health 
personnel during their pregnancy (ANC 4+) is almost universally used to assess 
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health system performance of ANC.62 Several studies have pointed out the limited 
value of this indicator for monitoring health system performance, since it provides no 
information on the services received or the quality of care.71,72  
Kruk et al recommend the use of effective coverage of ANC that captures if women 
have a timely first ANC visit and receive specific ANC interventions, to assess health 
system performance as opposed to only measuring ANC 4+.8 The theoretical 
definition of effective coverage, as described by Shengelia et al (2005),73 contains 
“quality”, in addition to “utilization” and “need”. Provision of quality healthcare is a 
core aspect of a well-functioning and effective health system.8,74,75 Maximum health 
gain cannot be achieved if healthcare services are not of good quality.73  
Conceptually, measuring quality of care involves appraising care provision against a 
particular standard.76,77 Donabedian proposed measuring quality in terms of structure, 
process and outcomes, with the underlying premise that improvement in structure of 
care promotes optimal processes of care, which in turn results in better outcomes.77 
Good quality ANC is imperative to achieve the desired health outcomes for the 
mother and her baby.57,78 Studies that have measured technical “quality” of ANC in 
the context of effective coverage of ANC and otherwise6,72, have typically assessed 
ANC content, measuring if pregnant women were provided with all or a majority of 
services once during ANC.6,79-81 Commonly reported measures of ANC content 
include a one-time measurement of weight and blood pressure, any urine and blood 
tests, iron-folate supplementation, tetanus immunization, counseling on pregnancy 
complications, and counseling for breastfeeding.6,82,83 
As an alternative to measuring ANC content as the one-time provision of screening 
and counseling, processes of care measures derived from clinical ANC guidelines can 
be used.84,85 Guidelines for clinical ANC interventions are reasonably well-defined 
and generally standard for pregnant women. The WHO provides normative 
guidelines of ANC, the latest being the 2016 WHO model for a positive pregnancy 
experience.86,87 NICE88 and ACOG89 are two important sources of up-to-date clinical 
guidelines of care during pregnancy, based on the latest available evidence from 
effectiveness studies.  
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Guidelines for ANC interventions that are widely recommended are those that are 
supported by evidence of clinical effectiveness in improving health. Then, it is 
reasonable to assume that a measure of whether pregnant women receive complete 
clinical interventions at appropriate times during ANC better encapsulates service 
provision, compared to measuring if interventions were provided once during ANC. 
For example, the timely identification and management of preeclampsia requires 
repeated blood pressure measurements throughout pregnancy, as opposed to a one-
time blood pressure measurement. However, guideline-based indicators are less 
commonly used in quality assessments of ANC, in comparison to certain other areas 
of healthcare, especially in LMIC.84 
Most studies that have reported on ANC content and service provision have used 
household survey-data, or national or sub-national SPA or SARA, or combinations of 
the two data sources. In many LMIC where health service utilization tends to be sub-
optimal, a household survey may be the only data source that provides a 
representative sample of the population. Given this, assessing if pregnant women get 
a set of healthcare services at least once during ANC is the most feasible metric to 
capture for “quality” assessments.83,85 Such an approach, however, does not take into 
account the timing of ANC interventions received by pregnant women, how often 
they were provided, if the care provided was appropriate, or whether women were 
followed-up after screening with timely referrals or other managements. Household 
surveys that contain self-reported data from women are not suited to perform such 
comprehensive assessments of technical process of care. SPA and SARA can be used 
to assess some processes of care but only provide cross-sectional data at given points 
in time.  
Health facility data from clinical records can be an alternative data source that can 
provide client-level information on the number, timing and results of screening and 
clinical examinations, and management information. 
As with monitoring of inequities in coverage of any ANC visit or ANC4+ in the 
MDG era, monitoring inequities in coverage of ANC content and “quality” of 
services is getting attention to track progress towards SDGs.8,90 The magnitude of 
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inequities in care provision was highlighted in a recent study of ANC in 91 countries, 
where wealthier women were much more likely to get blood pressure monitoring, 
urine and blood testing, and counselling during ANC, compared to poorer women.90   
9.4 Data for maternal and child health priority setting 
Health-related policy making is complex and depends on several factors, one of 
which is the availability of sound data. Shiffman and Smith (2007) described a 
framework for political priority of global health initiatives consisting of four 
important determinants – actor power, ideas, political contexts and issue 
characteristics.91 Issues characteristics include the availability of credible indicators 
and a shared understanding of the severity of the health problem.91  
As per the PRISM framework, information use is the output of a well-functioning 
RHIS. Despite the recognition of the importance of sound data for public health, 
accompanied by efforts and resources towards the strengthening of health information 
systems, many LMIC still lack health information systems that generate reliable and 
timely data that is relevant for local decision-making needs.58,92 Strengthening health 
information systems not only involves improving data collection processes, but also 
enhancing the use of data by stakeholders including policy makers.28  
Every data source within a health information system has its own share of strengths 
and limitations, and it is generally recognized that a health system benefits from a 
customized set of many data generation strategies, comprised of population-based 
and health facility data, to fulfil context-specific information needs. For example, 
household survey data provide representative estimates of populations, but surveys 
are typically conducted once in 4 or 5 years and have limitations in capturing content 
of care received, particularly for complex interventions.93 Facility surveys provide an 
assessment of infrastructure in health facilities and the provision of services in a 
sample of health facilities, but are also intermittent. Aggregate RHIS data can provide 
routine information on health determinants and health outcomes, but may be 
unavailable or sometimes non-representative. Individual-level data from clinical 
records can provide longitudinal data on processes of care and delivery of 
interventions for direct calculation, but are not routinely available in most LMIC.  
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9.4.1 Lives Saved Tool  
Modeling is valuable for public health program planning to evaluate effectiveness 
and cost-effectiveness of implementations.94 In addition, models are useful when the 
outcome of interest is rare or difficult to measure, for example, maternal mortality 
ratio.94 Among others, modeling has been used to evaluate vaccination programs, 
HIV/AIDS prevention and treatment programs,95 infectious diseases control efforts,96 
and maternal and child health programs. The Goals model for HIV prevention and 
treatment programs,97 the STDSim model for simulations of sexual relationship 
patterns among individuals with sexually transmitted diseases,98 and the Lives Saved 
Tool (LiST) for maternal and child health99 are some examples of modeling tools of 
health programs.  
LiST has been extensively used globally, to guide priority setting processes in 
maternal and child health.99-101 LiST is used to create population projections into the 
future, where the scale up of one or more interventions over a time period is modeled, 
and changes in numbers of maternal, neonatal and child deaths, and stillbirths are 
estimated. The structured outputs generated in LiST have been found to be intuitive 
for use by policy-makers.102 Currently, LiST finds use in three broad arenas: 1) to 
inform global recommendations of interventions and the effectiveness of scale-up; 2) 
for strategic planning and priority-setting at the national level; and 3) to assess the 
impacts of ongoing large-scale implementations.100  
Health status indicators, intervention effectiveness and baseline intervention coverage 
are the three primary inputs in LiST. Default proxies are used for baseline 
intervention coverage in LiST, considering the lack of actual coverage data in many 
settings. Coverage estimates are derived mainly from DHS and MICS. Facility 
surveys, research studies, and expert opinion have been used to configure default 
proxies in LiST. When available, RHIS data can be used to input health status and 
coverage indicators.  
The quality and properties of data that are input in any modeling tool determines the 
output, and LiST is no exception.103 As the availability, reliability and validity of data 
that are input in LiST improves, default proxies can be replaced with actual context-
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specific data and indicators, and the usability and accuracy of the output in 
identifying priorities are likely to be enhanced.104,105   
9.5 eRegistries  
As described so far, traditional RHIS have gaps in capturing data for comprehensive 
maternal and child health monitoring and priority setting. The problem is not one of 
quantity of data collected at health facilities. Care providers typically document large 
volumes of client-related data during clinical care, although only a relatively small 
sub-fraction of these data is made available or used to report on aggregated indicators 
as part of traditional RHIS. If a health information system is designed to capture all 
the data collected at the point-of-care, these data can then be utilized to serve 
information needs of multiple different stakeholders. 
eRegistries for maternal and child health are electronic health information systems 
that are purposefully designed to facilitate maximal data utilization downstream as 
well as upstream.9 In an eRegistry, electronic data collection happens at the point-of-
care at the individual client level. This single, unified source of data collected at the 
point-of-care can then be used to support multiple data-driven digital health 
interventions such as: clinical decision support, automated RHIS reporting, 
performance feedback dashboards for care providers, and SMS messages to 
clients.9,106 The point-of-care data collection system allows for capturing vast 
amounts of data over time, which then allow for recombinations of data points to 
formulate a variety of types of indicators.  
As part of the development of the eRegistries concept, a suite of indicators for the 
WHO essential interventions was developed to illustrate the type of data that could be 
collected in eRegistries.85 The indicators are reflective of different components of 
each essential intervention, and consist of 4 broad types: 1) process indicators of 
screening; 2) outcome indicators of screening; 3) process indicators of management; 
and 4) outcome indicators of management.85  
29 
 
9.6 The West Bank – study context 
Data for this dissertation were collected from the West Bank, Palestine. The West 
Bank has a population of 4.5 million and a fertility rate of 4.3.107 There are about 
70,000 – 80,000 births per year in the West Bank, of which over 95% occur in health 
facilities.107 The infant mortality rate was 11 per 1000 live births and the published 
stillbirth rate was 5 per 1000 births in the West Bank as of 2017.107 The maternal 
mortality ratio in 2015 was 45.5 per 100,000 live births, according to UN 
estimates.108 The Palestinian MICS 2014 reported that 95% of the women received 
ANC 4+.109 Various reports have documented Caesarean section rates ranging from 
14% to 25.8%.107,110 According to a study from 2012, 2% of births were cases of 
maternal near-miss.111  
The health system for maternal and child health consists of public, private, non-
governmental organizations and the United Nations Relief and Works Agency for 
Palestine Refugees in the Near East (UNRWA).112 Health services in the public sector 
are organized as primary healthcare clinics and secondary health facilities. Public 
primary healthcare clinics provide antenatal and postpartum care, and newborn care 
including vaccinations. Labor and delivery services are only provided in secondary-
level health facilities (hospitals). Every administrative district in the West Bank 
typically has one public hospital that caters to more than 80% of all the deliveries in 
that district, and several hospitals run by the private sector or by non-governmental 
organizations (NGO) catering to the rest of the population.107 
As of 2018, there were 396 public primary healthcare clinics located throughout the 
West Bank, and more than 90% of these clinics provided ANC. Women in the West 
Bank have one designated primary healthcare clinic that is closest to their place of 
residence where they are supposed to seek antenatal, postpartum and newborn care 
(figure 1).113 Pregnant women identified with certain conditions in primary healthcare 
clinics are referred to a high-risk (referral) clinic, to receive appropriate follow-up of 
the condition and continue with subsequent ANC. Women registered in public clinics 
may also seek care from private providers, as has been reported in other studies from 
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the West Bank.114,115 No published literature exist on the exact patterns of use of the 
health system for ANC. 
Figure 1: Flow of clients of antenatal care, delivery and postpartum care in the 





Maternal and child health are high on the policy agenda and a priority area for the 
Palestinian health system.116 In the Lancet commentary “Health in the Occupied 
Palestinian Territory”, Mataria and colleagues call for revitalized efforts to strengthen 
the health system in Palestine along the lines of the WHO health system building 
blocks.117 The authors call for strengthening of primary healthcare in general and the 
health information system in particular. The importance of robust health information 
systems is reiterated in the article on maternal and child health in Palestine, where the 
authors point out the need for routine data on context-specific prevalence and service 
delivery to inform resource allocation in an already fragile health system setting.116 




9.6.1 The existing health information system  
Until the second half of 2016, the RHIS for primary healthcare in the West Bank was 
paper-based. Aggregate reports of event counts were manually prepared by the care 
providers and submitted every month from each primary healthcare clinic (figure 1). 
For ANC, all clinics were obliged to report on a set of predefined indicators to the 
Ministry of Health (box 1).  
Box 1. List of indicators from antenatal care available in the existing routine health 
information system 
Published 
1. Antenatal visits to the primary healthcare clinics by district: 
1.1. Number of pregnant women registered for antenatal care 
1.2. Total number of antenatal visits 
1.3. Rate of visits per pregnant woman1 
1.4. Coverage of antenatal care in public primary healthcare clinics2 
1.5. Distribution of new registered pregnant women according to age (<16, 16-40, >40)  
2. Iron and folic acid supplementation by district 
2.1. Number of folic acid tablets distributed 
2.2. Number of iron and folic acid tablets distributed 
2.3. Rate of folic acid and iron per pregnant woman 
3. Referrals of high-risk pregnancies 
3.1. Number of pregnant women referred by age group 
3.2. Percentage of referrals among all registered pregnant women 
3.3. Number of women referred for: gestational diabetes mellitus, multiple pregnancy, 
malpresentation at term, recurrent miscarriage, pre-eclampsia, rhesus negative blood 
group, fundal height discrepancy, history of Cesarean section, oligohydramnios, 
polyhydramnios, bleeding during pregnancy, premature rupture of membranes, 
others 
4. Anemia among pregnant women by district: 
4.1. Total number of hemoglobin tests at 36 weeks 
4.2. Number of tests of Hemoglobin <7 g/dl among total hemoglobin tests 
4.3. Number of tests of Hemoglobin 7 – 9 g/dl among total hemoglobin tests 
4.4. Number of tests of Hemoglobin 9 – 11 g/dl among total hemoglobin tests 
4.5. Percentage of mild, moderate and severe anemia4 
Not published 
1. Number of women referred to hospitals for delivery or antenatal complications 
2. Number of pregnant women examined by doctor, nurse: 
3. Number of miscarriages among all registered pregnant women 
4. Number of home visits (if any) 
Calculations of proportion indicators (done centrally at the Ministry of Health)  
1 Total number of antenatal visits/ Number of pregnant women registered for antenatal care 
2 Number of pregnant women registered for antenatal care/total number of births by district 
3 Number of positive tests/total number of blood sugar tests 
4 Number of hemoglobin test results indicating anemia/total number of hemoglobin tests 
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A description of the RHIS processes and RHIS determinants of the paper-based RHIS 
in the West Bank, along the lines of the PRISM framework, is provided below.  
9.6.1.1 RHIS processes 
In the paper-based RHIS, care providers in primary healthcare clinics used paper-
based, structured clinical records (appendix 1) for documentations of clinical care 
during ANC.113 According to standard practice, a clinical record was opened for each 
woman at registration of her pregnancy at the clinic. Two clinic registers – one for 
general ANC and one for antenatal ultrasounds – were used for reporting purposes. 
From the paper-based clinical records, care providers (typically nurses) manually 
counted and copied specific information needed for monthly reports into clinic 
registers at the end of each workday or in some cases, once a week. Information from 
the clinic registers was then summarized into counts and written on the RHIS 
reporting forms. 
All clinics submitted reports of indicators of ANC, postpartum and newborn care, 
while referral (high-risk) clinics additionally reported on maternal conditions from 
the referrals received from primary healthcare clinics (figure 1).  
The monthly reports were first submitted to the district-level supervisors of maternal 
and child health services, who checked the reports for completeness and subsequently 
sent the reports to district health authorities. At this stage, the reports were 
computerized by a data entry clerk at the district health offices and sent to the 
Ministry of Health and Bureau of Statistics.  
A few of the event counts were converted to proportion indicators centrally at the 
bureau of statistics. Most of the routinely reported indicators from the clinics were 
published by the Palestinian Ministry of Health once a year (box 1).  
Although hospitals may provide ANC services for pregnant women, they are not 
obliged to report on any data regarding ANC to the RHIS. However, all health 
facilities providing labor and delivery services, private and public, are obliged to 
report on maternal deaths and the number of deliveries, stillbirths and neonatal deaths 
disaggregated by sex. 
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9.6.1.2 RHIS determinants 
RHIS reporting from ANC followed a complex structure consisting of separate data 
flows from primary healthcare clinics and high-risk clinics (for maternal conditions 
from referrals) for the same population of pregnant women. It was unclear if the high-
risk clinics reported on one or more maternal condition for each pregnant woman 
referred.  
Care providers in the clinics typically consist of nurses, midwives and non-
nurse/midwife health workers, who are involved with the bulk of health data 
collection and preparation of RHIS reports. Doctors usually visit clinics once or twice 
a week and perform clinical examinations and antenatal ultrasounds. As per protocol, 
district-level supervisors were supposed to visit all clinics once a month. During such 
visits, supervisors were required to check five randomly selected clinical records for 
completeness, assess accuracy of data transfer from the clinical records to the clinic 
registers and subsequently provide feedback to the nurses in the clinics. In reality 
(from expert opinion of the study team in the West Bank), supervisory visits were 
erratic and the exact content of feedback was often unclear.  
Care providers reportedly spent a significant portion of their time in repetitive 
documentation of health data in clinical records, registers and monthly reports, which 
may have had an impact on the RHIS data quality.  
From the start of the project in 2014 and through 2018, no published studies of 
assessments of RHIS data quality were identified from the West Bank. 
9.6.2 Transformation of the routine health information system 
9.6.2.1 Implementation of an electronic maternal and child health registry  
The health authorities of Palestine made the decision to implement a national 
electronic maternal and child health registry (MCH eRegistry, named after the parent 
global initiative) as a measure towards strengthening and modernizing the RHIS in 
primary healthcare. As a result, the paper-based RHIS, providing only aggregated 
data, is currently transitioning to an electronic health registry consisting of individual-
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level data collected at the point-of-care for ANC services.113 The transition started in 
late 2016 and was ongoing as of 2019. 
At the outset, this implementation was targeted towards improving RHIS input, 
optimizing RHIS processes and minimizing duplicative documentation efforts of care 
providers. In the long term, the intention of the Palestinian Ministry of Health is to 
enhance the use of data at all levels of the health system by different maternal and 
child health stakeholders.9  
The planning phase of the implementation started in 2014. The initial stage was 
devoted to design and software customization of the MCH eRegistry.113 A national 
multidisciplinary stakeholder group composed of doctors and nurses providing 
maternal and child health services, midwives, district health supervisors, Ministry of 
Health staff, and representatives from NGO-run health facilities was established.  
ANC services were the first to be included in the implementation. Care providers of 
maternal and child health services directly enter clinical data during client care into 
electronic checklists; checklists are identical in structure and content to the paper-
based clinical records.9,113 As of 2018, the MCH eRegistry supported two digital 
health interventions driven by the clinical data entered at the point-of-care in the 
clinics – 1) individualized clinical decision support based on guidelines for care; and 
2) automated generation of RHIS reports, where the manually aggregated and 
reported indicators are now generated electronically every month, using the clinical 
data entered into the MCH eRegistry for each primary healthcare clinic. 
Both of the abovementioned digital health interventions were formulated in 
collaboration with the stakeholder group. Specific nationally recommended clinical 
interventions pertaining to antenatal, postpartum and newborn care were identified 
and their corresponding national guidelines were gathered. Algorithms for clinical 
care were drafted based on the available guidelines for each of the interventions and 
then discussed in two stakeholder seminars to ascertain if they reflected national 
recommendations and clinical practice. Clinical algorithms based on the final set of 
agreed guidelines were then used to build the clinical decision support functionality 
in the MCH eRegistry.113  
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Primary healthcare clinics in the West Bank have been provided with desktop 
computers and an internet connection, and the care providers have access to the MCH 
eRegistry through a web browser. The Palestinian MCH eRegistry is hosted in the 
DHIS2 software platform.119  
9.6.2.2 Mechanisms of change 
Table 1 shows the mechanisms by which the introduction of the MCH eRegistry in 
primary healthcare clinics will modify the existing landscape of RHIS processes, as 
identified for this dissertation. In the short term, the implementation of the MCH 
eRegistry acts as a technical determinant of RHIS that would lead to modifications in 

















Table 1: Summary of expected changes to RHIS processes and outputs with the 
transformation from the manual, paper-based RHIS to the MCH eRegistry 
RHIS processes 
Characteristics 
Existing RHIS Transformed RHIS 
1. Data 
collection 
1.1 Documentation of clinical 
datapoints on paper-based 
antenatal records at point-of-
care 
1.2 Manual diagnosis and 
classification of maternal 
conditions  
1.3 Data entry into 
ledgers/registers 
1.4 Summarize counts for 
indicators and prepare reports  
1.5 Reports sent to district health  
supervisors  
Documentation of clinical 
datapoints in electronic 
antenatal records at point-
of-care   
2. Data 
transmission 
2.1 Primary healthcare clinics 
report on all indicators except 
for maternal conditions 
2.2 High-risk (referral) clinics 
report on maternal conditions 
from referrals   
Automated electronic 
reports of all health and 
health system indicators 




3.1 Paper reports of event counts 
(submitted by care providers) 
computerized by data entry 
staff  
3.2 Denominators and definitions 
applied at the national level for 
some indicators 
Definitions for indicators 
applied to clinical 
datapoints at the 
individual-level with a 
single denominator (total 
number of registered 
clients)  
4. Data analysis  Limited usable/available data for 
health system performance 
monitoring 
Data available on content 
of care, frequency, timing 
of health interventions 
during antenatal care 
RHIS: Routine health information system 




9.7 Rationale for dissertation 
The expected changes in the data-related processes, as a result of the transition from 
an RHIS based on manual aggregations to an electronic health registry, may lead to 
significant changes in the values of all health and health systems indicators. Such 
potential shifts of data could be disruptive to the health system if not anticipated and 
understood by health systems owners, managers, and care providers, as they may 
base their planning and policies on such data. This dissertation, therefore, includes an 
assessment of the characteristics of change in health- and health system performance 
indicators, as outlined in the mechanism of change, with the goal of preparing the 
health system for modified understanding that might emerge.  
Figure 2 shows the focus areas of the papers that constitute this dissertation, where 
different aspects of the mechanism of change were evaluated through indicators of 
health status and health system performance. 
Figure 2: Main characteristics of changes expected to occur with the transition of the 







10 Study objectives 
10.1 Hypothesis 
Transition from an RHIS based on manual aggregations to an RHIS based on 
individual-level data will lead to significant changes in the values of routinely-
reported indicators and interpretations of health system performance of ANC.   
10.2 Research questions 
1. How will the change from the existing RHIS based on manual aggregation, to 
individual-level data from clinical records, affect values of routinely reported 
ANC indicators in the public clinics? 
2. How will the change from contact coverage reports in the existing data 
ecosystems, to effective coverage indicators for ANC interventions from 
individual-level data, affect measures of health system performance of ANC in the 
public clinics? 
3. How will the outputs from the Lives Saved Tool be affected by using different 
sources – aggregate RHIS reports, individual-level data from clinical records and 
population-based survey data? 
10.3 Aim 
To assess the consequences of using individual-level clinical data to generate health- 
and health system performance indicators, compared to data from a household survey 
and the existing aggregated RHIS. 
10.4 Objectives 
The specific objectives of this dissertation are to: 
1. Calculate routinely reported indicators from individual-level clinical data from 
antenatal paper records, mimicking an eRegistry, and compare these with 




2. Calculate coverage of at least one screening, appropriate number of screenings of 
ANC interventions, and effective coverage of ANC interventions in public 
primary healthcare clinics in the West Bank, Palestine, and explore selected 
infrastructure-related and maternal sociodemographic factors potentially 
associated with effective coverage (paper II).  
 
3. Assess the implications of using different available data sources in Palestine – 
routine data, a population-based survey, extracted paper-based records and the 
eRegistry – when used for modeling the scale up of ANC interventions in the 















11 Materials and methods 
11.1 Setting and design 
The overall implementation of the MCH eRegistry and the resultant RHIS 
transformation were operationalized as a combined research-implementation 
initiative.  
The study area from which data were collected for this dissertation consisted of five 
districts in the West Bank, namely, Bethlehem, Jenin, Nablus, Ramallah/Al-Bireh and 
Salfit (figure 3).113 In total, there were about 32,000 births per year in these five 
districts, constituting almost 50% of all the births reported annually in the West 
Bank.107 Out of the 180 clinics in these districts that were run by or reported to the 
Palestinian Ministry of Health, 165 clinics that offered routine ANC services were 
included in the first phase of the implementation. These 165 clinics enrolled 11,416 
new pregnancies in 2014 (the number of new registrations of pregnancy per clinic 
was available from a facility inventory checklist described in section 11.2.1), an 
average of 70 pregnancies per clinic per year. There were nine high-risk (referral) 
clinics operating in the five districts.  
A subsample of the 165 phase 1 clinics was included in the cross-sectional study 
presented in this dissertation (described in section 11.2.2). 
A cluster-randomized controlled trial (the eRegQual study) was embedded in the 
phased national implementation of the MCH eRegistry.113 Clinics included in the 
eRegQual study and randomized to the intervention arm received the eRegistry for 
ANC, and the control clinics continued to operate with paper-based clinical records 
throughout the period of the trial.113 The eRegQual study started recruitment in 
January 2017. After completion of the follow-up period in July 2018, the control 
clinics were included as part of the eRegistry implementation. 

















11.2 Data collection and data sources  
All activities related to data collection were conducted in close collaboration with the 
field coordinators of the study at the Palestinian National Institute of Public Health 
(PNIPH), WHO, Palestine.12 Figure 4 shows the specific timing of the data 
collections for the papers constituting this dissertation, in relation to the timeline of 
the overall project and the eRegQual trial between 2014 and 2018.113 
Figure 4: Project plan indicating timing of data collections for the papers 
constituting this dissertation 
 
 
11.2.1 Facility inventory 
An assessment of all primary healthcare clinics in Palestine using a facility checklist 
was conducted in 2014, as a first step towards the national implementation of the 
MCH eRegistry/eRegQual trial (figure 4).113 The list of data elements collected in the 
facility checklist (box 2) was prepared jointly by the researchers and the country 
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implementation team. The PNIPH coordinated the data collection, while the district 
health supervisors facilitated the process. Midwives or nurses from each clinic 
completed the assessment form and returned them to the district supervisors, who 
then checked the information for completeness and forwarded them to the PNIPH. 
Project staff at PNIPH computerized the completed forms. The researchers checked 
all the data for accuracy and completeness for every clinic and requested 
clarifications or additional information from the clinics, where needed. Specific data 
from the facility checklist were used for the following purposes in this dissertation:  
 Referral patterns of primary healthcare clinics: to understand flow of health 
information in primary healthcare (papers I, II, III).   
 Number of new pregnancies registered in each clinic over one year in 2014: 
sampling and sample size estimations for data collection from paper-based clinical 
antenatal records (described below) (papers I, II, III).  
 Information related to clinic infrastructure: to understand availability of service, 
staffing and care provision in the clinics (paper II).  
Box 2. List of information collected in the facility inventory checklist 
Clinic infrastructure 
Types of MCH service provided 
Computer availability  
Internet connectivity 
Days of operation 
Number of rooms used to provide MCH services 
Availability of beds, measuring tapes, sphygmomanometers 
Laboratory and ultrasound availability 
Human resources 
Number of doctors, nurses, midwives, specialists and non-nurse/midwife health workers 
Number of full-time and part-time staff positions 
Client-related 
Number of new pregnancies registered over one year (in 2014) 
Number of total pregnancies handled by the clinic over one year 
Number of primigravidae 
Number of pregnant women<16 years and >40 years 
Health system mapping 
Place of referral of high-risk pregnancies  
Place of referral for laboratory and ultrasound examinations  
Place of referral for secondary and tertiary MCH care 
Place of referral for deliveries of pregnant women  
44 
 
11.2.2 Paper-based clinical records 
Data were collected from paper-based clinical records for ANC of all pregnancies 
registered in 2015 in a cross-sectional sample of primary healthcare clinics. Paper-
based clinical records were the source of individual-level data in the clinics in the 
existing RHIS. Paper-based clinical records were printed centrally at the Ministry of 
Health and distributed to all clinics. One clinical record was opened for each woman 
at the time of registration for ANC. The clinical record (appendix 1) consisted of the 
following sections of documentation:  
i. Background sociodemographic information: mother’s name, age, date of birth, 
address, phone number, age at marriage, age at first pregnancy, number of years 
of education 
ii. Current pregnancy: last menstrual period, expected date of delivery, gestational 
age at pregnancy registration, obstetric score (gravida, parity, number of living 
children and number of abortions) 
iii. Obstetric history: consecutive abortions, perinatal deaths, Caesarean sections, 
birth complications during previous deliveries 
iv. Medical and family history: diabetes mellitus, hypertension, renal and heart 
disease 
v. Clinical examinations: height, weight, blood pressure, symphysis fundus height, 
presentation, edema 
vi. Laboratory tests: blood group and Rh type, hemoglobin, blood sugar 
vii. Ultrasound examination: placenta, presentation, amniotic fluid index, estimated 
fetal weight, expected date of delivery, fetal growth parameters  
viii. Managements: tetanus toxoid immunization, iron-folate supplementation 
ix. Complications warranting referrals: gestational diabetes mellitus, pre-eclampsia, 
anemia (hb <9.5 g/dl), discrepancy between fundal height and gestational age, 
oligo- or polyhydramnios, malpresentation at term, multiple pregnancy, 




11.2.3 Aggregate RHIS reports  
Aggregate RHIS reports of event counts of all the indicators submitted by the care 
providers were obtained for: 1) the primary healthcare clinics included in the data 
collection of the paper-based clinical antenatal records (RHIS clinic reports); 2) the 
corresponding high-risk clinics reporting at the district-level (RHIS district reports); 
and 3) the national level reports for ANC for the West Bank (nationally reported 
statistics for the 5 districts) (table 2). Aggregate RHIS reports per clinic were 
obtained as electronic spreadsheets from the Ministry of Health for 2015. 
RHIS clinic reports contained the following three indicators: maternal age, antenatal 
visits and anemia at 36 weeks. RHIS district reports contained event counts of 
maternal conditions from referrals. RHIS national statistics included all routinely 
reported indicators. In the national reports, all indicators were published as event 
counts except anemia at 36 weeks published as a proportion (hemoglobin tests with 
value <11 g/dl/ hemoglobin tests reported).  
 
Table 2: Aggregate RHIS reports from different organizational hierarchies of the 
RHIS and the denominators used to transform event counts to proportion indicators 
Aggregate RHIS reports Denominator for computing indicators out of event 
counts 
RHIS clinic reports Number of pregnancies enrolled, as reported by 
care providers  
(n=1463) 
RHIS district reports Pregnancies enrolled in clinics included in phase 1 
of implementation  
(n=11,416) 
Nationally reported statistics Pregnancies enrolled in all clinics in the 5 districts  
(n=14,544) 
RHIS: Routine health information system 
 
11.2.4 eRegistry electronic clinical records 
A total of 76 primary healthcare clinics in the 5 districts started using the MCH 
eRegistry during the second half of 2016 (figure 4).113 Use of the MCH eRegistry is 
mandatory for all clinics, and all paper-based clinical antenatal records were removed 
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from the clinics during the time of the implementation, to secure full adherence to the 
use of the eRegistry for all clinical documentations.  
The eRegistry electronic clinical records were identical to the paper-based clinical 
records in terms of the datapoints collected. The main distinction between paper-
based clinical records and the eRegistry electronic clinical records is the way in 
which details of clinical management are captured in the two systems. Clinical 
decision support and referral recommendations are part of the functionalities of the 
eRegistry, triggered by the data that are entered into the electronic records at the 
point-of-care by the care providers. Subsequently, care providers are prompted to 
indicate if the recommended actions suggested by guideline-based clinical decision 
support are performed or not.  
11.2.5 Multiple indicator Cluster survey  
MICS is a household survey that is conducted once in 4 years in Palestine.109 The 
latest available MICS was conducted in 2014, when 13,367 women from the West 
Bank and Gaza were interviewed. Twenty-two per cent of the women (n=2940) 
included in MICS 2014 had at least one live birth in the 2 years prior to the survey.109  
11.3 Sample  
11.3.1 Sample size  
We made sample size estimations for data collection from paper-based clinical 
records to report on two sets of outcomes – indicators of health status (routinely 
reported indicators including maternal conditions) and indicators of health system 
performance (coverage of ANC interventions).  
Sample size was determined to enable the detection of a frequency of maternal 
condition of 1% (margin of error of 0.5%), and a coverage of ANC interventions of 
40-60% (margin of error of 2-3%). Severe anemia, with a frequency of 1% in this 
setting, is an example of a maternal condition that was important and feasible to 
capture in this data collection120. No reports on care provision in primary healthcare 
were available in published literature; coverage of ANC interventions for sample size 
calculations were based on best available knowledge.  
47 
 
To enable capture of these outcomes in a study population of 11,400 pregnancies, a 
sample of 1344 pregnancies was required. Sample size was calculated with the 
software ‘OpenEpi’, using the following formula:121 
Sample size n = [Np (1-p)]/ [(d2/Z21-α/2*(N-1) + p*(1-p)], where N is the finite 
population correction, p is the % frequency of outcome, d is the margin of error. 
11.3.2 Sampling 
The main goal of the sampling was to obtain a dataset of pregnancies that was 
representative of the healthcare received by pregnant women in the public health 
system in the West Bank. In order to avoid selecting a non-representative sample of 
small clinics that catered to fewer pregnant women, a random sample of primary 
healthcare clinics was selected by probability proportional-to-size sampling. 
Selection was continued until a certain number of clinics was available to achieve the 
required sample of pregnancies, on condition that data were extracted from paper-
based clinical records of all pregnancies registered for one year in 2015 in the 
selected clinics. There were no inclusion or exclusion criteria based on individual 
pregnancies and all clinical records were included in the data collection.  
Given that clinics were selected with unequal probability sampling, inverse 
probability sample weights were added such that pregnancies from smaller clinics 
were assigned higher weights than pregnancies from larger clinics. This would 
provide data from clinical records that were comparable to RHIS aggregate reports, 
produce indicators with robust standard errors, and provide results with more 
generalizability to the five districts from which the sample was selected.122 
Seventeen primary healthcare clinics were included in the cross-sectional study of 
paper-based clinical records. Data from clinical records were available for 1369 
pregnancies.  




Table 3: Sample characteristics of clinics and pregnancies included in the cross-
sectional study of paper-based clinical antenatal records 
Characteristics Number 
Laboratory and ultrasound Number of clinics (number of pregnancies) 
 Both  6 (n= 631) 
 Only laboratory 2 (n= 134) 
 Only ultrasound  2 (n= 138) 
 Neither 7 (n= 466) 
Age of women (years) Number of pregnancies 
 <20  222 
 21-35  1029 
 >35  118 
Education of women (years) 
 
 <10  149 
 10-13 591 
 >13  514 
Age of women at marriage (years) 
 
 <20  695 
 >20  573 
Parity  
 
 Nulliparous 501 
 Multiparous (less than 4) 666 
 Multiparous (more than 4) 186 
 
11.4 Data extraction 
Data were extracted from paper-based clinical records by two nurse midwives trained 
in data extraction. Data collection forms were set up in the DHIS2 software;119 the 
structure and content of the data collection forms matched the paper-based clinical 
records. Data entry staff conducted the extraction between January and April 2017 
(figure 4). Data from about 10% of all the clinical records (n=133) were entered twice 
– once by each of the data entry staff.113 The double-entered data were checked by the 
field coordinators for consistency. Any deviations in the two sets of entered data were 
solved through discussions between the field coordinators and the data entry staff. In 




Secondary data for analyses were exported from the eRegistry electronic clinical 
records. Data on all pregnancies registered on or after 1st of January 2017 and passed 
44 weeks of gestation as of 30th of April 2018 were included. There were no inclusion 
or exclusion criteria based on individual characteristics.  
We obtained the dataset of the 2014 MICS in Palestine, on request from the country 
MICS team. We only used data for the West Bank (55% of the survey sample, 
n=1609) available in MICS 2014.109 
11.5 Indicators   
Distinct sets of predefined indicators are presented in each of the original papers that 
constitute this dissertation. We identified all routinely available indicators in the 
existing health data ecosystem comprised of the existing aggregate RHIS and MICS. 
In addition, national guidelines for ANC were identified and used to define indicators 
of health system performance of ANC. 
11.5.1 Routine health information system indicators (paper I) 
We included indicators that were part of the existing RHIS (described in 9.6.1, box 
1), reported from primary healthcare clinics that could also be calculated using 
clinical records data. The included indicators are listed below:123  
 Mean number of ANC visits  
 Maternal age  
 Anemia: maternal anemia at 36 weeks  
 Reportable maternal conditions (from referrals): 
 Gestational diabetes mellitus 
 Multiple pregnancy  
 Malpresentation at term  
 Recurrent miscarriage 
 Preeclampsia 
 History of Cesarean sections 
 Anemia: at any gestational age 
 Rhesus negative blood group 
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 Fundal height discrepancy 
 Oligohydramnios or polyhydramnios 
The following indicators that were part of the aggregate RHIS reporting from primary 
healthcare clinics were excluded: 1) iron-folate supplementation that was reported as 
the number of units prescribed (box 2) and data for RHIS reporting were not derived 
from the clinical records per se; and 2) two maternal conditions – preterm rupture of 
membranes and antepartum vaginal bleeding, for which women were likely to be 
immediately referred from primary healthcare for emergency obstetric care to a 
secondary health facility, and as a result, documentation of data required to calculate 
these indicators in the clinical records may be incomplete.  
The health system-prescribed definition of each indicator meant to be used for 
manual aggregation while preparing monthly reports of event counts in the existing 
RHIS was documented. We used clinical datapoints from the paper-based clinical 
records, applied the definition of each indicator and reconstituted the selected 
indicators. For all the reportable maternal conditions, we calculated the value of the 
indicator as any occurrence of the maternal condition and then, including only those 
with the condition and referred, as is the reporting practice in the existing aggregate 
paper-based RHIS. Event counts of the aggregate RHIS reports of the same selected 
indicators were transformed to proportions using the predefined denominators 
(described in section 11.2.3).  
Calculated values of indicators from the clinical records data were then compared 
with aggregate RHIS clinic, district- and national reports. 
11.5.2 Health system performance indicators (paper II) 
Health system performance indicators were derived from guideline-based quality 
standards of the recommended clinical ANC interventions in the public health system 
in the West Bank.124  
We included the ANC interventions that were applicable to all pregnant women and 
appropriate for the level of primary healthcare. Five visits were recommended as part 
of ANC, with specific content to be provided during each visit. According to the 
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national guidelines, all pregnant women attending care in public primary healthcare 
clinics were to be provided with eight ANC interventions (table 4). Four of these 
interventions consisted of repeat screenings at specified timing during the pregnancy 
(table 4). Screening for gestational diabetes mellitus consisted of a two-step screening 
process – a urine sugar test and blood sugar test. Screening tests of the remaining 
interventions were recommended during the first ANC visit.  
The following ANC interventions were part of the recommendations in the West 
Bank, but not offered in primary healthcare: management of prelabour rupture of 
membranes and preterm labour, induction of labour for management of prelabour 
rupture of membranes at term, antibiotics for management of preterm rupture of 
membranes, management of eclampsia, and management of vaginal bleeding.  
Condition-specific clinical managements were also specified in the guidelines for the 
following conditions detected during screening: anemia, hypertension, likely 
diabetes, abnormal fetal growth, urinary tract infections, and Rh negative blood 
group. Managements primarily consisted of referrals to high-risk (referral) clinics or 
to secondary and tertiary care facilities. 
Three sets of metrics were assessed for the ANC interventions (table 4): 
1. Coverage of at least one screening, applicable to all ANC interventions 
2. Coverage of appropriate number of screenings, applicable to ANC interventions 
that consist of repeat screening 
3. Effective coverage of ANC interventions incorporating the appropriate number 
and timing of screenings, applicable to ANC interventions with a specified timing 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































11.5.3 Lives Saved Tool indicators (paper III) 
Context-specific coverage and health status indicators from ANC for input in LiST 
were first identified.125 These included:  
 % of women with diabetes with appropriate management 
 % of women with hypertensive disorders in pregnancy with appropriate 
management 
 % of women with appropriate tetanus toxoid vaccination 
 % of women with pre-eclampsia with appropriate management 
 % of pregnant women taking iron or folic acid supplements 
 % of pregnant women with anemia 
 % of women with severe anemia 
 Low body mass index 
Values of these indicators were derived from each of the four available data sources: 
1) RHIS reports (2016); 2) MICS (2014); 3) paper-based clinical records (2015); and 
4) eRegistry electronic clinical records (2017).    
Diabetes case management and hypertension case management were calculated using 
data from the paper-based clinical records and the eRegistry electronic clinical 
records, based on management algorithms as per the recommended guidelines.  
In order to calculate the case management indicators, we first estimated the number 
of cases in the sample given by:  
      
%  × %   
 
For diabetes (two-step screening) and hypertension (repeat screening during every 
ANC visit), each of the screening stages were accounted for and the formula 
subsequently included the number of abnormal results at each screening as well as the 




Statistical analyses were preformed using Stata version 15 (StataCorp. 2015. Stata 
Statistical Software: Release 14. College Station, TX: StataCorp LP). Descriptive 
statistics were generated as weighted proportions with 95% confidence intervals (CI), 
using the STATA command svyset126 (papers I and II).  
Using logistic regression analysis, we studied the associations of potential 
explanatory variables and effective coverage of ANC interventions (paper II). All 
infrastructure-related and maternal sociodemographic variables were entered into the 
model as explanatory variables, and adjusted odds ratios with 95% CI were 
generated. Laboratory and ultrasound availability in the clinics were the two 
infrastructure-related variables that were included. Maternal sociodemographic 
variables were analyzed using the pre-defined categories available in the anonymized 
dataset as follows: women’s age at pregnancy registration (<21 years, 21-34 years, 
>34 years); age at marriage (<20 years and ≥20 years); education (<10 years, 10-13 
years, >13 years); and parity (nulliparous, multiparous<4, multiparous ≥4).  
Analysis in the Lives Saved Tool was done using LiST version 5.71 (Avenir Health) 
(paper III). As per the LiST modeling approach, the estimate of effectiveness of the 
specific intervention multiplied by the change in coverage gives the number of 
maternal and newborn deaths, and stillbirths averted. If a single intervention is input, 
the underlying formula is given by:99  
Lives saved= (cause-specific deaths) × (change in coverage) × (intervention 
effectiveness × affected fraction), where ‘affected fraction’ is the proportion of 
deaths amenable to benefit from this particular intervention. 
The primary result of our LiST analysis was the difference in the number of deaths 
and anemia cases averted between the following two scenarios: 1) a steady state 
scenario where coverage of ANC interventions remain unchanged from 2017 to 2025; 
and 2) a scenario where coverage of ANC interventions increased to 90% from 
baseline in public clinics only (with no change in non-public sector health facilities) 
in 2018, and then remained at a steady state through 2025. 
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11.7 Summary of methods used 
The data sources used, study design and indicators presented in the three papers that 
constitute the dissertation are presented in table 5.  
Table 5: Overview of methods used in the papers - objectives, data sources, study 
design and indicators  
 Paper I Paper II Paper III 
Objective To compare indicators 
routinely generated by the 
health information system 
computed from individual-
level data and aggregate 
reports 
 
To assess coverage of at 
least one screening, 
coverage of appropriate 
number of screening and 
effective coverage of 
antenatal care interventions 
and to explore factors 
associated with effective 
coverage 
To examine the 
implications of multiple 
sources of data for 
modeling in the Lives 
Saved Tool (LiST) 
Data source Paper-based clinical 
antenatal records (2015) 
(n=1369) from 17 clinics 
Aggregate RHIS reports 
(2015): clinics, district and 
national reports 
Paper-based clinical 
antenatal records (2015) 
(n=1369) from 17 clinics  
Facility inventory (2014) 
Paper-based clinical 
antenatal records (2015) 
(n=1369) from 17 clinics 
eRegistry electronic clinical 
antenatal records (2017) 
Aggregate RHIS reports 
(2016) 
Multiple Indicator Cluster 
Survey (2014) 
Study design Cross-sectional study  Cross-sectional study Secondary data analysis 
Indicators   Antenatal visits  
 Maternal age 
 Maternal anemia  
 Gestational diabetes 
mellitus  
 Multiple pregnancy 
 Malpresentation 
 Recurrent miscarriage 
 Preeclampsia  
 History of Caesarean 
section 
 Rhesus negative blood 
group 
 Fundal height 
discrepancy 
Screening indicators of 
ANC interventions, 
including:   
 Anemia screening 
 Diabetes screening 
 Hypertension screening  
 Tetanus toxoid 
immunization 
 Fundal height 
measurement 
 Rh-typing 
 Urine analysis 
 Antenatal ultrasound 
 Diabetes case 
management 
 Hypertensive disorders 
in pregnancy with 
appropriate 
management 






 Anemia, severe anemia 




weighted proportions and 
95% CI 
Descriptive statistics, 
weighted proportions and 
95% CI  
Exploratory logistic 
regression analysis 
Modeling in the Lives 
Saved Tool 
RHIS: Routine Health Information System  
ANC: Antenatal care  
CI: Confidence Interval 
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11.8 Ethics approvals 
Ethical approvals for data collection from paper-based clinical records were obtained 
from the Palestinian Health Research Council and the Regional Committee for 
Medical and Health Research Ethics, South-East, Norway. Approval for use of 
secondary anonymous data from the eRegistry was obtained from the Palestinian 
Ministry of Health, Ramallah, in line with the legal framework for eRegistry data use. 
Only pre-specified variables of completely anonymous data were obtained for the 
analyses. Age of women, education, age at marriage and age at first pregnancy were 
only available as predefined categories, as per the standard operating procedures of 
routine registry operations in Palestine. Clinic- and district names were not available 
















12 Synopsis of results  
This section contains a summary of the results that are presented in detail in the 
papers that constitute this dissertation.  
12.1 Paper I  
Comparing individual-level clinical data from antenatal records with routine health 
information systems indicators for antenatal care in the West Bank: a cross-sectional 
study123 
Maternal age was consistent across the clinical records data (age<16 years: 0.1%, 
95% CI: 0, 0.4; age>40 years: 1.2%, 95% CI: 0.6, 2.1; 2), RHIS clinic reports 
(age<16 years: 0.1%, 95% CI: 0, 0.4; age>40 years: 1.4%, 95% CI: 1, 2), and 
nationally reported statistics for the five districts (age<16 years: 0.2%, 95% CI: 0.1, 
0.3; age>40 years: 1.7%, 95% CI: 1.5, 2). Mean number of ANC visits as calculated 
from the clinical records data (4.5, SD 2.3) was similar to the RHIS clinic reports 
(mean 4.5), and nationally reported statistics from the five districts (mean 4.7).  
There were 280 documented hemoglobin tests at 36 weeks in the clinical records data 
(20% screening coverage), compared to 890 hemoglobin tests recorded in the RHIS 
clinic reports (61% screening coverage) and 7602 hemoglobin tests at 36 weeks in the 
nationally reported statistics (52% screening coverage). The indicator anemia at 36 
weeks calculated from clinical records data was 32% (95% CI: 22, 44); from RHIS 
clinic reports was 31% (95% CI: 29, 35); and the nationally reported statistics for the 
five districts was 30% (95% CI: 29, 31). Maternal conditions calculated from clinical 
records data, RHIS clinic reports, district reports and nationally reported statistics are 








Table 6: Selected indicators computed from clinical records data, and those reported 
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None 1 0.01 
(0, 0.04) 
RHIS: Routine health information system 
 
The proportion of women that were referred from the primary healthcare clinics was 
generally low and ranged from a maximum of 71% for preeclampsia to 16% for 
fundal height discrepancy. A substantial proportion were referred to health facilities 
that did not report on ANC indicators to the RHIS, and these data were not captured 










12.2 Paper II 
Effective coverage of essential antenatal care interventions: a cross-sectional study 
of public primary healthcare clinics in the West Bank124 
Coverage of any five ANC visits was 48% and coverage of any four ANC visits was 
60%, not considering the schedule or timing of visits. Timely, scheduled attendance 
at all ANC visits according to the national ANC guidelines was 6% (ANC visits <16 
weeks, at 16 weeks, and at 24-28, 32 and 36 weeks). Thirteen per cent attended 
timely scheduled visits, when attendance was calculated disregarding early first ANC 
visit before 16 weeks and only considering timely visits after pregnancy registration 
at any time. Timely attendance of all ANC visits was 17% in clinics with a laboratory 
and ultrasound, and 9% in clinics without (OR 2.0, 95% CI 1.4, 2.8).  
Effective coverage of appropriate and timely screening of ANC interventions ranged 
from a low of 6% for hypertension screening to a high of 64% for Rh-typing (table 
7).124 Coverage of at least one screening ranged between 35% for screening for 
tetanus immunization status to 98% for hypertension screening, and coverage of 
appropriate number of screening of ANC interventions ranged from 31% for anemia 
screening to 78% for Rh typing (table 7). 
Among those that attended ANC visits according to the prescribed guidelines, 77% 
were screened for hypertension, 73% received antenatal ultrasound, 61% were 









Table 7: Coverage of ANC interventions – at least one screening, appropriate 
number of screening and effective coverage, and ANC visits 

















98 (96, 99) 38 (31, 47) 10 (8, 13) 
48 (38, 58) 13 (9, 17) 
SFH measurement 66 (50, 80) 35 (24, 48) 6 (4, 9) 
Screening for 
anemia 
93 (89, 96) 31 (23, 40) 14 (9, 21) 73 (62, 81) 33 (26, 41) 
Antenatal 
ultrasound 








55 (45, 64) 42 (36, 49) NA 
Screening for Rh-
type* 





35 (23, 50) NA 
ANC: Antenatal care 
SFH: Symphysis fundus height 
*only one screening test is recommended during ANC according to the national guidelines
Clinics with a laboratory and ultrasound had a statistically significant higher odds 
ratio of effective screening for the following interventions: hypertension screening 
(OR: 2.2, 95% CI: 1.5, 3.1), anemia screening (OR: 1.5, 95% CI: 1.1, 2.1), ultrasound 
(OR: 2.2, 95% CI: 1.7, 2.8), Rh-typing (OR: 1.7, 95% CI: 1.3, 2.1).  
Except for parity and effective coverage of screening for tetanus immunization status 
(higher odds of screening for multiparity ≥4, OR: 2.1, 95% CI: 1.4, 3.2), none of the 
other maternal sociodemographic variables had statistically significant associations 
with effective coverage of ANC interventions.  
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12.3 Paper III 
Antenatal care data sources and their policy and planning implications: a 
Palestinian example using the Lives Saved Tool125 
For input in LiST, data from paper-based clinical records and eRegistry electronic 
records could populate all the five coverage indicators and all the three health status 
indicators. Two coverage indicators were available in the national statistics, while 
three coverage indicators were indirectly calculated (using the Kanyangarara method) 
from the MICS data (table 8).125 None of the health status indicators were available 
from either the aggregate RHIS reports or MICS. 
Table 8: Values of ANC indicators for input in LiST from RHIS aggregate reports, 
MICS, paper-based clinical records and eRegistry electronic clinical records 
  Aggregate 
RHIS 
reports 

























  % of all pregnant women who have 
completed the appropriate tetanus toxoid 
vaccination schedule  
NA NA 85.4 92.1 
% of pregnant women taking the 
appropriate iron or folate supplementation 
NA NA 90.3 64.4 
% of women with hypertensive disorders in 
pregnancy who are correctly managed 
NA 68.9† 15 35 
% of women with diabetes with appropriate 
case management 
71.9 35.1† 7 10 
% of women with pre-eclampsia during 
pregnancy who are correctly managed 
51.7 72.9† 11 14 
Anemia 27* 27* 37.3 37.7 
Severe anemia 0.272* 0.272* 0 0.1 









































% of all pregnant women who have 
completed the appropriate tetanus toxoid 
vaccination schedule 
NA NA 92,0 95,7 
% of pregnant women taking the 
appropriate iron or folate supplementation 
NA NA 94.7 80.6 
% of women with hypertensive disorders in 
pregnancy who are correctly managed 
NA 75.5† 53.6 64.5 
% of women with diabetes with appropriate 
case management 
84.7 47.3† 49.2 50.9 
% of women with pre-eclampsia during 
pregnancy who are correctly managed 
73.6 74.5† 51.4 50.9 
Anemia 27.2* 27.2* 37.3 37.7 
Severe anemia 0.272* 0.272* 0 0.1 
Body mass index (BMI) 3.1* 3.1* 2.8 4.4 
*LiST defaults: Finucane 2011 127, Stevens 2013 120; †Using the Kanyangarara method 104  
RHIS: Routine health information system 




Using RHIS reports, increasing coverage of appropriate care to 90% in the LiST 
analysis, estimated that 16 maternal deaths and 239 stillbirths and would be averted. 
With MICS data, fewer maternal deaths (n=5) and stillbirths (n=45) were estimated to 
be averted. When using RHIS national statistics or MICS, no averted newborn deaths 
or anemia cases were identified.  
The number of maternal deaths averted on increasing coverage was similar when 
using data from paper-based clinical records (n=35) and eRegistry electronic records 
(n=39). Further, 285 stillbirths and 49 newborn deaths were averted using paper-
based clinical records data, while 270 stillbirths and 39 newborn deaths were averted 
using eRegistry electronic clinical records. While 16,444 cases of maternal anemia 
would be averted with paper-based clinical records, 42,064 cases were averted using 
eRegistry electronic clinical records. Percent reduction in the maternal mortality ratio 
ranged from 1% with MICS data, to 6% using ANC records data.  
Preeclampsia management and hypertension disease management accounted for a 
large proportion of lives saved (table 8).  
Table 9: Interventions averting mortality in the Lives Saved Tool using different 
sources of input data   
Mortality/ 
morbidity  
Interventions averting mortality and morbidity 
RHIS aggregate 
data 











































Anemia - - Iron Folate (100%) Iron Folate (100%) 
RHIS: Routine health information system 




The main aim of this dissertation was to assess the consequences of using individual-
level clinical data to generate health- and health system performance indicators, 
compared to data from a household survey and the existing aggregate RHIS. There 
were three specific objectives. Firstly, we compared the values of routinely reported 
indicators calculated from clinical records data, with values in the manually reported 
aggregate RHIS reports. Secondly, we used clinical records data to assess effective 
coverage of ANC interventions and examined associations of effective coverage with 
clinic infrastructure and maternal sociodemographic variables. Lastly, we calculated 
indicator values from paper-based clinical records data, eRegistry electronic clinical 
records data, obtained the indicator values from aggregate RHIS reports and MICS 
data, as distinct inputs in the Lives Saved Tool (LiST), and assessed the implications 
of using the different data sources for modeling.  
The joint findings supported the study hypothesis that the transition from an RHIS 
based on manual aggregations to an RHIS based on clinical records data will lead to 
significant changes in the values of routinely-reported indicators, and the 
interpretations of health system performance of ANC. 
Pilot implementations with structural similarities to the RHIS transformation 
portrayed in this dissertation have been described in Rwanda128, Malawi and Kenya, 
where data collected in clinical records are being used for automated generation of 
routine indicators and for health system performance monitoring. In many of these 
settings, data-related changes of RHIS strengthening efforts have been appraised in 
terms of completeness, timeliness and availability.129,130 In the Kenyan setting, the 
assessment was primarily done to check for interoperability of electronic clinical 
records with an existing electronic RHIS, where only aggregated event counts were 
manually entered into electronic RHIS reporting forms. In this case, indicator 
completeness improved from 66.7% to 100% and accuracy improved from 33.3% to 
100% with automated indicator calculations using clinical records data, mainly 
because of a reduction in transcription errors.131  
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In Malawi, point-of-care data collections were designed to overcome identified 
problems in the existing RHIS, such as incomplete reporting from health facilities 
and low motivation of healthcare staff to perform RHIS tasks. Following the 
introduction of a system that uses electronic clinical records data for RHIS indicators, 
the availability of data on clinical diagnosis and treatment information improved.132  
The RHIS transformation, as described in section 9.6.2, was planned for 
implementation at scale for the entire West Bank, with the intention of replacing 
existing manually aggregated reports with an electronic RHIS consisting of a 
distinctive underlying data source for computations of indicators. In contrast to the 
abovementioned studies, availability and completeness of RHIS aggregate reports 
were not of primary concern in our study setting; all RHIS clinic- and district reports 
were available for the present study (paper I) with non-zero values of event counts.123 
Timeliness of RHIS reporting was expected to be addressed with the introduction of 
the eRegistry, and electronic RHIS reports were scheduled to be generated 
automatically every month. Beyond completeness and timeliness of RHIS reports, we 
included quantitative evaluations of changes in the values of routinely reported 
indicators compared to the RHIS aggregate reports. In addition, we have 
demonstrated some implications for use of data for monitoring health system 
performance of ANC.   
13.1 Discussion of main findings  
Key facets of a health information system are to develop indicators generated from 
data-related processes including data transmission, processing and analysis, as 
described by Lippeveld et al (2000).20 The construction of indicators using clinical 
data can be done using two types of data: 1) sequences of datapoints with recorded 
results of the screening (eg. blood pressure values); or 2) dichotomous ‘yes/no’ 
response data of whether a screening was provided (eg. blood pressure measured: 
yes/no).133 The former is preferable for generating indicators due to its inherent 
flexibilities for computations as well as for minimizing reporting bias. All routinely 
reported indicators (paper I), most of the health system performance indicators 
(except screening for tetanus immunization status) (paper II) and the indicators input 
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in LiST from the clinical antenatal records data (except iron-folate supplementation) 
(paper III) were constructed using the actual recorded results of screening. Similar to 
our study, indicator computations in the eRegistry are configured to use the actual 
recorded values of results of screening and management as primary data.  
13.1.1 Routine Health Information System indicators 
The PRISM Toolkit that accompanies the PRISM framework (described in section 
9.2) recommends assessing RHIS data quality by comparing aggregate RHIS reports 
with the source document in health facilities.33 Paper-based clinical records were the 
primary documentation source of the RHIS in our setting, documentations in clinical 
records preceded any other steps in the RHIS data aggregation process in the clinics.  
Our findings showed that while indicator values within the existing aggregate RHIS 
clinic, district and national reports were largely consistent, discrepancies were 
uncovered between the values of some of the indicators calculated from the clinical 
records data and the existing aggregate RHIS reports. 
In general, values of demographic indicators were consistent between the clinical 
records data and aggregate RHIS reports. Similar tendencies have been reported in 
assessments in Tanzania,38 and Ghana,134 where data quality was better for 
demographic data, compared to manual reporting of clinical risk factors or 
conditions.  
The indicator of ANC visits had similar values when computed from clinical records 
data as the aggregate RHIS reports. However, ANC visits from the clinical records 
data had a wide distribution around the mean (mean 4.5, SD 2.3), indicating that 
many pregnant women in our sample did not get ANC 4+. This finding is similar to 
the results from two comparable health system settings – Jordan and Egypt – where a 
study using survey data reported wide variability in the number of ANC visits.72 
Standard deviations were not available in the existing aggregate RHIS reports.  
The substantial discrepancy in the values of maternal conditions between the clinical 
records data and the aggregate RHIS reports can be attributed to issues related to 
RHIS data collection, processing and transmission, outlined in the mechanism of 
66 
 
change (section 9.6.2.2). Specifically based on our findings, issues contributing to the 
discrepancies included inconsistent denominators, errors in manual computations, and 
production of unreliable indicators due to a complex RHIS reporting structure.123  
Maternal anemia at 36 weeks is an indicator of public health significance.120,135 Our 
findings point towards inconsistencies in manual aggregations and manual 
calculations for this indicator. An overall higher number of hemoglobin tests were 
reported by care providers compared to the clinical records data, possibly because all 
hemoglobin tests were being counted and not only those done at 36 weeks. 
Inadequate understanding of what to report may be the underlying challenge, also 
identified in many other studies as a critical issue affecting RHIS data 
quality.44,47,50,136 In the RHIS clinic reports, three of the 17 clinics reported more 
hemoglobin tests than the number of pregnancies registered in the clinic, presumably 
because the number of hemoglobin tests were counted as opposed to the number of 
pregnant women with at least one hemoglobin test at 36 weeks, resulting in less 
reliable indicators. Counting conditions instead of clients is not restricted to only the 
West Bank. In Tanzania, a study reports similar counting of number of diagnoses of 
childhood illness as opposed to number of children with illnesses.38 A 14-36% error 
rate in reporting of anemia at 36 weeks was found in the RHIS assessment in 
Ghana.134  
Factors relating to a complex RHIS reporting structure outlined in the ‘data 
transmission’ processes in the mechanisms of change (described in section 9.6.2.2), 
appears to have contributed to the overall discrepancy. In the existing structure of the 
RHIS, only referred cases with reportable maternal conditions were reported from the 
high-risk clinics. But our results showed a clear mismatch between the recommended 
guidelines for referrals and clinical practice, resulting in underestimations of maternal 
conditions in the aggregate RHIS reports.123 In addition, referral practices varied 
among our sample of clinics. Another study in the West Bank from 2017 reported 
similar findings, where mean referral rate ranged from 7.3% (SD 8.3) to 12% (SD 
11.7) in a sample of 39 primary healthcare clinics.137  
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A precursor for appropriate referrals is the correct diagnosis and classification of 
maternal conditions (mechanisms of change, described in section 9.6.2.2). Errors in 
the case identification process have been identified as the leading cause of poor 
quality of RHIS data in other settings.136,138 In our analysis of clinical records data, 
we generated values of indicators of maternal conditions using constituent datapoints. 
It is possible that misdiagnosis or incorrect classification of conditions by care 
providers contributed to the discrepancy between the clinical records data and 
aggregate RHIS reports. 
The PRISM framework, a comprehensive framework of information systems 
development and evaluation (described in section 9.2), does not endeavor to 
explicitly identify if available RHIS indicators satisfy information needs.34 The 
definitions of some of the routinely reported indicators may need to be revisited, in 
order to improve their usability and comparability to other settings. Definitions of 
RHIS indicators also have implications for understanding the magnitude of the 
problem. Applying the WHO’s diagnostic cut-offs for calculations using the clinical 
records data generated an indicator value of 6% (95% CI: 4-10) for gestational 
diabetes, compared to a value of 0.8% (95% CI: 0.4–1.7) using the existing 
Palestinian definition used by their RHIS. 
Certain other indicators may not be valuable in fulfilling information needs, simply 
because clinical practices may no longer align with the reporting requirements of the 
RHIS. For example, fundal height discrepancy was a reportable maternal condition 
and recommended management is by referral. This indicator had the largest 
magnitude of discrepancy between clinical records data (20%, 95% CI: 12.4, 30.8), 
compared to the aggregate RHIS reports (0.01%, 95% CI: 0, 0.04). Our data also 
showed that only 6% of those with a fundal height discrepancy were referred to the 
high-risk clinic,123 and as a result, no fetal growth monitoring indicators were 
captured in the RHIS reporting. Antenatal ultrasound is widely available and used in 
this region of the world; 74% of the women in our sample received at least one 
documented ultrasound.124 Further, we found that in clinics with ultrasound 
equipment, only 29% of the women had a fundal height measure.124 Given this, better 
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understanding of fetal growth monitoring in public clinics would require a 
comprehensive screening strategy as well as including ultrasound results of fetal 
growth monitoring as part of RHIS reporting.  
13.1.2 Health system performance indicators  
In settings with an electronic RHIS, the PRISM Toolkit suggests assessing whether 
the RHIS can provide denominators for calculating coverage of ANC first visit.33 
More detailed evaluations were warranted in our setting, given the nature of the RHIS 
transformation.  
Early first ANC visit before 12 weeks (47%, 95% CI: 38, 55) was lower in our study 
compared to other reported figures from the Middle East and North Africa region 
using population-based survey data, where proportions attending an early first ANC 
visit ranged between 70-80%.139 According to MICS 2014, 93% of the respondents 
had a first ANC visit in the first trimester in the West Bank.109  
While almost half of all the women in our sample had at least five ANC visits, 
coverage of appropriately timed ANC visits was lower at 13%. Underlying 
contributing factors to the low coverage of appropriately timed ANC visits may 
include care providers’ insufficient knowledge of ANC guidelines, inadequate 
training and supervision, lack of ANC utilization by pregnant women or 
combinations of these factors. Frequent use of antenatal ultrasound, purportedly a 
common practice in the West Bank, could inflate the coverage of any five ANC 
visits, compared to ANC attendance according to the recommended schedule during 
which other important ANC interventions are to be provided. A study in Syria 
assessing antenatal ultrasound use found that women’s preference for repeated 
ultrasound scans may result in frequent visits to the clinics during pregnancy, where 
ultrasound was performed while other care content may not be provided.140  
Coverage of at least one screening test, as defined in our study, is the conceptual 
equivalent of what other studies have reported as ANC “content”72,141,142 or 
“quality”6,71 or “adequacy”.81,139 In these studies, data sources used to quantify ANC 
content include survey data,72,81 self-reported journals of clients,141 direct 
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observations of ANC at health facilities,7 clinical records data142 or a combination of 
population-based survey and health facility data.143 Coverage of at least one screening 
can, therefore, be interpreted in light of such studies, with due awareness of the 
fundamental differences in the underlying data sources.  
Any blood pressure measurement and hemoglobin testing are two ANC interventions 
that have relatively high coverage in many other LMIC.71,72 Similarly, in our analysis, 
the coverage of at least one screening of blood pressure and hemoglobin was over 
90%.124  
Screening for tetanus immunization status had the lowest coverage (35%) of all the 
ANC interventions. In Jordan, the coverage of tetanus immunization during ANC was 
found to be 31.5%.72 In LMIC with lower institutional delivery rates than in our study 
setting, screening and providing tetanus immunization during ANC are critical 
indicators to monitor.144 Hospital delivery rates are high in both Jordan and the West 
Bank (>98% institutional delivery),107 and no cases of neonatal tetanus have been 
reported in the West Bank in the past 4 years.107 The underlying reasons for low 
coverage of screening for tetanus immunization status during ANC need further 
exploration.   
We assessed two additional metrics: 1) coverage of appropriate number of screenings 
(not factoring in timing of screening); and 2) effective coverage of ANC 
interventions. According to our definitions, percentage screening multiplied by timely 
attendance rates gives effective coverage of ANC interventions. Hence, both 
attendance and ANC content are, theoretically, equally important drivers of effective 
coverage. Our findings indicate that the gap towards “100% timely attendance” is 
larger than the gap towards “100% coverage of interventions” in the West Bank. The 
lowest intervention coverage was for tetanus immunization at 35%, while only 13% 
of women attended all recommended visits in a timely fashion. We have, therefore, 
presented this as one metric “effective coverage of ANC interventions”, to indicate 
quality-corrected coverage to quantify the provision of clinical ANC interventions. 
Consequently, for ANC interventions consisting of one-time screening, the difference 
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between coverage of at least one screening and effective coverage of ANC 
interventions was less pronounced.124  
Poor quality of ANC, measured in terms of the receipt of a set of clinical ANC 
services, has been highlighted in many studies.71,72,81 The “quality-coverage gap” is 
one of the main contributors to the low effective coverage of ANC in LMIC.6,71 
Effective coverage of ANC was about 45% in Kenya,83 50-80% in different states in 
Mexico,145 and about 20%-50% in eight LMIC.7 The authors of the Lancet 
commentary on maternal and child health in the occupied Palestinian territory allude 
to frequent ANC visits with poor content of care, and care that does not always 
consist of evidence-based interventions.116 Our finding of relatively low effective 
coverage of ANC interventions has commonalities with a multi-country study using 
survey data, where ANC content was quantified as the coverage of six routine ANC 
interventions. The study found that the coverage of ANC interventions among women 
that had ANC was lowest in Jordan (9.9%) among the 10 included LMIC.72 In Oman, 
coverage of ANC content, assessed in terms of at least one blood pressure 
measurement, blood and urine samples taken, an ultrasound and counseling for 
danger signs using population-based survey data, was 71.7% although 96.8% had 
four or more ANC visits.139 Despite fundamental differences in the data sources and 
metrics used, a general trend may be noted between these studies and our finding of 
low effective coverage of ANC interventions.  
Health facility surveys such as SPA and SARA collect data on clinic infrastructure 
availability that serve as input measures of quality of care. However, recent evidence 
showed a modest correlation between the availability of infrastructure and clinical 
ANC content in the sub-Saharan African setting.146 In our study, some of the 
statistical associations between effective coverage of ANC interventions and clinic 
infrastructure availability were intuitive to explain. For example, clinics with 
laboratory and ultrasound availability had a higher effective coverage of laboratory-
dependent screening such as for anemia and Rh-type. The lower effective coverage of 
SFH in clinics with infrastructure availability is perhaps due to the use of ultrasound 
for fetal growth monitoring in these clinics. Timely scheduled ANC attendance was 
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higher in clinics with infrastructure (17%) compared to clinics without (9%), and this 
can explain the higher effective coverage of hypertension screening in clinics with 
infrastructure availability.  
In our analysis of associations of maternal sociodemographic factors and effective 
coverage, we were reliant on the equity stratifiers collected in the paper-based clinical 
records, namely, mother’s age, age at marriage, education and parity, each with 
predefined categories of data. In many LMIC, routine data for equity analysis are 
mainly available from censuses and vital registrations, and some equity-data are 
usually collected in household surveys.61 Health facility and administrative data are 
less common sources of data on equity stratifiers. Further, studies of inequities in 
maternal and child health services or outcomes have used population-based data and 
are probably better poised to unravel sociodemographic disparities,80,147 which may 
not have been captured in our study using health facility data of those who seek care. 
Besides, commonly used equity stratifiers such as household expenditure, individual 
income or household wealth index were not available for analysis in this study.  
Ideally, the metric of equity and the metric of health required for equity analysis are 
available from one data source.61 Household income and number of members in the 
household (to calculate average monthly household income) were two data points 
added to data collections in the eRegistry, in an attempt to capture more robust equity 
stratifiers alongside individual-level health data (data not included in the present 
study).113 
13.1.3 Lives Saved Tool analysis 
LiST is a linear mathematical modeling tool.100 LiST models are characterized as 
deterministic, that is, the model output, consisting of population-level risk factors and 
cause-specific mortality, is determined by the specified parameters of changes in 
intervention coverage.100 Several research studies using LiST have acknowledged that 
the validity of LiST outputs depend on the quality and availability of input data, 
acknowledging this as a general limitation for modeling.103,148 However, few studies 
have assessed the implications of using different sources of data for modeling in 
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LiST. Default values of coverage and health status indicators are provided in the 
LiST software; the values can be modified with locally available data and estimates. 
As far as we are aware, this is the first study to assess implications of using different 
data sources for modeling of ANC in LiST. Through our findings, we have illustrated 
the implications of using data sources that commonly constitute a health information 
system in LMIC for computing intervention coverage, including population-based 
MICS, RHIS aggregate reports and clinical records data.125 Until this study, LiST had 
not been used in the Palestinian health system setting. 
Munos et al found that household surveys were generally unsuitable sources of data 
for measuring coverage of interventions that are complex and require clinical data for 
calculations.93 Our findings reiterated this; none of the LiST input indicators were 
directly populated by the MICS data. Given the general lack of availability of 
measured indicators for input, Kanyangarara and Chou (2017) developed a method to 
obtain indirect estimates of intervention coverage for LiST with focus on sub-Saharan 
Africa.104 In this method, predicted values of intervention coverage are derived 
through a linking approach of commonly available data on ANC from population-
based surveys – ANC 4+, early first ANC visit before four months, and blood or 
urine sample taken during ANC – with data from facility surveys like SPA or SARA. 
Coverage of diabetes and hypertensive disease case management are two LiST 
indicators that do not typically have readily available measured data.148 These were 
available from the paper-based clinical records data and the eRegistry electronic 
records, while the method proposed by Kanyangarara and Chou was used to generate 
estimates of “likelihood of care” using proxy indicators from MICS and RHIS 
aggregate reports. As an illustration of how measured coverage and estimates of 
“likelihood of care” compare, we applied the prediction formula to paper-based 
clinical records data; the resulting indirect estimate for hypertension case 
management was 62%, which is a considerable overestimate of the measured case 
management indicator of 15% based on measured coverage of appropriate screening 
and management.  
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Of the four data sources used in the LiST analysis, measured data for direct 
calculations of indicators were available from paper-based clinical records and 
eRegistry electronic clinical records. Consequently with these two data sources, 
comparatively fewer assumptions were required while generating input indicators. 
The absolute mortality reductions were small in the study context (1-6% in maternal 
mortality, and 0-3% for neonatal mortality, stillbirth cases and anemia cases). In 
settings with higher mortality and morbidity levels than the West Bank, these results 
are likely to be magnified. Similar numbers of maternal, newborn and stillbirth lives 
saved were obtained with input data from paper-based clinical records and eRegistry 
electronic records, except for the number of anemia cases averted. The two-fold 
higher number of anemia cases averted with the eRegistry electronic record compared 
to paper-based clinical records (42,064 vs. 16,444) could be due to the underlying 
differences in the data capture process between the two systems. In the paper-based 
clinical records, datapoint of iron-folate supplementation was collected as a single 
checkbox to indicate whether or not supplements were provided. This might have 
overestimated performance with respect to this indicator in the paper-based clinical 
records, compared to the eRegistry. In the eRegistry, clinical management data are 
collected more systematically with validation rules for data entry. This highlights the 
need to consider exactly how questions are asked in an electronic RHIS in order to 
obtain the most useful data for action.  
The interventions averting deaths were distinct for each data source used, and even 
when there was some degree of overlap, the composition of interventions averting 
deaths varied. Using MICS data as the input, efforts to reduce maternal mortality 
should be focused on strengthening hypertension disease management (75% of 
mortality and morbidity averted by hypertension disease management), whereas using 
RHIS aggregate data indicated that all efforts should target preeclampsia management 
(100% of mortality and morbidity averted by preeclampsia management). Similarly, 
for stillbirth reduction, improving coverage of diabetes case management would be 
down-prioritized compared to pre-eclampsia management if clinical records data 
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were used, while with MICS data for LiST modeling the coverage of both of these 
interventions would then get equal priority.  
This LiST analysis per se has some limitations. The different data sources for 
coverage data were from slightly different time periods (2014-2017), while maternal 
mortality estimates were derived from 2015 WHO reports.108 We assumed that 
referral of pregnant women is an indication of receiving appropriate care, which may 
not be the case. For instance, appropriate management of preeclampsia, according to 
LiST definitions is with magnesium sulfate. Yet, the lack of use of magnesium sulfate 
has been pointed out in the West Bank.116,118  
In our analysis, we modeled mortality reductions through increased coverage of just 
ANC interventions, which may still only explain a small proportion of lives saved. 
Obstetric services and interventions during labor and delivery, and postnatal care 
have been demonstrated to be important, and perhaps more effective in averting 
maternal and neonatal deaths in many other LMIC.149  
LiST has inherent technical restrictions that are also applicable to our analysis. There 
is some degree of fundamental uncertainty in the effectiveness estimates of ANC 
interventions. The mortality rates used in LiST are themselves derived from modeled 
estimates.108 Validation studies comparing LiST models with measured mortality 
reductions can provide an understanding of the validity of the modeled results. For 
instance, validations studies of child mortality reductions found that modeled 
projections of mortality estimates were reasonable matches to the measured estimates 
in Ghana150 and South Asia,151 while LiST models were found to underestimate actual 
mortality reductions Mali.150 Maternal mortality projections of LiST have not been 
validated, and this is an important limitation. No validation studies have been 
conducted for LiST projected mortality reductions for a health system setting in the 
Middle East and North Africa region, and subsequently, many of the assumptions in 
modeling may be inappropriate for the West Bank. Finally, the assumed target 
coverage of ANC interventions of 90% in the public clinics may not be feasible to 
achieve, considering that the public health system in the West Bank already suffers 
from several financial constraints.117  
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13.2 Health system implications 
Strengthening of health information systems in the Eastern Mediterranean region has 
been identified as a priority by the WHO.152 The present study was performed in a 
real-world RHIS transformation. We have used context-specific indicators that were 
either already routinely available in the Palestinian RHIS (paper I), or were part of 
MICS (paper III), or based on the recommended clinical guidelines in the public 
health system (papers II, III). These increase the relevance of our findings to health 
systems managers in the West Bank.  
Our findings have immediate significance for the health system as they were 
presented to the Palestinian Ministry of Health, in order for them to understand that 
transitioning from an RHIS based on manual aggregations to an RHIS based on 
individual-level data will lead to significant changes in the values of routinely-
reported indicators. Lomas (1997) emphasized the importance of better cooperation 
of researchers and policy-makers, in order to achieve maximum gain in sound policy-
making based on evidence.153 In keeping with this philosophy, all results mentioned 
in this dissertation were presented to the Palestinian Ministry of Health, in an attempt 
to foster uptake of study findings and interpretations by those that are able to take 
action based on health information.34 Efforts to increase RHIS data quality are critical 
towards strengthened data-driven decision-making and quality improvement efforts 
of health systems.129,154  
In terms of use of indicators for routine health systems monitoring, it should be 
highlighted that all of the health system performance indicators of ANC interventions 
presented in this dissertation may not carry equal relevance. While the identification 
and finalization of national ANC guidelines were derived through expert opinion and 
consensus, the indicators themselves have not yet been subjected to any evaluations 
to assess their use in the health system. The RAND/UCLA Appropriateness method 
is one methodology that could be used to arrive at an optimal list of indicators for 
routine health systems monitoring in the West Bank.155 Purposeful selection of 
indicators for routine monitoring could also be done based on burden of disease of 
maternal and child health conditions in Palestine, and tailored to reflect specific 
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stakeholder perspectives or according to the level of care provision.155 Guidelines for 
the number and timing of ANC visits, and the clinical ANC interventions are 
periodically revised according to emerging evidence,156-159 and the corresponding 
indicators should subsequently be updated.  
In order to make appropriate interpretations of health systems implications, it is 
important to understand the calculations underlying the metrics. In calculating the 
effective coverage of ANC interventions, we adopted an “all or nothing” approach,133 
that is, we calculated the proportion of pregnant women receiving all screening tests, 
if they are registered for ANC in public clinics. Other analytic approaches such as 
“opportunity scores” and “average of averages” could be tested.133 In the 
“opportunity scores” approach, the denominator only takes into account the instances 
when women had ANC visits after registration of pregnancy and the numerator 
counts all instances in which the intended ANC interventions are provided.133 With an 
“average of averages” approach, each individual pregnancy is assigned a score based 
on screening and appropriate management during ANC, and an average of the 
individual scores is subsequently generated for the health facility.133 In addition, if 
such performance indicators are to be implemented in practice to monitor health 
system performance, several other aspects should be considered by health systems 
managers and decision-makers, such as acceptability, feasibility, reliability, 
sensitivity and predictive validity of the metrics.155 
Crucial factors that determine RHIS performance according to the PRISM framework 
include organizational factors of governance, resource-availability, training and 
supervision, and behavioral factors such as demand for data and motivation of 
healthcare staff. Demand for data and health workers’ motivation for behavior change 
will play a vital role in improving RHIS and health system performance.32 In the long 
run, organizational and behavioral factors are crucial for the sustainability of an 
electronic RHIS, as has been demonstrated in other settings.160,161  
Certain issues with RHIS documentations and reporting will not be directly addressed 
just with the introduction of the eRegistry, but warrants training of care providers. 
For instance, 1463 pregnancies were registered in the 17 clinics according to the 
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aggregate RHIS reports submitted by the care provider, while only 1369 of these had 
a paper-based clinical record, leaving 94 pregnancies presumably with no 
documentation trail.123 
The PRISM framework has a restrictive definition of health system performance and 
includes only two aspects of a health systems that can directly be subjected to 
monitoring through RHIS, namely healthcare service delivery and resource 
management.32 This dissertation has a similar underlying premise. Any RHIS, be it an 
aggregate paper-based system or an individual-level eRegistry, is primarily designed 
to capture health facility data, and may not be suited for routine capture of data to 
assess other aspects of quality of health systems. While effective coverage of ANC 
interventions capture effectiveness of care to monitor service delivery, patient-
centeredness and user-experience, efficiency and responsiveness of health systems 
are some of the other critical aspects of health system performance that still need to 
be monitored for ensuring health systems quality.133  
13.2.1 RHIS data in a fragmented health system  
Our study design fulfils the objective of this dissertation of assessing the changes to 
the values of indicators due to the RHIS transformation in public clinics, and the 
findings can provide insight into ANC provided in public clinics.  
However, in order to make stronger interpretations of the overall care received by 
pregnant women from the entire health system based on the results of the present 
study or using data from the transformed RHIS, better understanding is required as to 
where women seek ANC, and whether or not they shift between public, private and 
other healthcare providers. As per the Palestinian Ministry of Health, 40-50% of all 
delivering women attended ANC in public clinics in the West Bank; similar to health 
systems in the Middle East and North Africa region in general.162 According to MICS 
2014, only about 20% reported attending ANC in public clinics. We did not have data 
on the actual ANC utilization pattern in our sample of pregnancies, to understand if 
women registered for ANC in public clinics also seek additional services in non-
public sector health facilities.  
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From the wider health systems perspective, an RHIS that only includes data from one 
part of a scattered health system may not reach its full potential in serving the needs 
of policy makers, whether it is a traditional paper-based system or one transformed 
into an electronic health registry. Shengelia et al (2005) in their foundational article 
on effective coverage, highlight the role played by the national health authorities as 
stewards in ensuring not just access to healthcare services in public clinics, but also 
that the clients get potential health gain.73 Including private sector statistics in the 
RHIS could provide better understanding the health system, the importance of which 
has been highlighted for LMIC in general, where health systems are fragmented.163 
13.3 Discussion of methods 
13.3.1 Study design  
A cross-sectional study design was used to collect paper-based clinical records data. 
This study design was suitable for the present study, where the goal was primarily to 
provide descriptions using the data. Cross-sectional studies have many advantages, 
including the feasibility and relatively inexpensive nature of data collection. Such a 
design allows for several outcomes to be assessed simultaneously,164 as presented in 
this dissertation, where one data collection from paper-based clinical records was 
used to assess three sets of outcome indicators. Cross-sectional studies are unsuitable 
for drawing causal inference.164 They can, however, provide indications of 
associations between the outcome and the explanatory variables of interest. In paper 
II, logistic regression analysis was done with the primary purpose of gaining an 
understanding of the associations between effective coverage of ANC interventions 
and infrastructure-related and maternal sociodemographic variables.124  
In order to address the first two objectives of this dissertation, paper-based clinical 
records data were used for two reasons. First, we wanted to compare values of 
indicators calculated from clinical records data with manually aggregated RHIS 
reports submitted during the same period, and for the year immediately prior to the 
RHIS transformation.123 Second, we wanted to generate values of indicators and 
evaluate the data-related changes that were attributable to the nature and properties of 
individual-level data collected at the point-of-care, without having to account for 
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possible influences from using an electronic health information system. At the same 
time, the structure and content of the electronic form for data entry from the paper-
based clinical records were set up to be identical to the eRegistry electronic clinical 
records so as to ensure that our findings are a reflection of the expected data-related 
changes of the RHIS transformation.  
The final dataset of paper-based clinical records was obtained by double data entry 
along with quality checks of data, a technique widely used in epidemiologic research 
to improve data quality.165 We used sample weights in the analyses of paper-based 
clinical records data, which is recommended for survey data to produce robust 
standard errors.122  
In the West Bank, a clinical record is supposed to be opened for every woman 
registered for ANC in public clinics. The paper-based clinical records were retained 
at the clinics, and supposed to be stored for up to 5 years after the expected 
completion of the pregnancy. Retrieving paper-based clinical records may not be 
feasible in other LMIC.  
The number of women that were registered for ANC in each clinic was known from a 
facility inventory assessment done towards the end of the year preceding the data 
collection for the present study, and appeared to be fairly constant over time, enabling 
us to establish appropriate denominators to transform event counts from aggregate 
RHIS reports to proportions, and subsequently make comparisons. Often, populations 
are mobile resulting in difficulties in establishing denominators, negatively impacting 
the validity of indicators generated using RHIS data.68  
In terms of documentation and reporting in the paper-based system, RHIS processes 
in the clinics throughout the West Bank were generally homogenous, and all clinics 
in the various administrative districts were obliged to report on the same set of 
indicators as that included in our study as part of RHIS reporting. As of 2018, there 
were no vertically organized donor-funded programs of maternal and child health in 
the West Bank that would require separate reporting. In many other LMIC, 
fragmented RHIS reporting systems51 and over- or under-reporting of indicators have 
been described, conditional on donor-funded programs.38 A study of RHIS processes 
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and changes in values of indicators in a sample of clinics in these other settings 
should also account for such factors, before the results can be generalized to the 
larger geographical area from which the sample is derived.  
Preceding the data collection and analyses of the present study, extensive processes 
of identifying and refining guidelines of ANC in primary healthcare had already been 
undertaken,113 which then made it possible to define effective coverage of ANC 
interventions and case management indicators for LiST. All public clinics, 
irrespective of size and infrastructure availability, are prescribed the same set of 
national ANC guidelines and can, in theory, be subjected to health systems 
monitoring with the same ANC indicators, similar to those presented in this 
dissertation. 
A potential limitation of the data collection from paper-based clinical records is the 
smaller sample of clinics (n=17), relative to the total number of clinics in the study 
area (n=165) and the West Bank. The clinics in our sample did not vary in terms of 
profiles of healthcare staff; all clinics in our sample had a nurse or midwife providing 
ANC, with doctors visiting once a week. A larger number of clinics may have 
allowed for the examination of effects based on geographic location of clinics, 
profiles of health care staff or other infrastructure-related differences. In contrast to 
our sampling strategy, the estimated sample size of pregnancies could have been 
achieved by selecting a larger number of clinics, and then performing a simple 
random sampling of equal numbers of paper-based clinical records from each clinic. 
This sampling approach is commonly used in household surveys, where the objective 
is to select individuals from widespread geographical areas so as to generate 
population-representative estimates,166 as opposed to the mainly clinic-level 
assessments presented in this dissertation.  
13.3.2 Assumptions in using clinical records data  
In our study, we made certain assumptions that may be considered appropriate for 
any study that uses data from clinical records.  
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First, we assumed that documentation was proof of having provided the healthcare 
service, and lack of documentation was regarded as an absence of having provided 
care. This may not necessarily be problematic for outcome indicators presented here; 
data points used for analyses in papers I, II and III are of importance for optimal 
clinical care for the care provider, and would therefore be important to document 
irrespective of the relevance of data for RHIS reporting or health systems monitoring. 
Gestational ages were estimated as per standard clinical practice in primary 
healthcare in the West Bank and were available in both paper and electronic clinical 
records.  
Second, we assumed that all clinical documentations were primarily done on the 
clinical records pertaining to individual clients. However, this may not be the case, 
and alternative documentations may be carried out in the clinics. One additional 
documentation source is the Maternal and Child Health Handbook, introduced in 
2008 in Palestine as personal records held by pregnant women.114 The Handbook 
contains the same information as the clinical records, including clinical examinations 
and results of lab tests. A study done in Kenya comparing different sources of 
documentation in clinics showed that data completeness was highest in the MCH 
Handbooks out of all documentation sources.55 We did not compare completeness of 
clinical records versus MCH handbooks, since only the data from the clinical records 
are captured in the eRegistry and made available in the RHIS. 
As such, these assumptions are unlikely to have adversely impacted the interpretation 
of our findings, given that the definitions and calculations of values of indicators 
were aligned with the expected data collection processes of the eRegistry.  
13.3.3 Generalizability 
Generalizability is the extent to which the results of the study can be transferred to 
other settings or populations.167 In principle, such types of calculations using 
individual client-level data can be set up in any RHIS and subsequently, the 
implications ensuing from these fundamentally different data capture systems 
presented in this dissertation can be generalizable to other settings.  
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Maternal age, anemia at 36 weeks and ANC visits are important indicators that are 
typically reported as part of RHIS reports in many LMIC. The sequence of first 
documenting in clinical records and then manually copying select data to clinic 
registers, and manually aggregating to monthly reports reflects a fairly standard set of 
RHIS processes in most LMIC, and published studies have reported an identical 
RHIS process in health facilities in South Africa,37 Benin,44 Malawi,47 Ghana,134 the 
Philippines,136 Indonesia,138 and Mozambique.168 Many of these studies have also 
identified steps where the greatest proportion of errors occur in a given setting, 
whether during manual counting of events, copying of data from clinical records to 
clinic registers, or during the preparation of monthly reports. An RHIS data quality 
assessment in the context of prevention of mother-to-child HIV transmission showed 
that there were significant errors during the data collation process from the clinic 
registers to monthly reports.36 Similar results were also observed in the context of 
immunization reporting.40 One study from Tanzania showed that with every 
additional step in the handling of data, the chance of error increases by two times.169 
Using clinical records directly for electronic automated computations of indicators in 
these settings will probably provide similar results as our study, simply by 
minimizing transcription errors involved in manual handling of data.  
WHO’s 2016 guidelines for a positive pregnancy experience are empirical 
recommendations meant to be adopted by LMIC in general.87 Three of the ANC 
interventions included in our assessment were similar to the WHO’s essential 
interventions (screening for hypertension, anemia, and tetanus immunization status),86 
while another three are recommended as part of the WHO’s guidelines for a positive 
pregnancy experience (SFH measurement, screening for gestational diabetes mellitus, 
and asymptomatic bacteriuria).87 Health system performance indicators based on 
context-specific clinical interventions can be used for health systems monitoring in 
other LMIC through a similar approach of using individual-level data collected at 
health facilities.  
The implications of various data sources on model-based program planning and 
evaluation are relevant in the many settings where LiST is used. Different resultant 
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numbers of deaths averted, morbidity reduction and compositions of interventions 
averting deaths raises critical questions for the importance of input data in LiST.  
Nevertheless, large-scale implementations of electronic health information systems 
with point-of-care routine individual-level data collections are complex, resource-
intensive, and have high initial start-up costs. Such implementations are often 
perceived as infeasible in low resource settings. This can limit the applicability of this 
model of RHIS in other LMIC, despite our findings of better validity of routinely-
available RHIS indicators, and the availability of more granular data for health 



















14 Summary and conclusions 
A health information system that provides routine, good quality data is one of the 
pillars of the health system. Digital health interventions offer unprecedented 
opportunity for improving the availability of health systems data. Simultaneously, 
utilization of health services has increased enormously in most LMIC, and health 
facility data collected during clinical care can be a viable as well as important source 
by itself. In addition, facility-based clinical records could also complement 
population-based surveys for more comprehensive monitoring.  
Bearing these in mind, the following general conclusions can be drawn from our 
findings:  
 An RHIS that uses individual-level clinical data to produce RHIS reports can 
eliminate transcription errors in data aggregation, and subsequently improve the 
reliability of routinely reported indicators. 
 The choice of metric used for health systems monitoring of ANC, can have an 
impact on ascertaining the magnitude of the problem as well as identifying 
potential solutions. Effective coverage of ANC interventions, a comprehensive 
measure of effectiveness, can help understand if complete care is provided at 
appropriate times during the pregnancy.  
 Various data sources commonly used to support evidence informed decision-
making at national levels have pros and cons, and subsequently, selection of the 
most complete and appropriate data source for policy and planning is critical. 
Individual-level clinical data can provide the largest quantity of data for 
calculations of indicators and be a solid basis for local decision-making processes.  
Specifically for the West Bank, Palestine, the following conclusions can be drawn:  
 As the RHIS transitions from manually aggregated data to the eRegistry, the 
values of routine indicators will be different from what were available in the 
existing reports consisting of manual calculations. The values of the indicators 
produced in the eRegistry are more complete and capture the health status of 
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pregnant women receiving ANC in public primary healthcare clinics more 
accurately.  
 Effective coverage of ANC interventions in public clinics in the West Bank can 
be increased by improving the timely and complete provision of ANC 
interventions. Some aspects of care provision, such as care providers’ adherence 
to guidelines, and women’s utilization of ANC services, should be explored 
further to understand and address the underlying factors to increase effective 
coverage. 
 The LiST analysis demonstrated notable variability of information available for 
decision-making based on the data source chosen. Program managers and 
decision-makers should be aware of the implications of the data source used, in 


















15 Future perspectives 
Several avenues for future research have emerged from the present study, some of 
which are listed below as research questions.  
General:  
 How can the approach of routine point-of-care data collections of individual-level 
clinical data be implemented at scale in health facilities in other LMIC?  
 What factors would determine the feasibility and acceptance of such a system? 
 What is the cost-effectiveness of an RHIS based on such a system? 
Methodology:  
 What is the validity of using clinical records data for performance monitoring? 
How does it compare to direct observations and health facility surveys?   
 How can other metrics of health system performance indicators be calculated?  
 Can linking approaches of population-based survey data and clinical records data 
from health facilities be used for establishing population estimates of effective 
coverage?  
RHIS data quality:  
 How can we standardize assessments of quality of RHIS data and indicators 
generated from individual-level clinical data?  
Effective coverage of ANC interventions:  
 Can performance indicators of effective coverage of ANC interventions be 
operationalized in LMIC?  
 What is the reliability, sensitivity and predictive validity of the indicators of 
clinical ANC interventions that measure if appropriate and complete screening 





Lives Saved Tool analysis:  
 How can we create a framework that characterizes and supports evidence-
informed decision-making at national levels, based on the pros and cons of 
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In most low- and middle-income settings, national aggregate health data is the most consis-
tently available source for policy-making and international comparisons. In the West Bank,
the paper-based health information system with manual aggregations is transitioning to an
individual-level data eRegistry for maternal and child health at the point-of-care. The aim of
this study was to explore beforehand how routine health information systems indicators for
antenatal care can change with the introduction of the eRegistry.
Methods
Data were collected from clinical antenatal paper records of pregnancy enrollments for 2015
from 17 primary healthcare clinics, selected by probability sampling from five districts in the
West Bank. We used the individual-level data from clinical records to generate routinely
reported health systems indicators. We weighted the data to produce population-level esti-
mates, and compared these indicators with aggregate routine health information systems
reports.
Results
Antenatal anemia screening at 36 weeks was 20% according to the clinical records data,
compared to 52% in the routine reports. The clinical records data showed considerably
higher incidences of key maternal conditions compared to the routine reports, including fun-
dal height discrepancy (20% vs. 0.01%); Rh-negative blood group (6.8% vs. 1.4%); anemia
with hemoglobin<9.5 g/dl (6% vs. 0.6%); and malpresentation at term (1.3% vs. 0.03%).
Only about a sixth of cases with these conditions were referred according to guidelines to
designated referral clinics.
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Conclusions
Differences between indicators from the clinical records data and routine health information
systems reports can be attributed to human error, inconsistent denominators, and complexi-
ties of data processes. Key health systems indicators were prone to underestimations since
their registration was dependent on referral of pregnant women. With a transition to individ-
ual-level data, as in the eRegistry under implementation, the public health authorities will be
able to generate reliable health systems indicators reflective of the population’s health status.
2 Introduction
The monitoring of global progress in reproductive, maternal, newborn and child health hinges
on the routine availability of good quality data [1–3]. Low and middle-income countries
(LMIC) typically rely on common sources of data for decision-making, such as censuses and
population-based surveys, and to a lesser extent on clinical records and other forms of pro-
vider-reported data [4, 5]. The majority of process indicators to assess the delivery of essential
interventions in maternal and child health are not amenable to measurement solely through
population-based surveys [6, 7]. Strengthening of routine data collections in health facilities is
important, since these data may be the most suitable source for many maternal and child
health indicators [8–10]. Globally, there has been a sustained call for improving the quality
and availability of data from Routine Health Information Systems (RHIS) [11–14]. Despite
this, RHIS data for maternal and child health are often lacking in most LMIC settings and if
available are incorrect, incomplete or of poor quality [8, 15–17]. There are increasing efforts to
improve health system-wide data collection in many LMIC with electronic health information
systems, although most of these systems focus on collection of aggregated data [18]. Data
aggregation, however, is fraught with its own issues, such as incorrect and inconsistent defini-
tions of the indicators and denominators and errors in counting, and this is partly due to
RHIS reporting processes and partly due to behavioral factors [19–23]. The indicators col-
lected in RHIS seemingly have little direct consequence on delivery of health services and it is
sometimes challenging to impart the importance of good quality routine data collection to the
care providers [24–27].
The paper-based health information system at the primary healthcare level in the West
Bank is now transitioning to an eRegistry for maternal and child health [25, 28, 29]. The eReg-
istry will in the future compute and automatically generate RHIS indicators from individual-
level clinical data collected by care providers at the point-of-care in primary healthcare clinics,
thus eliminating the need for manual aggregations and reporting [25].
The objective of this study was to compute routinely reported indicators from individual-
level clinical data from antenatal paper records, mimicking an eRegistry, and compare these
with indicators reported in the existing health information system in the West Bank.
3 Materials and methods
First, we selected indicators of antenatal care that were routinely reported in the health system
in the West Bank. We used data from clinical records available from a cross-sectional sample
of primary healthcare clinics to generate the selected indicators (Fig 1). These indicators were
then compared with the indicator values in aggregate RHIS reports available at the clinic-, dis-
trict- and national levels (Fig 1).
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3.1 Study setting
In the West Bank, two types of healthcare facilities provide antenatal care in the public health sys-
tem–primary healthcare clinics and referral clinics, also known as high-risk clinics [28]. Accord-
ing to the clinical guidelines in the public health system, when pregnant women are detected with
certain conditions during antenatal care in the primary healthcare clinics, they are referred to pre-
specified high-risk clinics [28].
In the paper-based RHIS in primary healthcare in the West Bank, care providers first docu-
ment data in clinical records in the primary healthcare clinics. The clinical records used for
antenatal care consist of socio-demographic data; obstetric, surgical and medical history; lab
test results and ultrasound examinations. Using the clinical records, care providers manually
identify and aggregate reportable conditions and events, and document the event counts in
dedicated register books on a daily or weekly basis. Aggregate monthly reports of event counts
are then prepared and sent from all primary healthcare clinics to the district-level, and subse-
quently to the national health authorities (Fig 1). The high-risk clinics, in addition, report on
the number of maternal conditions observed in referred women who attend care, and submit
aggregate reports on behalf of all primary healthcare clinics from which they receive referrals
in each district (Fig 1). A select list of RHIS indicators are published annually as part of
national health reports for the West Bank with statistics reported per district [30]. In the West
Bank, obstetric services are only provided at the hospitals, but they do not report to the RHIS
on maternal conditions that may have been identified during antenatal care.
In 2016, the first phase of the national implementation of the eRegistry was launched with the
intention to include five districts in the West Bank [28, 29]. In preparation for the eRegistry imple-
mentation, data, equivalent to the planned data in the eRegistry, was extracted from paper-based
clinical records for the year of 2015 in a random sample (see below) of primary healthcare clinics.
According to an inventory assessment of the primary healthcare clinics in Palestine completed in
Fig 1. Aggregate reporting in the paper-based routine health information in the West Bank, Palestine, and sources of data used
for analyses in this study.
https://doi.org/10.1371/journal.pone.0207813.g001
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2014, these clinics enrolled about 11,400 pregnancies a year, an average of 70 pregnancies per clinic
per year [28, 29]. These clinics referred to one of 9 high-risk clinics located in the five districts [28].
3.2 Sample size and sampling
Sample size estimations for data collection from the clinical records were made using ‘Open-
Epi’ for a population size of 11,400, aiming to enable the detection of a frequency of 1% for the
least prevalent outcome in the population (for example, severe anemia in pregnancy) with an
absolute precision of 0.5% [31]. A minimum sample of 1344 clinical records was required, cor-
responding to all pregnancies registered over a year from 15–20 clinics.
Primary healthcare clinics were selected using the probability proportional to size method, in
order to obtain a data set of pregnancies that was representative of the healthcare received by preg-
nant women in the West Bank [32]. Selection was continued until a minimum number of clinics
was available to achieve the required sample size, provided the clinical records of all pregnant
women enrolled over one year in the sampled clinics were included in the data collection.
3.3 Indicators
To enable the comparisons we selected antenatal care indicators that were routinely reported
to the RHIS by the health system, and could be computed in an identical manner with data
from clinical records (Table 1). We then ascertained the definitions, diagnostic classifications
and data categorizations of the indicators as they are intended to be used for aggregate RHIS
reporting. We excluded from our analyses those indicators that cannot be computed using
datapoints from clinical records, such as antenatal supplementation of iron and folic acid that
was reported in the RHIS as number of units prescribed. Conditions such as preterm rupture
of membranes and antepartum vaginal bleeding were part of RHIS reporting, but were
excluded since women with these conditions were most likely referred to hospitals and these
data were, therefore, unlikely to be accurately collected in clinical records.
3.4 Data extraction
3.4.1 Clinical records data. Two trained nurse-midwives completed the data extraction
during January–April 2017, and entered data from paper-based clinical records into electronic
data entry forms hosted on the District Health Information System 2 (DHIS2) software plat-
form [34]. Data from approximately 10% of all antenatal records were entered by both the data
extractors, and these data were checked for quality and consistency [28, 29].
3.4.2 Aggregate RHIS reports. For the comparisons, RHIS reports of aggregate event
counts and indicators were obtained from the Ministry of Health as electronic spreadsheets
(Table 2). Event counts for three of the selected indicators were available in the RHIS reports sent
from the primary healthcare clinics (RHIS clinic reports) (Table 2). Event counts of reportable
maternal conditions were available at the district-level, and reported from the high-risk (referral)
clinics (RHIS district reports) (Table 2). All the indicators were part of the publicly available RHIS
national reports (nationally reported statistics for the five districts) (Table 2).
3.5 Analyses
3.5.1 Clinical records data. We used the clinical datapoints and definitions of indicators
listed in Table 1 to reconstitute each of the selected indicators from the clinical records data.
Gestational ages were computed from the first day of the woman’s last menstrual period,
according to usual clinical practice in this context. If these data were missing, the ultrasound
estimated expected date of delivery was used to calculate gestational ages. We calculated
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prevalence of reportable maternal conditions in the entire sample as well as the occurrence of
maternal conditions only among referred women. The latter was similar to how these indica-
tors were generated as part of the aggregate RHIS reporting. Only test or examination results
were documented in the paper records, and “no data” in these data fields were interpreted as a
test or examination not performed.
Sample weights were added such that pregnant women from smaller clinics were assigned
higher weights than those from larger clinics (the inverse of the probability of the clinic being
selected, as to create data that can be compared to the RHIS district reports) [35]. Analyses
were carried out using STATA version 15 (StataCorp. 2017. Stata Statistical Software: Release
15. College Station, TX: StataCorp LLC), and the STATA command svyset was used to calcu-
late weighted proportions and 95% confidence intervals (CI) [36].
3.5.2 Aggregate RHIS reports. Event counts from the aggregate RHIS reports were trans-
formed to proportions with 95% confidence intervals using pre-defined denominators (Table 2).





Definition for computation of event counts (numerators) Datapoints from clinical records for computations
1. Antenatal visits (mean) Total number of antenatal visits, total number of pregnancies enrolled
2. Maternal age Age of woman at the time of registration of pregnancy� Date of birth of the pregnant woman; date of first
antenatal visit
3. Anemia: maternal
anemia at 36 weeks
Pregnant women who have Hb less than 11 g/dl at 35–38 gestational
weeks
Lab test: Hb (g/dl); gestational ageᵻ
4. Reportable maternal conditions from referrals
4.1 Gestational diabetes
mellitus
Women with a random blood sugar > = 140 g/dl or a 1 hour 50 g oral
glucose challenge test of > = 140 mg/dl
Lab test: random blood sugar, oral glucose challenge
test
4.2 Multiple pregnancy Women with multiple pregnancy Ultrasound examination: number of fetuses
4.3 Malpresentation at term Non-cephalic presentations at or after 36 gestational weeks Ultrasound examination: fetal presentation;
gestational ageᵻ
4.4 Recurrent miscarriage Three consecutive pregnancy losses prior to 20 gestational weeks Obstetric history: 3 or more consecutive pregnancy
losses prior to 20 gestational weeks
4.5 Preeclampsia1 [33] New onset hypertension plus new onset proteinuria after 20 weeks of
gestation; hypertension defined as a systolic blood pressure of 140 mm
Hg or greater, and/or a diastolic blood pressure of 90 mm Hg or greater
Clinical examination: systolic and diastolic blood
pressures (mm Hg); lab test: proteinuria; gestational
ageᵻ
4.6 History of Cesarean
sections
Cesarean section(s) in the previous delivery(ies) Obstetric history: previous delivery/ies by Cesarean
section
4.7 Anemia: at any
gestational age
Pregnant women who ever have a Hb<9.5 g/dl Lab test: Hb (g/dl); gestational ageᵻ
4.8 Rhesus negative blood
group
Pregnant women with a Rhesus negative blood group Lab test: Rhesus typing of blood group
4.9 Fundal height
discrepancy
A symphysis fundus height measurement of more or less than 2 cm
compared to gestational age (in weeks) at the time of measurement




Pregnant women with an ultrasound-detected increase or decrease in
amniotic fluid
Ultrasound examination: diagnosis of
oligohydramnios or polyhydramnios��
RHIS: Routine Health Information System; Hb: Hemoglobin
1American College of Obstetricians and Gynecologists. Task Force of Hypertension in Pregnancy.
ᵻ Best estimate of gestational age computed from the dates of visits/ lab tests and date of last menstrual period, or from ultrasound estimated expected date of delivery.
�Categorized as <16 and >40 years according to the reporting requirement in the RHIS.
��No defined diagnostic criteria, subject to clinical diagnosis.
https://doi.org/10.1371/journal.pone.0207813.t001
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3.6 Ethics approval
Ethical clearance was obtained from the Palestinian Health Research Council (PHRC/HC/272/
17) and the Regional Committee for Medical and Health Research Ethics in Norway (2017/
1537-3). We adhered to the Palestinian Ministry of Health’s legal framework in obtaining
access to anonymized data for secondary analyses [29].
4 Results
Seventeen primary healthcare clinics from 5 districts in the West Bank were included in the
data collection and data from clinical records were available for 1369 pregnancies enrolled for
antenatal care in 2015 in these clinics. Of these, 501 women (37%) were nulliparous. Sixteen-
per-cent (n = 222) of the women were <20 years of age and 9% (n = 118) were >35 years age
at the time of enrollment at the clinic. Complete RHIS clinic reports for 2015 were obtained
from all the primary healthcare clinics that were included in the data collection of the clinical
records (n = 17) (Table 2). RHIS district reports were available from all their corresponding
high-risk clinics (n = 9) (Table 2).
4.1 Maternal age
There was consistency in the indicator maternal age at pregnancy registration between the
clinical records data (age<16 years: 0.1%, 95% CI: 0–0.4; age>40 years: 1.2%, 95% CI: 0.6–
2.1), RHIS clinic reports (age<16 years: 0.1%, 95% CI: 0–0.4; age>40 years: 1.4%, 95% CI:
1–2), and the nationally reported statistics for the five districts (age<16 years: 0.2%, 95% CI:
0.1–0.3; age>40 years: 1.7%, 95% CI: 1.5–2).
Table 2. Data sources used for comparative analyses and their descriptions. �
Name of data
source used in the
study
Generated from Sample for analyses and
comparison
Data content Indicators available/
generated







Clinical paper records from
probability sample of 17 clinics,
cross-sectional data
Clinical datapoints All All pregnant women registered for antenatal
care from 17 primary healthcare clinics, whose
clinical records were extracted
(n = 1369)
RHIS clinic reports Primary
healthcare
clinics
Aggregate RHIS reports from 17
clinics
Event counts Maternal age,
antenatal visits,
anemia at 36 weeks







Aggregate RHIS reports from 9
high-risk clinics
Event counts Maternal conditions
from referrals
Pregnancies enrolled in clinics that refer to the











All Pregnancies enrolled in clinics in study- and
non-study areas (n = 14,544)
RHIS: Routine Health Information System; Hb: Hemoglobin
�all data and indicators are for the year 2015 for 5 districts in the West Bank, Palestine.
¥ refers to the area in the five districts from where the sample for this study was derived.
��contains values of all event counts/indicators sent from primary healthcare clinics and high-risk (referral) clinics as part of the RHIS.
ᵻ ᵻanemia at 36 weeks published as a percentage of total hemoglobin tests with value <11g/dl, of all hemoglobin tests reported.
https://doi.org/10.1371/journal.pone.0207813.t002
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4.2 Antenatal visits
The number of antenatal visits per pregnant woman in the clinical records data (mean = 4.5;
standard deviation = 2.3), RHIS clinic reports (mean = 4.5) and nationally reported statistics
for the five districts (mean = 4.7) were all comparable.
4.3 Anemia at 36 weeks
The proportion of women with anemia at 36 weeks in the clinical records data (32%, 95% CI:
22–44) was similar to the RHIS clinic reports (31%, 95% CI: 29–35) and the nationally reported
statistics for the five districts (30%, 95% CI: 29–31). However, there were 280 documented
hemoglobin tests at 36 weeks in the clinical records data, representing a 20% anemia screening
coverage at 36 weeks, compared to 890 reports of such hemoglobin tests (61% screening cover-
age) in the RHIS clinic reports. According to the nationally reported statistics for the five dis-
tricts, there were 7602 hemoglobin tests at 36 weeks (52% screening coverage).
4.4 Reportable maternal conditions
In the clinical records data, the incidences of malpresentation at term (1.3%; 95% CI: 0.6–2.8),
anemia (hemoglobin<9.5 g/dl) (6%, 95% CI: 4.1–8.7), Rh-negative blood group (6.8% 95% CI:
4.5–10.2) and fundal height discrepancy (20%; 95% CI: 12.4–30.8) were higher compared to
the incidence of these reportable conditions for referral in the RHIS district reports and
nationally reported statistics for the five districts (Table 3). In the clinical records data, 7%
(95% CI: 6–9) of the women had two and 1% (95% CI: 0.5–2) had three of the reportable
maternal conditions.
According to the clinical records data, the proportion of women with a documented referral
from the primary healthcare clinics to any health facility, ranged from 16% for fundal height
discrepancy to 71% for preeclampsia (Fig 2). Proportions that were referred to the pre-speci-
fied high-risk clinic for reportable maternal conditions were lower (Fig 2).
Table 3. Routinely reported maternal conditions from antenatal care–comparison of indicators from all clinical records data and only referred women, and aggre-
gate RHIS reports.
Reportable condition Clinical records data—all�
(N = 1369)








n Weighted % (95% CI) Weighted % (95% CI) n % (95% CI) n % (95% CI)
Gestational diabetes
mellitus
12 0.8 (0.4–1.7) 0.05 (0.01–0.4) 79 0.7 (0.6–0.9) 79 0.5 (0.4–0.7)
Multi-fetal pregnancy 20 1.3 (0.8–2.0) 0.4 (0.2–1.0) 84 0.7 (0.6–0.9) 97 0.7 (0.5–0.8)




Recurrent miscarriages 26 1.7 (0.9–3.5) 0.7 (0.2–2.4) 144 1.3 (1.1–1.5) 150 1.0 (0.2–3.0)
Preeclampsia 7 0.6 (0.2–1.3) 0.2 (0.02–1.2) 26 0.2 (0.1–0.3) 31 0.2 (0.1–0.3)
History of Cesarean
sections
93 6.4 (4.1–9.7) 2.2 (1.3–3.6) 631 5.5 (5.1–5.9) 777 5.3 (4.9–5.7)
Anemia (Hb<9.5 g/dl) 88 6.0 (4.1–8.7) 0.9 (0.4–2.0) 87 0.8 (0.6–0.9) 93 0.6 (0.5–0.8)
Rh-negative blood group 95 6.8 (4.5–10.2) 1.2 (0.6–2.1) 180 1.6 (1.4–1.8) 202 1.4 (1.2–1.5)
Fundal height discrepancy 253 20 (12.4–30.8) 0.9 (0.5–1.6) None None 1 0.01 (0–0.04)
RHIS: Routine Health Information Systems; CI- confidence interval; Hb- hemoglobin
�No cases of oligohydramnios or polyhydramnios in the clinical data
��Estimates of indicators after accounting for missed data in the RHIS reporting from women not being referred according to guidelines
https://doi.org/10.1371/journal.pone.0207813.t003
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If reportable maternal conditions were estimated only among pregnant women that were
referred to high-risk clinics, malpresentation at term (0.2%, 95% CI: 0.1–0.7) and fundal height
discrepancy (0.9%, 95% CI: 0.05–1.7) were the only two conditions that continued to have a
higher value in the clinical records data compared to RHIS reports (Table 3).
For all routinely reported aggregate RHIS indicators of antenatal care, there was consis-
tency between what was reported by the primary healthcare clinics (RHIS clinic reports) and
high-risk clinics (RHIS district reports), and the publicly available national reports (Table 3).
5 Discussion
Appraisal of RHIS data and indicators are important components of assessment of health sys-
tems [37, 38]. In this study, we compared RHIS reports with individual-level data from clinical
records, which revealed important pitfalls in the generation of the indicators, and these would
have been missed by only performing consistency checks of reports within the existing RHIS.
The divergences between the clinical records data and RHIS reports were due to previously
recognized issues with RHIS in general, such as inconsistent denominators for calculating
indicators, errors in manual computations, and production of unreliable indicators due to a
complex reporting structure in the health system [17, 26, 39].
RHIS reporting of maternal anemia at 36 weeks was an illustration of an indicator with an
inconsistent denominator. Apart from reporting an overall higher number of hemoglobin
tests at 36 weeks compared to the clinical records data, three out of the 17 primary healthcare
clinics reported more hemoglobin tests than the total number of pregnancies enrolled in 2015,
and appeared to be including hemoglobin tests of pregnancies enrolled in the previous year.
With the denominator reported and used in the RHIS for maternal anemia, it was neither fea-
sible to estimate the true incidence of maternal anemia for a given year of reporting nor quan-
tify the coverage of hemoglobin testing.
Fig 2. Women with maternal conditions that were referred to health facilities that report to the RHIS, and to
health facilities that do not report on antenatal care indicators to the RHIS. RHIS: Routine health information
system.
https://doi.org/10.1371/journal.pone.0207813.g002
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In our study, issues with manual computations were particularly evident for the indicator
fundal height discrepancy. The gestational ages documented by the care providers often varied
from the gestational ages generated for this study. While some care providers may have deter-
mined fundal height discrepancy based on the current exact gestational age, others may have
used the nearest completed gestational week. For example, a gestational age of 30 weeks and
three days may be interpreted as 30 weeks or 31 weeks. Using the gestational ages documented
by the care providers for computing this indicator from the data in the clinical records yielded
an incidence of fundal height discrepancy of 9% (95% CI: 4–19), which was still higher than
the RHIS reports (0.01%, 95% CI: 0–0.04). Additional reasons for the observed difference
between the clinical records data and RHIS reports for this indicator include the lack of more
comprehensive fetal growth monitoring strategies, non-compliance to guidelines to refer
women with any fundal height discrepancy as per the existing definition, and known issues in
the measurement itself [40–42]. Ultrasound examinations during antenatal care are reportedly
widely used in the West Bank. Given this, ultrasound-based fetal growth monitoring may take
precedence over serial fundal height measures. However, there were neither diagnostic stan-
dards nor reporting guidelines for results from other forms of screening of fetal growth.
Three factors relating to a complex RHIS reporting process contributed to the disparity in
the reportable maternal conditions between the clinical records data and RHIS reports. First,
maternal morbidities (except maternal anemia at 36 weeks) were reported from the high-risk
clinics and not from the referring primary healthcare clinics, making the registration of the
indicators conditional on referral and utilization of care. However, there was low compliance
of the primary healthcare clinics to the recommended guidelines for referrals to high-risk clin-
ics (Fig 1). Second, in the RHIS district reports, only one reportable maternal condition was
registered per referred pregnant woman. Third, there were notable variations among the dis-
tricts in the selection of the principal maternal condition for reporting to the RHIS. In one of
the 5 districts, history of Caesarean sections constituted 26% of all the reported maternal con-
ditions and gestational diabetes mellitus 9%. In another district, 55% of all the reporting was
for history of Cesarean sections, with gestational diabetes mellitus constituting less than 1%.
Similarly, there may be variations in referral practices among the primary healthcare clinics.
In the clinical records data from the sample of clinics included in this study, a lower propor-
tion of women with history of Cesarean sections (2.2% vs. 5.3%) and gestational diabetes melli-
tus (0.05% vs. 0.5%) were referred to the high-risk clinics, compared to RHIS reports.
Other studies in the West Bank have reported Cesarean section rates of at least 14–23% [30,
43]. The proportions of women with history of Cesarean sections from the clinical records
data as well as RHIS reports were clear underestimations, probably due to incomplete docu-
mentation of this datapoint in the clinical records.
The generalizability of all RHIS indicators can be improved by adopting more standardized
definitions. As an illustration, if the World Health Organization’s diagnostic cut-off for fasting
blood sugar levels was used for computations of the clinical records data, the resulting inci-
dence of gestational diabetes mellitus was 6% (95% CI: 4–10), compared to the 0.8% (95% CI:
0.4–1.7) obtained from the clinical records data using the current definition in the public
health system [44].
The reporting of the mean number of antenatal visits is not representative of antenatal care
coverage for an individual. The variability in antenatal visits for individual pregnant women
was evident from the wide standard deviation (SD = 2.3) around the mean.
A strength of this study was its ability to identify issues beyond the quality of RHIS data and
processes, such as variations in adherence to guidelines for referrals as well as selective report-
ing of indicators in the health system. The quality of healthcare services may be improved by
understanding and addressing issues related to referrals. The public health authorities may
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need to revisit the value of certain guidelines for referral, particularly for non-critical condi-
tions during pregnancy. The feasibility and effectiveness of different fetal growth monitoring
strategies in primary healthcare for this population are themes for future research. One of the
functionalities of the eRegistry, the interactive checklists and clinical decision support, pro-
vides guideline-based recommendations for referral and clinical reminders for the care provid-
ers at the point-of-care in the primary healthcare clinics [28].
One limitation of this study is that only data that were documented in the antenatal records
were considered in the analyses. We have regarded any undocumented visits or tests as not
having occurred. Some primary healthcare clinics may have additional or alternative sources
of documentation that are used specifically for the purpose of RHIS reporting, particularly for
lab test results (for example, for reporting of maternal anemia at 36 weeks). Lack of exclusive
use of clinical records for all documentation by the care providers may also explain the differ-
ences in the number of new enrollments of pregnancies from the clinical records data
(n = 1369) and RHIS reports (n = 1463). About 50% of all pregnant women in the West Bank
receive antenatal care in the private and non-governmental sector that are not part of RHIS
reporting for antenatal care, and the incidences of maternal conditions reported in this study
may not be representative of the entire population of the West Bank.
6 Conclusion
The eRegistry for maternal and child health aims to eliminate sources of errors that impact the
quality of health systems data, by using individual-level clinical data to directly produce RHIS
reports at the individual, clinic, sub-national and national levels. As the health system in the
West Bank shifts from manually aggregated data to the eRegistry, it will be possible to generate
more reliable and complete health systems indicators.
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The proportion of women attending four or more antenatal care (ANC) visits is widely used
for monitoring, but provides limited information on quality of care. Effective coverage met-
rics, assessing if ANC interventions are completely delivered, can identify critical gaps in
healthcare service delivery. We aimed to measure coverage of at least one screening and
effective coverage of ANC interventions in the public health system in the West Bank, Pales-
tine, and to explore associations between infrastructure-related and maternal sociodemo-
graphic variables and effective coverage.
Methods
We used data from paper-based clinical records of 1369 pregnant women attending ANC in
17 primary healthcare clinics. Infrastructure-related variables were derived from a 2014
national inventory assessment of clinics. Sample size calculations were made to detect
effective coverage ranging 40–60% with a 2–3% margin of error, clinics were selected by
probability sampling. We calculated inverse probability weighted percentages of: effective
coverage of appropriate number and timing of screenings of ANC interventions; and cover-
age of at least one screening.
Results
Coverage of one screening and effective coverage of ANC interventions were notably differ-
ent for screening for: hypertension (98% vs. 10%); fetal growth abnormalities (66% vs. 6%);
anemia (93% vs. 14%); gestational diabetes (93% vs. 34%), and antenatal ultrasound (74%
vs. 24%). Clinics with a laboratory and ultrasound generally performed better in terms of
effective coverage, and maternal sociodemographic factors had no associations with
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effective coverage estimates. Only 13% of the women attended ANC visits according to the
recommended national schedule, driving effective coverage down.
Conclusion
Indicators for ANC monitoring and their definitions can have important consequences for
quantifying health system performance and identifying issues with care provision. To
achieve more effective coverage in public primary care clinics in the West Bank, efforts
should be made to improve care provision according to prescribed guidelines.
Introduction
Antenatal care (ANC) provides an opportunity to detect risk factors, prevent complications
and improve birth preparedness of pregnant women in order to reduce maternal and neonatal
morbidity [1, 2]. The proportion of women who attend four or more ANC visits (ANC 4+), is
used extensively as an indicator for monitoring health of pregnant women as well as health sys-
tem performance [3, 4]. However, measuring contact of pregnant women with the health sys-
tem has limitations, since attending an ANC visit does not imply that pregnant women receive
good quality care [5–7]. The quality of care received may also be inequitable. In low and mid-
dle-income countries (LMIC), even with high levels of ANC 4+, wealthier and better-educated
women are significantly more likely to receive quality care [8].
Effective coverage, in contrast, combines utilization of healthcare services with the quality
of care received. Conceptually, effective coverage is “the proportion of the population who
need a service that receive it with sufficient quality for it to be effective” [9]. For ANC, effective
coverage is conventionally comprised of ‘ANC attendance’, defined as having at least one or at
least four ANC visits; and ‘quality’, assessed in terms of ANC content [10]. Standard ANC con-
tent includes a set of interventions, which entail single, two-step or repeat screening tests and
managements at specified times during pregnancy [11, 12]. The World Health Organization
has published widely accepted recommendations for ANC [13], including suggestions for
appropriate contact (frequency and timing between clients and the health system) and content
(screening and management) based on evidence of effectiveness [14, 15].
Whether pregnant women have received some or all components of a set of interventions
as part of ANC at least once during pregnancy has been used to indicate quality of care [9, 16,
17]. This measure, without timing or frequency, is not adequate to measure effectiveness or
quality of care provided. For example, one hemoglobin measurement in pregnancy does not
correspond to the provision of effective interventions for prevention and management of ane-
mia as recommended by the WHO guidelines–being tested only late in pregnancy excludes
the opportunity for treatment, and being tested only early does not imply a safe hemoglobin
level at delivery. Measuring effective coverage of essential ANC interventions is, therefore,
more comprehensive than ANC4+ for assessing ANC service provision [10].
Assessing effective coverage can help identify critical ‘bottlenecks’ around provision of
healthcare such as care providers’ knowledge of clinical practice guidelines and infrastructure
availability [18, 19]. Typical health systems ‘bottlenecks’, which limit its capacity to provide
effective care, include access to care, availability of trained human resources and health infra-
structure as well as utilization [20]. Studies assessing ANC content and quality in LMIC often
use population-based surveys as the main data source. In general, household surveys provide
limited information on processes of care and the accuracy of information collected is reliant
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on recall of survey participants [21]. Facility-based documentation and direct observations
[22] can be used to assess effective coverage of ANC interventions at a given visit. Facility-
based data, if available routinely over a period of time, can provide information on the number
and timing of screening tests of ANC interventions provided–aspects of healthcare provision
not available from household surveys [23, 24].
Better health information systems and improving the quality of healthcare services are of
high priority for the Palestinian health system [25, 26], with no published studies of health sys-
tem performance or ANC provision in public primary healthcare clinics in the West Bank
available. In the West Bank, maternal and child health services are organized in two tiers–pri-
mary healthcare where ANC, postpartum care and newborn care are provided; and secondary
or tertiary healthcare where obstetric services are provided. The public sector is reportedly the
single largest provider of ANC, catering to almost 50% of all women that give birth in a year
[27]. Based on place of residence, pregnant women are assigned to a governmental primary
healthcare clinic for care. ANC is also provided by private health facilities, non-governmental
organizations and the United Nations Relief and Works Agency for Palestine Refugees in the
Near East (UNRWA) [27]. A recent household survey suggests that more than 95% of women
attend 4 or more ANC visits [28]. The Palestinian Ministry of Health and the Palestinian
National Institute of Public Health are currently implementing an electronic health informa-
tion system for maternal and child health consisting of individual-level data collected at the
point-of-care (eRegistry) in public primary healthcare clinics [29]. As a result of this imple-
mentation, the existing data ecosystem for maternal and child health is shifting from aggre-
gated data on the mean number of ANC visits per pregnant woman to individual-level data
with accessible information on content and processes of ANC service delivery. Such a transi-
tion could be disruptive to the health system if the nature and magnitude of any changes to the
available data and indicators, and associated factors are not anticipated or not understood by
health system managers.
In this study, our objective was to assess the coverage of at least one screening and appropri-
ate number of screenings of ANC interventions, and effective coverage of ANC interventions
in public primary healthcare clinics in the West Bank, Palestine. Secondarily, we explored
selected infrastructure-related and maternal sociodemographic factors potentially associated
with effective coverage.
Materials and methods
We extracted data from paper-based clinical records of antenatal care to demonstrate the
potential changes in health and health systems performance indicators that would be observed
when transitioning from the existing aggregate health information system to the eRegistry.
Since the Palestinian national eRegistry implementation was rolled out in phases, we extracted
records from a random cross-sectional sample of clinics in the five districts that comprised
phase one, from the year 2015, before any clinics started using the eRegistry.
Study setting
ANC records (paper-based until 2016 and the eRegistry thereafter) are primarily used for clini-
cal documentation in all primary healthcare clinics. Paper-based ANC records were structured
data entry forms consisting of data elements pertaining to clients’ medical history, screening
tests results, clinical examinations, and clinical managements [29]. While nurses or midwives
typically provide routine ANC in primary healthcare clinics, doctors visit the clinic once or
twice a week and perform clinical and ultrasound examinations and interpret lab test results,
Effective coverage of essential antenatal care interventions
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and manage complications in pregnancies. Clinics may either have their own laboratory and
ultrasound or share these facilities with other clinics.
Sample size and sampling
A single data collection exercise was set up to measure maternal morbidity rates [30] as well as
effective coverage of ANC interventions. The overall sample size was determined by the least
prevalent outcome expected, corresponding to a 1% prevalence of severe anemia in pregnancy.
It was assumed that effective coverage of ANC interventions would be in the 40–60% range
(based on expert opinion in the absence of relevant data). In order to estimate indicators in
these ranges that were representative of the five phase 1 districts, and with margins of error of
2–3% for the coverage of ANC interventions and 0.5% for maternal morbidity rates, 1344
pregnancies were required [31]. OpenEpi was used for sample size calculations [31].
Primary healthcare clinics were selected by probability sampling proportional to clinic size
until a sufficient number of clinics was sampled to achieve the calculated sample size
(n = 1344), provided that clinical records of all women registered for ANC in these clinics dur-
ing January–December 2015 were included in the data collection. Since the primary healthcare
clinics were selected by unequal probability sampling, inverse probability sample weights were
assigned to individual pregnancies in order to produce results that were more generalizable to
the five districts included in the data collection, and to produce robust standard errors [32].
The same dataset was used for the calculation of prevalences of maternal health conditions and
details are presented elsewhere [30].
Data collection
Data were extracted from paper-based ANC records and entered into electronic forms on the
District Health Information System 2 (DHIS2) software, which were identical to the data cap-
ture forms of the eRegistry, to ensure similar data structures [33]. Two trained data collectors,
who were nurse-midwives, extracted data from clinical records. Ten per cent of the clinical
records were extracted and entered twice by each of the data collectors and the study team car-
ried out consistency checks of the double-entered data [34].
An inventory assessment of all public primary healthcare clinics in the West Bank was com-
pleted by the study team at the Palestinian National Institute of Public Health in December
2014. Information needed to support the implementation of the eRegistry was collected,
including details of infrastructure in the clinics, laboratory and ultrasound availability, and the
number and type of care providers for maternal and child health [29, 34]. Clinic staff were
asked to return completed assessment forms to the study team; 100% of clinics completed this
form.
Outcome variables
ANC interventions included in our analyses comprised those that were: 1) recommended as
part of routine ANC content in the public health system in the West Bank; 2) applicable to all
pregnant women irrespective of risk status; and 3) amenable to measurement using data from
ANC records. Applying these criteria, eight ANC interventions were selected (Table 1). Three
of these interventions were similar to the WHO Essential interventions [35], and four of the
interventions were recommended as part of the WHO ANC model for a positive pregnancy
experience [13] (Table 1). Six additional ANC interventions recommended in the public health
system were excluded from this analysis, either because the ANC records did not contain the
variables required to generate the indicators or because the interventions were not appropriate
for the primary healthcare level (S1 Text).
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For each ANC intervention selected, we defined indicators of coverage of at least one
screening test, coverage of appropriate number of screenings (only applicable to ANC inter-
ventions requiring repeat or two-step screening), and effective coverage, based on ANC guide-
line in the West Bank (Table 2). Definitions for effective coverage of ANC interventions
included both the recommended timing and number of screening tests of the intervention
(Table 2).
In the definitions for effective coverage of ANC interventions, the appropriate number of
timely screening tests were adjusted according to the gestational age of pregnant women at
Table 1. Recommended schedule of ANC visits and ANC interventions in the West Bank.
ANC interventions Recommended ANC visits schedule
Booking|i 16 weeks 24–28 weeks 32 weeks 36 weeks
Screening for hypertension� X X X X X
SFH measurement¥ X X X X X
Screening for anemia� X X X
Antenatal ultrasound§ X X X




Screening for asymptomatic bacteriuria¥ X
Screening for Rh-type¥ X
Screening for tetanus immunization status� X
�Similar to the WHO’s Essential Interventions for RMNCH
¥Recommended in the 2016 WHO ANC model for a positive pregnancy experience
§Context-specific recommendation
||Booking: refers to first antenatal visit at the clinic; ANC: Antenatal care; SFH: Symphysis-fundal height.
https://doi.org/10.1371/journal.pone.0212635.t001
Table 2. Definitions of indicators of coverage of at least one screening, coverage of appropriate number of screenings, and effective coverage of ANC interventions.
ANC intervention Coverage of at least 1 screening Coverage of the appropriate
number of screening
Effective coverage (appropriate number and timing of screenings)
Screening for
hypertension
Proportion with at least one
blood pressure measurement
Proportion with five blood
pressure measurements
Proportion with blood pressure measurements at all recommended
ANC visits
SFH measurement Proportion with at least one
SFH measurement
Proportion with five SFH
measurements
Proportion with SFH measured at all recommended ANC visits|




Proportion with hemoglobin tests at booking||, 24–28 and 36 weeks�








Proportion with either urine
sugar or blood sugar test
Proportion with both urine
sugar and blood sugar test




Proportion with urine microscopy test Proportion with urine microscopy test at booking||
Screening for Rh-type Proportion with Rh-typing Proportion with Rh-typing at booking visit
Screening for tetanus
immunization status
Proportion whose tetanus immunization status is checked by
asking for history of immunization or reviewing immunization
record
Proportion whose tetanus immunization is checked by asking for
history of immunization or reviewing immunization record at
booking||
|calculated for ANC visits that occur after 16 weeks
�given that registration of pregnancy was before the recommended timing of screening
||Booking: refers to first antenatal visit at the clinic.
ANC: Antenatal care; SFH: Symphysis-fundal height
https://doi.org/10.1371/journal.pone.0212635.t002
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registration for ANC. For example, women who were registered for ANC before 24 gestational
weeks were considered effectively screened for anemia if they had three hemoglobin tests–at
first ANC visit, at 24–28 weeks and 36 weeks (Table 2), while women that were registered for
ANC after 28 weeks were considered effectively screened if they received two hemoglobin
tests, one at their first ANC visit and another at 36 weeks (Table 2).
We calculated the proportion of women with any four and any five ANC visits irrespective
of timing of visits. Since coverage of appropriate number of screening tests and effective cover-
age are influenced by attendance rates following pregnancy registration, we calculated the pro-
portion attending all timely visits appropriate to when the first ANC visit occurs. We
measured the proportion of women attending ANC visits in the specific time windows where
interventions were recommended (Table 1). We also assessed the proportion attending all 5
timely visits including an early first ANC visit before 14 weeks.
Variables potentially associated with effective coverage
Laboratory and ultrasound availability were the infrastructure-related factors chosen for analy-
ses, since these were expected to be associated with effective coverage. Clinics were grouped
into those that had all relevant infrastructure and those that had one or more missing infra-
structure. Since the sample of clinics had similar cadres of care providers, and were expected
to be similar in terms of availability of other infrastructure needed for ANC (e.g. sphygmoma-
nometers), we did not use these for exploratory analyses.
Maternal sociodemographic variables used in the analyses were those available in the ANC
records, including women’s age at pregnancy registration, age at marriage, education and
parity.
Data analyses
All analyses were done using STATA version 15 (StataCorp. 2015. Stata Statistical Software:
Release 14. College Station, TX: StataCorp LP), using the command ‘svyset’ for generating
weighted proportions and 95% confidence intervals (CI) [36]. Descriptive statistics were pro-
duced for the following variables and categories: women’s age at pregnancy registration (<21
years, 21–34 years, >34 years); age at marriage (<20 years and �20 years); number of years of
education of women (<10 years, 10–13 years, >13 years); and parity (nulliparous, multi-
parous<4, multiparous�4). These categories were pre-defined in the dataset obtained for this
analysis in accordance with the data sharing policies outlined in the Standard Operating Pro-
cedures for routine registry operations [34].
Chi-square tests of differences were used for exploratory analyses of effective coverage of
ANC interventions across sub-groups based on infrastructure-related and maternal sociode-
mographic variables. Adjusted odds ratios (OR) and 95% CI were generated for each of the
interventions, through a logistic regression model consisting of infrastructure-related charac-
teristics (laboratory and ultrasound availability) and all maternal sociodemographic variables
(women’s age at pregnancy registration, education, age at marriage and parity).
Ethics approval
Anonymous secondary data for analyses were obtained with approvals from the Palestinian
Ministry of Health, in accordance with the data sharing principles outlined in the Standard
Operating Procedures for routine registry operations [34]. Ethics approvals for this study were
obtained from the Palestinian Health Research Council (PHRC/HC/272/17) and the Regional
Committee for Medical and Health Research Ethics in Norway (2017/1537). Descriptions to
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re-create identical data, as well as contact addresses to the data source, are available as support-
ing information (S2 Text).
Results
Data were collected from 1369 clinical records of pregnant women first registered for ANC in
2015 in 17 primary healthcare clinics. Totally, these women attended 6397 ANC visits during
2015 and 2016. One out of the 17 primary healthcare clinics had a non-nurse/midwife health
worker that was the sole provider of ANC, while all other clinics had a nurse or midwife pro-
viding ANC. All 17 clinics had a doctor visiting once a week to provide ANC. Of the 17 pri-
mary healthcare clinics, six were equipped with both a laboratory and ultrasound. Two clinics
each had either only a laboratory or only an ultrasound, while seven clinics had neither.
Fifty-four pregnancies in the sample (4%) ended in a documented spontaneous miscarriage.
The mean gestational age at first ANC visit was 14 weeks (SD = 7), 47% of the women (95%
CI: 38, 55, n = 638) attended their first ANC visit within 3 months and 67% of women (95%
CI: 60, 73, n = 914) attended their first ANC visit within 4 months. The majority (75%) of
women were between 21–35 years of age at the time of their first ANC visit, and 37% were nul-
liparous (Table 3).
ANC attendance
About half of the women attended at least five ANC visits, while 60% (95% CI: 50, 70) attended
at least four ANC visits, when not considering the schedule or timing of visits (Table 4). Only
6% (95% CI: 5, 8) of the women attended all ANC visits according to the recommended ANC
5-visit schedule, including an early first ANC visit before 16 weeks. Disregarding early atten-
dance and only considering the schedule of visits after pregnancy registration, 13% (95% CI: 9,
17) attended ANC visits as per the recommended national schedule (Table 4), and thus could
have received complete hypertension and SFH screening.
The proportion of women attending all recommended ANC visits according to the national
guidelines was higher in clinics with both laboratory and ultrasound (17%), compared to clin-
ics with one or no such infrastructure (9%), with an adjusted OR of 2.0 (95% CI: 1.4, 2.8).
Table 3. Background sociodemographic characteristics of pregnant women in the sample.














Multiparous (<4) 666 48
Multiparous (�4) 186 14
https://doi.org/10.1371/journal.pone.0212635.t003
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Coverage of ANC interventions
Coverage of at least one sreening of ANC interventions ranged between 55% (95% CI: 45, 64)
for screening for asymptomatic bacteriuria and 98% (95% CI: 96, 99) for hypertension screen-
ing (Table 4).
Compared to the coverage of at least one screening, coverage of the appropriate number
of screenings was considerably lower for all interventions requiring repeat or two-step screen-
ing (Table 4). In clinics that had ultrasound equipment, coverage of any symphysis fundus
height (SFH) measurement was 29%, while in clinics without ultrasound the coverage was
63%.
For diabetes screening, coverage of blood sugar test was 73% (95% CI: 65, 79) and urine
sugar test was 89% (95% CI: 82, 94).
Effective coverage
Effective coverage of ANC interventions was lower than the coverage of at least one screening
and coverage of appropriate number of screenings for all interventions except screening for
tetanus immunization status (Table 4). Regarding screening for gestational diabetes mellitus,
43% (95% CI: 35, 52) had a blood sugar test at 24–28 weeks and 71% (95% CI: 63, 78) had a
urine sugar test at booking visit.
Among those attending the prescribed number and timing of ANC visits (Table 4), the per-
centage receiving the relevant screening tests were as follows: hypertension screening: 77%,
antenatal ultrasound: 73%, gestational diabetes: 61%, SFH measurement: 46% and anemia
screening: 42%.
Effective coverage of six of the eight ANC interventions was highest in primary healthcare
clinics with laboratory and ultrasound availability (Table 5). Clinics with a laboratory and
ultrasound were associated with statistically significant higher odds of effectively screening for
four ANC interventions. Screening for tetanus immunization status was the only ANC
Table 4. Comparison of coverage at least one screening of ANC intervention, coverage of appropriate number of screenings prescribed for ANC interventions, and
effective coverage of ANC interventions (number and timing of screening of ANC interventions).











Screening for hypertension 98 (96, 99) 38 (31, 47) 10 (8, 13) 48 (38, 58) 13 (9, 17)
SFH measurement 66 (50, 80) 35 (24, 48) 6 (4, 9)
Screening for anemia 93 (89, 96) 31 (23, 40) 14 (9, 21) 73 (62, 81) 33 (26, 41)
Antenatal ultrasound 74 (59, 85) 43 (32, 54) 24 (18, 31)
Screening for gestational
diabetes mellitus
93 (88, 96) 69 (60, 77) 34 (26, 43) 85 (77, 90) 56 (50, 62)
Screening for asymptomatic
bacteriuria�
55 (45, 64) 42 (36, 49)¥ NA
Screening for Rh-type� 78 (67, 89) 64 (54, 73)¥ NA
Screening for tetanus
immunization status�
35 (23, 50) NA
§refer Table 2 for definitions of coverage indicators of ANC interventions
‡refer Table 1 for number of ANC visits and their timing for each ANC intervention recommended in the national guidelines
�only one screening test during ANC is recommended in the national guidelines
¥refers to screening test provided during the first ANC visit.
ANC: Antenatal Care; SFH: Symphysis-fundal height; CI: Confidence Intervals
https://doi.org/10.1371/journal.pone.0212635.t004
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intervention that had a statistically significant lower odds ratio (adjusted OR = 0.7, 95% CI:
0.5, 0.9) (Table 5).
A higher proportion of multiparous women (�four births) had their tetanus immunization
checked, compared to nulliparous women (41% vs. 29%; adjusted OR = 2.1, 95% CI: 1.4, 3.2)
(S1 Table). None of the other maternal sociodemographic variables had statistically significant
associations with effective coverage (S1 Table).
Discussion
This is the first study to our knowledge to use effective coverage metrics for assessment of the
Palestinian health system. By assessing the effective coverage of ANC interventions in public
primary healthcare clinics, along with infrastructure-related and maternal sociodemographic
factors that may be associated with effective coverage, it was possible to gain insight into ANC
service provision in these clinics.
Studies informed by household survey data or direct observations have demonstrated lower
effective coverage of ANC than crude service coverage in diverse settings such as Kenya [10],
Ethiopia [37] and other countries in sub-Saharan Africa [22]. These studies have assessed the
‘quality’ component of effective coverage using a checklist of services provided during ANC,
which would be conceptually equivalent to the outcome ‘coverage of atleast one screening of
ANC intervention’ in our study. Almost all pregnant women in our sample had received a
blood pressure measurement, and this result was similar to the findings from large multi-
country studies of ANC content using survey data [7, 23].
In contrast to other studies of effective coverage that have reported a one-time provision of
clinical interventions [10, 22], we also assessed the number and timing of screening tests for
the full duration of the pregnancy to produce quality-corrected coverage of ANC interventions
using facility-based data. According to outcome definitions used in this study, coverage of at
least one screening is not dependant on follow-up care of pregnant women throughout the
antenatal period. Coverage of appropriate number of screenings, on the other hand, reflects
care provision throughout the antenatal period, but did not factor the timing of screening
tests. Effective coverage of ANC interventions is essentially a combination of timely attendance
rates and the provision of the prescribed screening test during attendance in the clinics.
Our ANC 4+ coverage rate (60%) was similar to that found in a study using facility-based
data conducted in Jordan [38], which has a comparable population and health system as the
Table 5. ANC interventions and infrastructure-related characteristics: effective coverage (%) and adjusted odds ratios from logistic regression analyses.
ANC interventions Effective coverage (%) Adjusted odds ratio (95% CI)¥
One or more missing infrastructure (n = 728) Both lab and ultrasound (n = 631)
Screening for hypertension 7 14 2.2 (1.5, 3.1)
SFH measurement 7 4 0.6 (0.4, 1.0)
Screening for anemia 12 17 1.5 (1.1, 2.1)
Antenatal ultrasound 20 36 2.2 (1.7, 2.8)
Screening for gestational diabetes mellitus 32 37 1.2 (1.0, 1.5)
Screening for asymptomatic bacteriuria 42 43 1.0 (0.8, 1.3)
Screening for Rh-type 59 70 1.7 (1.3, 2.1)
Screening for tetanus immunization status 37 29 0.7 (0.5, 0.9)
¥derived from multivariable logistic regression analyses including all infrastructure-related and maternal sociodemographic variables: laboratory and ultrasound
availability, maternal age at pregnancy registration, age at marriage, education and parity
ANC: Antenatal care; SFH: Symphysis-fundal height; CI: Confidence Intervals
https://doi.org/10.1371/journal.pone.0212635.t005
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West Bank. Compared to ANC4+, attendance rates of ANC visits at guideline-specified tim-
ings was low in our sample of clinics. As a result, effective coverage of ANC interventions con-
sisting of two-step (screening for gestational diabetes mellitus) or repeat screening tests
(screening for anemia and hypertension, SFH measurement, and antenatal ultrasound) were
significantly lower than both coverage of atleast one screening and coverage of appropriate
number of screenings. A multi-country study reported that 10% of women in Jordan and 27%
in Egypt had received a set of routine care components as part of ANC [23]. Despite methodo-
logical distinctions in the data source used, this study hints at a trend of low coverage of essen-
tial ANC interventions and can corroborate our findings. The difference between coverage of
any screening test provided and effective coverage of screening for gestational diabetes (69%
vs. 34%) was primarily due to the timing at which the tests were provided.
For ANC interventions consisting of a one-time screening test, the magnitude of the differ-
ences between coverage of at least one screening and effective coverage were smaller because
timing of provision of ANC interventions played a less decisive role in achieving effective cov-
erage. Indicators of hemoglobin and blood pressure measurement, which are commonly
reported worldwide [39], had high coverage of at least one screening but much lower effective
coverage in our study.
In general, two underlying contributing factors will lead to low effective coverage of ANC
interventions, attendance and service provision. Hijazi et al [38] demonstrated that scheduling
of follow-up ANC visits and counseling by care providers were strongly associated with wom-
en’s utilization of ANC services in Jordan. Similar explorations are recommended to identify
possible issues with providing timely appointments for follow-up ANC visits and potential
barriers to ANC utilization in public clinics in the West Bank. Service provision is determined
by adherence of care providers to prescribed ANC guidelines, which, in turn, could be influ-
enced by training and supervision, or dissemination of guidelines. Other health systems factors
such as lack of supplies of sufficient lab test kits have been shown to be determinants of service
delivery in other contexts [19], but is less likely in our setting, considering the relatively high
coverage of at least one screening of interventions that need such supplies.
Structural inputs to care such as infrastructure in health facilities have been shown to be
weak predictors of content of ANC provided and clinical quality [40], although these results
were for countries in sub-Saharan Africa with health systems that may be different from the
West Bank. In our study, availability of laboratory and ultrasound in the clinics had varying
degrees of associations with effective coverage of the different ANC interventions. A much
lower proportion of women had SFH measured in clinics with an ultrasound compared to
clinics without, presumably because of the use of antenatal ultrasound for fetal growth moni-
toring instead. It was beyond the scope of this paper to assess the quality of ultrasound-based
fetal growth monitoring. Effective coverage of screening for hypertension and tetanus immu-
nization status, that can be provided to pregnant women without a laboratory or ultrasound in
the clinics were still associated with these infrastructure-related variables. Clinics with both a
laboratory and ultrasound had a higher effective coverage of hypertension screening due to
higher attendance rates in these clinics and relatively routine and non-invasive nature of tak-
ing blood pressure. The data available for this study could not shed light on the possible rea-
sons for lower effective coverage of a simple screening test for tetanus immunization status in
these better-equipped clinics.
In contrast to infrastructure-related factors, maternal sociodemographic characteristics
(maternal age at pregnancy registration, age at marriage, education and parity) were not signif-
icantly associated with effective coverage. Differences in effective coverage based on sociode-
mographic variables may be due to characteristics that were not available for our study. For
example, household income or expenditure are commonly used variables for equity analyses,
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but were not available from the clinical records. Other studies done in LMIC have reported dif-
ferences in the quality of ANC provided to clients based on their socioeconomic characteristics
[16, 41]. These studies used data from household surveys and may have been able to capture
populations across social, economic and demographic gradients, compared to our study using
only facility-based data of women that receive ANC in public clinics.
In this study, we have presented one approach to the generation of effective coverage using
facility-based data. For comprehensive health systems monitoring, such assessments capturing
the timing and frequency of care may be used to complement the deficiencies of population-
based survey data [23, 42]. Given the availability of routine health facility data from the newly
implemented eRegistry in Palestine, health systems monitoring through such metrics is more
feasible than with paper-based systems. Inferences derived from our analysis can provide pol-
icy-makers with information on some health system factors for consideration to increase effec-
tive coverage in public clinics. The eRegistry has incorporated several features designed to
increase the level of effective coverage in this population. Specifically, interactive checklists
with clinical decision support and automated dashboards providing performance feedback for
care providers, can support the provision of complete ANC interventions, while tailored SMS
messages to pregnant women, can encourage better uptake of ANC [29].
A limitation of this study was that only documented care was analyzed. Interventions may
have been provided without documentation, but for many of these interventions, undocu-
mented screening will be ineffective screening for the purpose of appropriate follow-up during
pregnancy. Women may also have received additional targeted tests based on symptoms, as
per care providers’ clinical judgements, and subsequently not been re-screened at the time rec-
ommended by the guidelines. Such targeted tests may represent reasonable substitutes for rou-
tine screening, but would have been missed in our analyses. Effective coverage indicators of
screening at specified timings will change over time, as the optimal number and timing of
ANC contacts, as well as ANC content, continues to be a matter of debate and subject to evalu-
ation [14, 43–45]. Similar to health systems in other countries in the region [23], pregnant
women in the West Bank reportedly seek ANC from private providers and non-governmental
organizations, sometimes in addition to receiving ANC from public health facilities. Therefore,
the results of this study may not be indicative of the totality of effective coverage of ANC at the
population-level in the West Bank, and cannot necessarily be used to estimate how changes in
effective coverage in the public health system alone will impact maternal and neonatal health
outcomes.
Conclusion
The choice and definitions of metrics can have substantial impact on health systems monitor-
ing of ANC, both in terms of ascertaining the magnitude of the problem as well as identifying
potential solutions. Effective coverage of ANC interventions in public primary healthcare clin-
ics in the West Bank can be increased by improving the timely and complete provision of
ANC interventions. Further exploration of specific aspects of care provision in primary health-
care clinics such as care providers’ adherence to guidelines and women’s perceptions and utili-
zation of of ANC services in public clinics, can help address these issues to increase effective
coverage of ANC interventions.
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Additional file to paper II 
Effective coverage and maternal sociodemographic variables 
Table: Effective coverage (%) of essential ANC interventions across sub-groups based 




Effective coverage (%, 95% CI) 
Screening for 
hypertension  
SFH  Screening 
for anemia 















Age (years)         
<=20 8 5 15 27 32 48 71 33 
21-34 11 5 14 27 33 41 63 35 
>=35 12 6 16 30 38 42 61 38 
Education 
(years) 
        
<10 10 5 12 30 34 41 67 37 
10-13 10 6 16 27 34 42 68 37 




        
<20 11 5 14 27 33 44 67 35 
>20 10 6 15 28 33 41 60 34 
Parity         
0 10 6 15 27 29 44 67 33 
1 – 4  10 5 14 26 35 41 62 36 
≥4 13 6 12 33 41 44 62 35 











Table: Associations of effective coverage and maternal sociodemographic variables: 




Adjusted OR (95% CI) ¥ 
Screening for 
hypertension  


















Age (years)         
<=20 1 1 1 1 1 1 1 1 


































        
<10 1 1 1 1 1 1 1 1 



































        
<20 1 1 1 1 1 1 1 1 
















Parity         
0 1 1 1 1 1 1 1 1 
































¥derived from multivariable logistic regression analyses including all infrastructure-related and maternal 
sociodemographic variables: laboratory and ultrasound availability, maternal age at pregnancy registration, 
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Abstract
Background: Policy making in healthcare requires reliable and local data. Different sources of coverage data for
health interventions can be utilized to populate the Lives Saved Tool (LiST), a commonly used policy-planning tool
for women and children’s health. We have evaluated four existing sources of antenatal care data in Palestine to
discuss the implications of their use in LiST.
Methods: We identified all intervention coverage and health status indicators around the antenatal period that could
be used to populate LiST. These indicators were calculated from 1) routine reported data, 2) a Multiple Indicator Cluster
Survey (MICS), 3) paper-based antenatal records and 4) the eRegistry (an electronic health information system) for
public clinics in the West Bank, Palestine for the most recent year available. We scaled coverage of each indicator to
90%, in public clinics only, and compared this to a no-change scenario for a seven-year period.
Results: Eight intervention coverage and health status indicators needed to populate the antenatal section of LiST
could be calculated from both paper-based antenatal records and the eRegistry. Only two could be calculated from
routine reports and three from a national survey. Maternal lives saved over seven years ranged from 5 to 39, with
percent reduction in the maternal mortality ratio (MMR) ranging from 1 to 6%. Pre-eclampsia management accounted
for 25 to 100% of these lives saved.
Conclusions: The choice of data source for antenatal indicators will affect policy-based decisions when used to
populate LiST. Although all data sources have their purpose, clinical data collected directly in an electronic registry
during antenatal contacts may provide the most reliable and complete data to populate currently unavailable but
needed indicators around specific antenatal care interventions.
Keywords: Lives Saved Tool (LiST), Antenatal care indicators, Priority setting in maternal and child health, Data for
policy-making
Background
Setting effective and appropriate national, sub-national or
sector-wide policies is a complex endeavor for health
systems everywhere. Investigations of priority setting at
national levels have demonstrated a high degree of simi-
larity; critically, a unified understanding of the importance
of the health problem is vital [1, 2]. A common complaint
among policy makers is the inability to trust the evidence
and data, especially when international and local numbers
differ [3]. As a result, consistent sources of high quality and
trustworthy data, tailored to the local context to inform
planning processes, have proven to be a clear gap [4].
High quality data can be used at different points in the
policy planning cycle, including for informing discussions
as well as projecting the impacts of potential decisions,
both of which are commonplace activities. The Lives
Saved Tool (LiST) is a policy planning tool which utilizes
information on the current health status of a country to
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project the health (mortality) implications of implement-
ing specific health interventions for women or children
[5]. LiST has been used for over ten years for evaluation,
advocacy and strategic planning [6], across a wide variety
of settings [7, 8]. An unsurprising criticism of LiST is the
quality of data available to populate it [9] – in many
instances, significant assumptions and estimations are re-
quired given the lack of primary data [10]. For any model-
ling tool, as for any policy setting process, high quality
data is required to ensure that the results are accurate
enough for usability [9].
LiST requires health status indicators (such as mortal-
ity and morbidity), effectiveness data (impact of inter-
ventions on health status), and coverage indicators
(levels of utilization of health interventions). The cover-
age indicators required to populate LiST come from a
variety of sources, including national statistics, house-
hold surveys, facility surveys and research studies, and
are less amenable to global evaluation and summarizing
due to variability in the implementation of many of these
interventions. Few countries have routine high quality
data on effective coverage (proportion of those getting
an intervention among those in need) for assessing all
aspects of their health system within the LiST structure.
The frequency and quality of routinely reported data
from health systems vary by topic and country, leaving
alternative sources of data necessary. Many countries
rely on externally funded, population-based surveys such
as UNICEF’s Multiple Indicator Cluster Survey (MICS)
[11] and the Demographic and Health Surveys (DHS)
[12] to collect service related data by asking women to
remember the care received during their most recent
pregnancy [13], often up to 2–5 years in the past.
The ever-expanding arena of information technology
and digital registries has the potential to improve data
availability around interventions delivered during ante-
natal care, childbirth and the postpartum period [13].
‘eRegistries’ are electronic registries used at the point of
care for recording health services delivered [14]. They
are specifically designed to facilitate implementation of
several digital health interventions such as: decision
support tools, and audit and feedback (to aid health care
workers in providing quality care); tailored behavior
change communication text messages (to encourage
women to attend care); and reporting (to provide aggre-
gate data for health system managers and policy
makers). An eRegistry for antenatal, postpartum and
newborn care has been rolled out in primary health care
clinics in the public sector in Palestine as part of a
national implementation [15].
The validity of LiST outputs and results is closely
linked to the kind of data that is input [5]. However, few
studies have assessed the nature and magnitude of con-
sequences to LiST results when using different sources
of data. Users of LiST should be aware of such conse-
quences to make informed decisions about intervention
effectiveness when considering scale-up. Our objective
was to model the scale up of antenatal care interventions
in LiST, using all available data sources in Palestine –
routine data, survey results, extracted medical records
and the eRegistry, to explore how the results might vary,




This secondary data analysis utilized multiple sources of
health information for modeling mortality and morbidity
impacts of scaling up coverage of routine health inter-
ventions delivered during the antenatal period in the
Lives Saved Tool.
Indicators for the Lives Saved Tool
We identified all coverage and health status indicators
needed to fully model antenatal care in the Lives Saved Tool
(LiST). For each of those indicators, we then selected those
that were: 1) relevant to the population in the West Bank
and 2) available in any of the known data sources. Malaria,
HIV/AIDS and syphilis indicators were not considered as
these are not common health issues in the Palestinian popu-
lation. Neither calcium supplementation nor balanced en-
ergy supplementation were part of the national guidelines
recommended for the public health system in the West
Bank, and were not considered. Although mortality data
were also needed, they were not extracted from any of the
data sources; identical default mortality data from the World
Health Organization and LiST were used for all analyses.
Data sources
Routine reporting data
Routine data for 2016, as reported by clinical workers,
were available for the West Bank, including number of
women attending antenatal care at public vs. other
centers [16].
Population based survey data
The most recent population-based survey in Palestine
which included antenatal care data was the 2014 Mul-
tiple Indicator Cluster Survey, published in 2015 [17].
As part of this population-weighted survey, a nationally
representative sample of women were asked about
utilization of antenatal care, including the location and
type of tests performed for pregnancies completed
within the past 2 years. Using the published weights, we
calculated the proportion of women attending antenatal
care at public facilities. All data from live births in the
West Bank were included in this analysis; no available
records were excluded for any reason.
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Data from antenatal records
Paper-based records In preparation for the national
implementation of the eRegistry in Palestine, all ante-
natal records from 17 primary healthcare clinics in five
districts in the West Bank were extracted for the year
2015, for a total of 1369 pregnancies [18]. The clinics
were randomly selected to be representative of the dis-
tricts where the first phase of the national implementa-
tion would take place. There were no individual
inclusion or exclusion criteria; records from all pregnant
women were extracted. Clinical data were extracted
from the paper-based records and entered into elec-
tronic data entry forms that were identical to the data
entry forms of the eRegistry (see below). Quality checks
of data entry were carried out; 10% of all paper-based re-
cords were entered twice by the data extractors.
eRegistry data Care providers at public antenatal clinics
in 76 facilities in five districts in the West Bank directly en-
tered antenatal care records into an eRegistry throughout
the year 2017. These clinics include all the primary health
care clinics in the same five districts as the paper-based rec-
ord extraction. There were no individual inclusion or exclu-
sion criteria; records from all pregnancies entered into the
eRegistry were included in the analysis. Records with no
valid data entered were excluded. We used this data for all
pregnant women registered on or after January 1, 2017 and
passed 44 weeks of gestation as of 30th of April 2018.
Differences between the paper and eRegistry records
Although the paper extraction and the eRegistry were de-
signed to be identical, differences did exist; specifically, they
contained notably different data on iron-folate supple-
mentation (Table 1). In the paper records, a single data
point recorded whether iron-folate supplements were given.
In the eRegistry, integrated clinical decision support
reminded the care provider of the specific dose of
iron-folate required, and care providers documented
whether or not the suggested management was performed.
Calculation of LiST indicators from paper-based and
eRegistry antenatal record data For LiST analyses,
management indicators require data on 1) the propor-
tion of women eligible for screening (including seeking
care) who were screened correctly and at the correct
time, and 2) the proportion of those identified who were
correctly managed, among those that had a positive
screening test (Fig. 1). This reflects the proportion of
women who truly had a condition and were correctly
managed of those that attended care at public facilities
(Fig. 1).
In the West Bank, diabetes screening consists of urine
sugar testing of all pregnant women at the booking ante-
natal visit, a blood sugar test at 24–28 gestational weeks
for those not already positive, and a glucose challenge test
based on blood sugar test results (Fig. 1). For women with
a result greater than 140mg/dl on the glucose challenge
test, correct management is referral. Hypertension screen-
ing requires serial blood pressure measurement at all ante-
natal care visits. For mild hypertension, recommended
management includes urine protein testing. Screening for
pre-eclampsia requires a urine protein test following
measurement of hypertension after 20 weeks gestation.
Referral is the recommended management for women
with chronic hypertension, moderate or severe gestational
hypertension, hypertension with proteinuria or symptoms
of preeclampsia. We assumed correct management for all
correct referrals regardless of whether women sought that
additional care at the referral facility or not. We also as-
sumed equitable screening and management of all preg-
nant women irrespective of health or socio-economic
characteristics. Figure 2 contains a worked example of
how the indicator for diabetes management was
calculated, based on the construction in Fig. 1. Additional
File 2 displays the detailed calculations. All data are avail-
able upon request.
For indicators unable to be calculated directly from
the data sources, we utilized the Kanyangarara method
[19], developed specifically to utilize distal determinants
to predict coverage for LiST.
Lives Saved Tool analyses
LiST (version 5.71; Avenir Health) predicts the number
of deaths and anemia cases that would have occurred
under a given population and health scenario, combined
with coverage of health interventions and how they
change over time [20]. We compared two national level
scenarios: 1) a steady state scenario from 2017 to 2025
and 2) a scenario where coverage of antenatal care inter-
ventions increased to 90% from baseline in public facil-
ities only (with no change in other facilities) in 2018,
and then remained at a steady state through 2025. The
primary result is the difference in the number of deaths
and anemia cases during 2018–2025 between the two
scenarios. All sources reported data from slightly differ-
ent time periods, and to mimic a typical situation, we
applied the most recently available data to the year 2017.
We assumed that the quality of care delivered to women
attending both public and other facilities was constant.
The proportion of women attending antenatal care in
public facilities for the MICS analysis came directly from
the survey itself. For LiST analyses using the other three
data sources, we used the routinely reported estimates of
the proportion of women attending public facilities. Over
time, we assumed no change in the proportion of women
attending public vs. other clinics nor in the quality of care
provided at other clinics.
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Results
Data to indicators
The coverage and health status indicators available for
input in LiST are presented in Table 1 along with the
exact definitions and calculations for each data source.
The number of women managed with diabetes or
pre-eclampsia were available from the routine data, al-
though incidence values were not available. To allow this
analysis to proceed, we required a source of incidence,
which we derived from our medical record (paper-based)
review. Indicators of management of diabetes, hyperten-
sive disorders and pre-eclampsia were not available from
the MICS. They were indirectly calculated using the
Kanyangarara method [19] (Additional File 1). Although
available in some MICS, the Palestinian survey did not
include indicators related to tetanus vaccination or iron
supplementation. Although data on symphysis-fundal
height measurement were available in both the
paper-based records and eRegistry data, management
data were not; identification and management of fetal
growth restriction was not calculated for any source.
Data from paper-based records and the eRegistry
included all pregnancy indicators of interest. Women
with moderate or severe hypertension or potential
pre-eclampsia are referred to hospitals and do not return
to the primary care clinics for ANC management; as a
result, the proportion of women correctly identified and
managed with pre-eclampsia may be incomplete. In
addition, the amount of missing data for tetanus toxoid
vaccination was notably different with 42% missing in
Fig. 1 Conversion of diabetes guidelines in Palestine into an indicator for the Lives Saved Tool (LiST)
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paper records and only 7% missing in the eRegistry,
although missing data proportions were much more
similar in the two data sources for other indicators.
Five coverage indicators and three health status indica-
tors for the West Bank could be calculated from the four
sources of antenatal care data (Table 2). The routinely
reported data populated two coverage indicators and
none of the health status indicators, while the MICS
data could directly populate none of the coverage or
health status indicators. The MICS data could be used
to indirectly calculate three of the coverage indicators.
Data from paper-based antenatal records and the eRegis-
try were used to calculate all five of the coverage indica-
tors and all three of the health status indicators.
LiST analysis
Table 3 summarizes the baseline and target inputs to a
national level LiST analysis with coverage of appropriate
care in public West Bank clinics increased to 90%, as-
suming no change in the proportion of women attending
public facilities and no change in quality of care pro-
vided at other facilities. When we used routinely re-
ported data or MICS data as the source for LiST
analyses, increasing coverage would lead to no newborn
deaths or anemia cases being averted (Table 4). Using
routinely reported data, the LiST analysis estimated that
16 maternal deaths and 239 stillbirths would be averted.
Using MICS data, LiST suggested that far fewer maternal
deaths and stillbirths would be averted (Table 4). In con-
trast, the LiST analysis using individual level data from
both the paper-based antenatal care records or the eReg-
istry led to comparable estimates of more maternal
deaths potentially being averted, and that improving the
quality of care in Palestine would also avert a number of
newborn deaths. While LiST analyses based on routine
data and MICS would be unable to identify a reduction
in anemia cases by improving anemia prevention, both
sources of individual level data suggested significant
gains from better prevention.
The specific interventions resulting in these deaths
being averted were similar across data sources, with
tetanus toxoid preventing all newborn deaths and iron
folate supplementation preventing all anemia morbidity.
The lack of data on hypertension management in the
routine data resulted in all deaths being averted by
pre-eclampsia management, while only 25% were pre-
vented by pre-eclampsia management using the MICS
data. Both data from paper-based records and the eReg-
istry suggested a similar proportion of maternal deaths
being averted by pre-eclampsia management and hyper-
tensive disorders management. Stillbirths were predom-
inantly averted by pre-eclampsia management with a
varying proportion averted due to diabetes management,
based on the source utilized (Table 4).
Discussion
Data for decision-making is a common cry in public
arenas. However, not all data are the same, and the im-
plications of using the various alternative data sources
available can be significant, especially when multiple
choices exist, such as in the case of Palestine. Selection
of data source can be even more critical when used as
inputs into a formal analytic framework, as many policy
Fig. 2 Worked example of converting diabetes screening and management practices into indicators for Lives Saved Tool (LiST)
Table 2 Summary of indicator availability by source
Routine Data MICS Paper records eRegistry
Coverage Directly 2/5 0/5 5/5 5/5
Indirectly* 0/5 3/5 0/5 0/5
All 2/5 3/5 5/5 5/5
Health status 0/3 0/3 3/3 3/3
*Using the Kanyangarara method [19]
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makers do not see the raw data but only the results of
the processing, assumptions, estimates, and analysis.
Global agencies and research teams publish consensus
estimates of mortality with uncertainty bounds, but esti-
mates of health intervention coverage show more vari-
ability and are less widely available in general. The
availability of new sources of local and timely data and
indicators is likely to increase as countries shift towards
digital data and case-based collection methods. The
evaluation of these new data sources is critical to assess
their potential for improving the care being delivered
and to appropriately inform planning processes.
In this analysis, the four data sources yielded notably
different results when utilized in LiST. The maternal
deaths averted ranged from 5 to 39, or a reduction of
maternal mortality from 1 to 6%. At the same time, the
composition of interventions to save these lives varied
from 100% for pre-eclampsia management to 75% for
hypertensive disorders management. These differences
would likely result in different policy and practice deci-
sions being taken. Similar, but less dramatic differences
could be seen in newborn, stillbirth, and anemia results
using the different data sources. Although the absolute
differences were relatively small in this particular con-
text, they would be magnified greatly in countries and
settings with higher mortality and morbidity rates, or if
interventions beyond antenatal care were included.
The power of the Lives Saved Tool can be maximized
when data of better quality and quantity are available to
populate it. However, in most country settings, several
data points are not directly available in either routine re-
ports or household surveys. Drawing data directly from
clinical records allows for a more complete and complex
picture of antenatal care and covers almost all data
needs. Many surveys, such as the MICS, only include
data from live-births [17], thus excluding data on women
who experienced stillbirths or miscarriages and their po-
tentially complicated pregnancies. Another aspect of
clinical data, not present in most survey or routine data
sources, is the longitudinal perspective within a preg-
nancy. Longitudinal analyses across periods of time and
healthcare contacts allow the ability to include only
Table 3 National level Indicators from all sources used as inputs in the LiST analysis
Reporting Survey Antenatal Records
Analysis Indicators Routine
(2016)
MICS (2014) Paper (2016) eRegistry
(2017)
National baseline (applied to 2017) % of all pregnant women who have completed
the appropriate tetanus toxoid vaccination schedule
NA NA 85.4 92.1
% of pregnant women taking the appropriate iron
or folate supplementation
NA NA 90.3 64.4
% of women with hypertensive disorders in
pregnancy who are correctly managed
NA 68.9† 15‡ 35‡
% of women with diabetes with appropriate
case management
71.9 35.1† 7‡ 10‡
% of women with pre-eclampsia during pregnancy
who are correctly managed
51.7 72.9† 11‡ 14‡
Anemia 27* 27* 37.3 37.7
Severe anemia 0.272* 0.272* 0 0.1
BMI 3.1* 3.1* 2.8 4.4
National target assuming 90%
coverage in public sector
(applied to 2018–2025)
% of all pregnant women who have completed
the appropriate tetanus toxoid vaccination schedule
NA NA 92,0 95,7
% of pregnant women taking the appropriate iron
or folate supplementation
NA NA 94.7 80.6
% of women with hypertensive disorders in
pregnancy who are correctly managed
NA 75.5† 53.6 64.5
% of women with diabetes with appropriate
case management
84.7 47.3† 49.2 50.9
% of women with pre-eclampsia during
pregnancy who are correctly managed
73.6 74.5† 51.4 50.9
Anemia 27.2* 27.2* 37.3 37.7
Severe anemia 0.272* 0.272* 0 0.1
Body mass index (BMI) 3.1* 3.1* 2.8 4.4
*LiST defaults: Finucane 2011 [28], Stevens 2013 [29]; †Using the Kanyangarara method [19] ‡See Additional File 2 for details
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managements based upon true conditions, ensuring that
only appropriate and correct referrals are included in
the calculation rather than all referrals. An ideal data
source for complex indicators would be longitudinally
collected at the point-of-care to minimize the need for
post data-collection processing. This would ensure that
both numerators and denominators were collected sim-
ultaneously, and mitigate issues from recall bias of either
care providers or mothers. In addition, one of the largest
criticisms of the Lives Saved Tool is the quality of esti-
mates around maternal mortality. The current use of in-
direct estimates greatly increases the likely uncertainty
around the LiST estimates of maternal mortality. These
results should increase the validity and reliability of fu-
ture analysis with such data, simply because fewer as-
sumptions will be needed.
The paper-based routine health information systems in
Palestine, as in many other places, rely on care providers
identifying key characteristics about patients and report-
ing to district and national health authorities, who ag-
gregate and process the data to generate national
indicators. The validity of any individual diagnosis is
unknown. This additional reporting burden on care
providers limits the ability to demand reporting of a
comprehensive set of clinical data, and thus results in a
reporting system focused on only the highest priority in-
dicators. Complex health conditions and reporting
chains can lead to either over- or under-reporting. For
example, knowing the number of women referred for
diabetes is useful, but does not indicate the proportion
of women correctly diagnosed with diabetes or appropri-
ately referred, leaving the system unable to rectify under-
lying problems. To create more actionable indicators,
providers would need to document every diabetes test,
the number of women positive and the number referred
according to recommended guidelines. This extensive
task is not likely to be a valuable use of time in a
paper-based system. The routine system in Palestine also
relies on reporting by two different levels of clinics
(primary and referral), which makes it difficult to ensure
that women are correctly included only once, in either
the numerator or denominator, potentially leading to
biases. Routine reporting data should be limited and
focused on critical indicators that cannot be collected
easily in clinical data sources or those needed to triangu-
late with other sources.
Table 4 Morbidity and mortality results
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Typically, the primary source of coverage data used in
LiST is household survey data, such as the MICS pre-
sented here. However, very little data are available from
these surveys to directly populate antenatal care (or
childbirth care) indicators. Information on antenatal ser-
vices received or antenatal care attendance can be used to
indirectly calculate several other indicators. However, these
estimates are dependent on maternal recall, which may be
biased towards experiences of women with difficult preg-
nancies who would tend to remember care more com-
pletely relative to uneventful pregnancies and deliveries,
while excluding pregnancies ending in stillbirth or miscar-
riage. Although these indirect indicators (together with
non-antenatal care indicators) can be useful for planning,
these surveys are typically conducted only every five years
making their input less timely for shorter-term planning or
course-correction. Additional questions should be asked
about the utility of these indirect estimates (which were for-
mulated with sub-Saharan African data) when compared to
actual values extracted from antenatal care records. If the
Kanyangarara formula is applied to the paper-based ante-
natal records and the eRegistry, respectively, approximately
62 and 61% of women are estimated to be correctly
managed for hypertension while the clinical data indi-
cated that only 7 and 10% were correctly managed.
The differences were much smaller for the diabetes
management indicator which were predicted to be 29
and 31% respectively, while the actual clinical values
were 13 and 35%, respectively.
Data extracted from paper-based antenatal care re-
cords and the eRegistry contained the greatest quan-
tity of data for direct analysis. They also allowed for
computing indicators that most closely matched the
ideals of the Lives Saved Tool (Table 3). Although
differences in documentation may account for the dif-
ferent values reported, it should also be noted that
indicators from the eRegistry document more care-
fully the details around management, which are not
typically recorded in the paper records, and thus
should theoretically be a more precise indicator of
correct management. The simplified single checkbox
of any iron-folate supplementation in paper records
may have over-estimated current performance as the
LiST analysis estimated more than two-fold higher
numbers of anemia cases being averted in the
eRegistry-based analysis compared with paper records.
Assuming that care providers are correctly completing
their documentation, these results should be more
valid and more reliable than survey based data or
routine reporting with the multiple additional layers
of data processing required. They are certainly more
direct estimates that have the potential to be more
representative of facility care since they also include
all pregnancies, not just all live-births.
Extracting data from paper-based records on a regu-
lar basis is neither feasible nor sustainable for routine
monitoring due to the expense and tardiness of such
a system, and without the quality assurance routines
used in this study, also by the likelihood of transcrip-
tion errors. In addition, paper records can be incom-
plete and do not have built-in validations at data
entry, as seen with the tetanus toxoid vaccination
data.
Although the development of an eRegistry is
time-consuming and resource-intensive, and up-front
implementation costs are relatively high, the benefits
can be wide-ranging by integrating multiple digital
health interventions in a single system. In Palestine,
the point-of-care data entry currently serves as an
interactive checklist with clinical decision support,
with integrated audit and feedback components and a
reminder system for pregnant women. On the
back-end, the system routinely generates key indica-
tors at national, sub-national and clinic levels without
requiring burdensome reporting.
A limitation of the eRegistry system in Palestine is
that it is currently only available in public sector facil-
ities and does not include private or non-governmental
organization (NGO) facilities, nor public hospitals.
Population coverage cannot be measured with the
eRegistry data in this setting. Although the lack of data
from private and NGO facilities does not affect the ana-
lysis of care delivered at public facilities, LiST analysis
might predict larger health improvements than actually
could occur, due to missing data on referred patients
who seek care in external facilities. At the same time,
population based surveys can provide the data needed
to understand the flow of patients between public and
private or NGO sectors and thus act as a calibration of
the clinical data, in conjunction with routine reported
data. The lack of data from any of the hospitals also
limited the ability to define the interventions in terms
of full quality of care at referral centers. However, it is
likely that adding this information would only decrease
the proportion of women correctly managed.
Conclusions
This study has clearly demonstrated the notable variabil-
ity of information available for decision making based on
the data source chosen in Palestine. Selection of the
most complete and appropriate data source for policy
and planning is critical. Many frameworks have been de-
veloped that attempt to characterize the features of pri-
ority setting and networks for informing policy decisions
[21–24]. Studies have evaluated the barriers and facilita-
tors to evidence-based decision making at national and
local levels, and systematic reviews have described systems
for incorporating research evidence into decision-making
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and less frequently, described the utilization of burden of
disease data in decision-making [25, 26]. This paper feeds
the discussion around how to support evidence informed
decision-making at national levels by outlining the pros
and cons of various data sources. We demonstrated the
significant data driven benefits for the health system from
utilizing data automatically extracted from a digital regis-
try of health contacts – both in terms of quantity and
quality. These distal benefits of an eRegistry along with
more immediate clinical benefits to care providers and cli-
ents can also be used to inform a cost-benefit analysis for
implementing complex health system interventions.
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Additional file 2: Detailed calculations of coverage indicators from
paper records and from the eRegistry. This file contains the detailed and
stepwise calculations of the hypertension, pre-eclampsia and diabetes
coverage indicators calculated from both the paper records and the
eRegistry. (XLSX 52 kb)
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Diabetes Proportion of women with diabetes  who are both 
diagnosed and treated i f needed
-3,21 2,61 95,5 97,6 97 34,0
Hypertens ion Proportion of women with pregnancy induced 
hypertens ion who are both diagnosed and trea ted 
i f needed
-1,62 2,5 95,5 97,6 97 69,1
Pre-eclampsia Proportion of women with pre-eclampsia who are 
both diagnos ed and treated i f needed
-6,44 2,56 4,91 95,5 97,6 97 68,9
Diabetes Proportion of women with diabetes  who are both 
diagnosed and treated i f needed
-3,21 2,61 61,3 89,5 85,2 29,4
Hypertens ion Proportion of women with pregnancy induced 
hypertens ion who are both diagnosed and trea ted 
i f needed
-1,62 2,5 61,3 89,5 85,2 62,5
Pre-eclampsia Proportion of women with pre-eclampsia who are 
both diagnos ed and treated i f needed
-6,44 2,56 4,91 61,3 89,5 85,2 38,3
Diabetes Proportion of women with diabetes  who are both 
diagnosed and treated i f needed
-3,21 2,61 53,5 91,9 83 30,8
Hypertens ion Proportion of women with pregnancy induced 
hypertens ion who are both diagnosed and trea ted 
i f needed
-1,62 2,5 53,5 91,9 83 61,2
Pre-eclampsia Proportion of women with pre-eclampsia who are 
both diagnos ed and treated i f needed
-6,44 2,56 4,91 53,5 91,9 83 36,4
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1st visit less than 20 weeks
Urine Sugar Positive Random BS Positive Refer
Normal Normal
24-28 week visit Blood sugar Refer
GCT Positive Refer
Normal Normal





74 % 65 % 1 % 62 % 31 % 100 % 13,4072          4 4
total pregnant women Number attend ANC <20 weeksUrin  test Positive Blood test Positive refer










1128 s2% Prop Pos2
not attend < 20 weeks 6 % 21 % 78 %
1153 Prop Pos1 s2% Prop Pos2
11 % 7 % 29 %





67 % 61 % 2 % 100 % 100 % 75 % 213,2              36,0                 19
Available to attend visit 
24-28 number attend 24-28 blood test postitve Refer
4399 2932 1786 32 32 32 16 17 % 8 % 75 % 46 %
not referred
16
intermediate GCT Positive Refer 78,8174692


















18 % 227                  40                    23
Overall management proportion
58 % 18 % 18 % 58 %
Appropriate screening and management of diabetes
List Input 10 %

















Hypertension – eRegistry data  
 
 
Booking BP High refer <=14 weeks Eligible
Normal
16 visit BP High Refer >=15 & <=17 weeks
Normal
18-22 visit BP High Refer >=18 & <=23
Normal
24-28 visit BP High refer >=24 & <=29
Mild urine protein refer
Normal
32 visit BP High refer >=31 & <=34
Mild urine protein refer
Normal
36 visit BP High refer >=35 & <=38
Mild urine protein refer
Normal
Attend % S1% Prop Pos M
57 % 99 % 2,5 % 97 % 96 %
Number attend booking prior to 16 wksBP measure High Refer
4386 2480 2450 61 59
No test True Pos obs Pos Man
2 109             61 59
Negative
2389 56 % 56 % 97 %
no test
30
not attend  booking early
1906
Attend % S1% Prop Pos M
35 % 98 % 2 % 63 % 61 %
number attending 16 wk visitBP measure High Refer
4327 1494 1467 24 15
No test True Pos obs Pos Man
9 71               24 15
Negative
1443 34 % 34 % 63 %
no test
27
not attend  16 week
2833
57 % 99 % 1 % 27 % 26 %
number attending20 wk visitBP measure High Refer
4312 2467 2434 15 4
No test True Pos obs Pos Man
11 27               15 4
Normal
2419 56 % 56 % 27 %
No BP
33
not attend  20 week s2% Prop Pos2
1845 0 % 83 % 30 % 0 %
Prop Pos1 s2% Prop Pos2 M
0 % 80 % 13 % 0 %
Attend % S1% Prop Pos1 S2% Prop Pos2 M
60 % 98 % 0 % 100 % 100 % 0 %
number attend 24-28BP measure High Refer
4312 2592 2550 2 2 2 0
not referred
2 True Pos obs Pos
Mild Urine protein Positive Refer 5,5              3,0              0
10 8 1 0










not attend 24-28 s2% Prop Pos2
1720 0 % 59 % 20 % 50 %
Prop Pos1 s2% Prop Pos2 M
1 % 53 % 0 % 50 %
Attend % S1% Prop Pos1 S2% Prop Pos2 M
49 % 98 % 0 % 100 % 100 % #DIV/0!
number attend 32 weekBP measure High Refer
4311 2094 2059 2 2 2 1
not referred
1 True Pos obs Pos
Mild Urine protein Positive Refer 4,2              2,0              1
15 8 0 0










not attend 32 week s2% Prop Pos2
2217 1 % 59 % 41 % 67 %
Prop Pos1 s2% Prop Pos2 M
2 % 52 % 19 % 67 %
Attend % S1% Prop Pos1 S2% Prop Pos2 M
44 % 98 % 0 % 100 % 100 % 67 %
number attend 32 weekBP measure High Refer
4305 1903 1873 6 6 6 4
not referred
2 True Pos obs Pos
Mild Urine protein Positive Refer 27,2            9,0              6
31 16 3 2








No BP Overall Pos Overall Obs PosOverall Manage
30 243,4          114,0          85,0            
Not attend 36 week





Appropriate screening and management of hypertension
List Input 35 %
total pregnant women 
eligible for 36 week visit
total pregnant women ever 
registered
total pregnant women 
eligible
total pregnant women 
eligible for 18-22 week
total pregnant women 
eligible for 24-28 week visit
total pregnant women 
eligible for 32 week visit
 
Hypertension – paper-based clinical records data  
 
 
Booking BP High refer <=14 weeks Eligible
Normal
16 visit BP High Refer >=15 & <=17 weeks
Normal
18-22 visit BP High Refer >=18 & <=23
Normal
24-28 visit BP High refer >=24 & <=29
Mild urine protein refer
Normal
32 visit BP High refer >=31 & <=34
Mild urine protein refer
Normal
36 visit BP High refer >=35 & <=38
Mild urine protein refer
Normal
Attend % S1% Prop Pos M
56 % 87 % 2 % 18 %
Number attend booking prior to 16 wksBP measure High Refer
1369 769 669 11 2
No test True Pos obs Pos Man
9 23               11 2
Negative
658 49 % 49 % 18 %
no test
100
not attend  booking early
600
Attend % S1% Prop Pos M
34 % 95 % 1 % 20 %
number attending 16 wk visitBP measure High Refer
1367 465 444 5 1
No test True Pos obs Pos Man
4 15               5 1
Negative
439 32 % 32 % 20 %
no test
21
not attend  16 week
902
58 % 96 % 1 % 0 %
number attending20 wk visitBP measure High Refer
1366 794 766 6 0
No test True Pos obs Pos Man
6 11               6 0
Normal
760 56 % 56 % 0 %
No BP
28
not attend  20 week s2% Prop Pos2
572 0 % 67 % 0 % 0 %
Prop Pos1 s2% Prop Pos2 M
0 % 67 % 0 % 0 %
Attend % S1% Prop Pos1 S2% Prop Pos2 M
55 % 99 % 0 % 0 % 0 % 0 %
number attend 24-28BP measure High Refer
1366 752 741 0 0 0 0
not referred
0 True Pos obs Pos
Mild Urine protein Positive Refer -              -              0
3 2 0 0 0










not attend 24-28 s2% Prop Pos2
614 1 % 100 % 71 % 100 %
Prop Pos1 s2% Prop Pos2 M
1 % 0 % 0 % 100 %
Attend % S1% Prop Pos1 S2% Prop Pos2 M
42 % 97 % 1 % 100 % 100 % 0 %
number attend 32 weekBP measure High Refer
1361 572 552 4 4 4 4
not referred
0 True Pos obs Pos
Mild Urine protein Positive Refer 9,9              4,0              5
3 3 1 1 5










not attend 32 week s2% Prop Pos2
789 1 % 60 % 67 % 50 %
Prop Pos1 s2% Prop Pos2 M
1 % 0 % 0 % 50 %
Attend % S1% Prop Pos1 S2% Prop Pos2 M
42 % 96 % 1 % 100 % 100 % 0 %
number attend 32 weekBP measure High Refer
1359 572 549 4 4 4 2
not referred
2 True Pos obs Pos
Mild Urine protein Positive Refer 9,9              4,0              2
6 2 0 0 4








No BP Overall Pos Overall Obs PosOverall Manage
23 68,4            30,0            10,0            
Not attend 36 week





Appropriate screening and management of hypertension
List Input 15 %
total pregnant women 
eligible for 36 week visit
total pregnant women ever 
registered
total pregnant women 
eligible
total pregnant women 
eligible for 18-22 week
total pregnant women 
eligible for 24-28 week visit
total pregnant women 
eligible for 32 week visit
Pre-eclampsia – eRegistry data  
 
Booking BP High refer <=14 weeks Eligible
Normal
16 visit BP High Refer >=15 & <=17 weeks
Normal
18-22 visit BP High Refer >=18 & <=23
Normal
24-28 visit BP High refer >=24 & <=29
Mild urine protein refer
Normal
32 visit BP High refer >=31 & <=34
Mild urine protein refer
Normal
36 visit BP High refer >=35 & <=38
Mild urine protein refer
Normal
Attend % S1% Prop Pos M
57 % 99 % 2 % 97 %
Number attend booking prior to 16 wksBP measure High Refer







not attend  booking early
1906
Attend % S1% Prop Pos M
35 % 98 % 2 % 63 %
number attending 16 wk visitBP measure High Refer







not attend  16 week
2833
57 % 99 % 0 % 78 % 14 %
number attending20 wk visitBP measure ANY HBP > 20 wksUrine protein Positive Refer
4312 2467 2434 9 7 1 1
True Pos obs Pos Man
2                 1 1
Normal
2425 44 % 100 %
No BP
33
not attend  20 week s2% Prop Pos2
1845 0 % 83 % 10 % 0 %
Prop Pos1 s2% Prop Pos2 M
0 % #DIV/0! #DIV/0! 0 %
Attend % S1% Prop Pos1 S2% Prop Pos2 M
60 % 98 % 0 % 0 % 10 % 0 %
number attend 24-28BP measure ANY HBP Urine protein Positive Refer
4312 2592 2550 12 10 1 0
True Pos obs Pos
2                 1 0









not attend 24-28 s2% Prop Pos2
1720 0 % 50 % 0 % #DIV/0!
Prop Pos1 s2% Prop Pos2 M  
0 % 0 % 0 % 0 %
Attend % S1% Prop Pos1 S2% Prop Pos2 M
49 % 98 % 1 % 50 % 0 % 0 %
number attend 32 weekBP measure ANY HBP Urine protein Positive Refer
4312 2094 2059 16 8 0 0
not referred True Pos obs Pos









not attend 32 week s2% Prop Pos2
2218 1 % 55 % 22 % 50 %
Prop Pos1 s2% Prop Pos2 M
0 % 0 % 0 % 6 %
Attend % S1% Prop Pos1 S2% Prop Pos2 M
44 % 98 % 2 % 55 % 22 % 0 %
number attend 32 weekBP measure ANY HBP Urine protein Positive Refer
4310 1903 1873 33 18 4 2
not referred True Pos obs Pos
2 17               4 2







No BP Overall Pos Overall Obs PosOverall Manage
30 21,2            6,0              3,0              
Not attend 36 week





Appropriate screening and management of hypertension
List Input 14 %
total pregnant women 
eligible for 36 week visit
total pregnant women ever 
registered
total pregnant women 
eligible
total pregnant women 
eligible for 18-22 week
total pregnant women 
eligible for 24-28 week visit
total pregnant women 
eligible for 32 week visit
Pre-eclampsia – paper-based clinical records data  
 
Booking BP High refer <=14 weeks Eligible
Normal
16 visit BP High Refer >=15 & <=17 weeks
Normal
18-22 visit BP High Refer >=18 & <=23
Normal
24-28 visit BP High refer >=24 & <=29
Mild urine protein refer
Normal
32 visit BP High refer >=31 & <=34
Mild urine protein refer
Normal
36 visit BP High refer >=35 & <=38
Mild urine protein refer
Normal
Attend % S1% Prop Pos M
56 % 87 % 2 % 18 %
Number attend booking prior to 16 wksBP measure High Refer







not attend  booking early
600
Attend % S1% Prop Pos M
34 % 95 % 1 % 20 %
number attending 16 wk visitBP measure High Refer







not attend  16 week
902
58 % 96 % 1 % 0 % #DIV/0!
number attending20 wk visitBP measure ANY HBP > 20 wksUrine protein Positive Refer
1366 794 766 4 0 0 0
True Pos obs Pos Man





not attend  20 week s2% Prop Pos2
572 0 % 67 % 0 % 0 %
Prop Pos1 s2% Prop Pos2 M
0 % #DIV/0! #DIV/0! 0 %
Attend % S1% Prop Pos1 S2% Prop Pos2 M
55 % 99 % 0 % 0 % 0 % 0 %
number attend 24-28BP measure ANY HBP Urine protein Positive Refer
1366 752 741 3 2 0 0
not referred True Pos obs Pos









not attend 24-28 s2% Prop Pos2
614 0 % 100 % 33 % 100 %
Prop Pos1 s2% Prop Pos2 M  
0 % 0 % 0 % 33 %
Attend % S1% Prop Pos1 S2% Prop Pos2 M
42 % 97 % 1 % 100 % 33 % 0 %
number attend 32 weekBP measure ANY HBP Urine protein Positive Refer
1366 572 552 3 3 1 1
not referred True Pos obs Pos
0 2                 1 1









not attend 32 week s2% Prop Pos2
794 1 % 38 % 33 % 0 %
Prop Pos1 s2% Prop Pos2 M
0 % 0 % 0 % 0 %
Attend % S1% Prop Pos1 S2% Prop Pos2 M
42 % 96 % 1 % 38 % 33 % 0 %
number attend 32 weekBP measure ANY HBP Urine protein Positive Refer
1365 572 549 8 3 1 0
not referred True Pos obs Pos
1 7                 1 0







No BP Overall Pos Overall Obs PosOverall Manage
23 9,1              2,0              1,0              
Not attend 36 week





Appropriate screening and management of hypertension
List Input 11 %
total pregnant women 
eligible for 36 week visit
total pregnant women ever 
registered
total pregnant women 
eligible
total pregnant women 
eligible for 18-22 week
total pregnant women 
eligible for 24-28 week visit
total pregnant women 
eligible for 32 week visit
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